1: General Dermatology


Part 1
General Dermatology


COMMON WORK‐UPS, SIGNS, AND MANAGEMENT


Dermatologic Differential Algorithm


Courtesy of Dr. Neel Patel



  1. Is it a rash or growth?
  2. If it is a rash, is it mainly epidermal, dermal, subcutaneous, or a combination?

  3. If the rash is epidermal or a combination, try to define the characteristics of the rash. Is it mainly papulosquamous? Papulopustular? Blistering?


    After defining the characteristics, then think about causes of that type of rash: CITES MVA PITA:


    Congenital, Infections, Tumor, Endocrinologic, Solar related, Metabolic, Vascular, Allergic, Psychiatric, Latrogenic, Trauma, Autoimmune. When generating the differential, take the history and location of the rash into account.


  4. If the rash is dermal or subcutaneous, then think of cells and substances that infiltrate and associated diseases (histiocytes, lymphocytes, mast cells, neutrophils, metastatic tumors, mucin, amyloid, immunoglobulin, etc.).
  5. If the lesion is a growth, is it benign or malignant in appearance? Think of cells in the skin and their associated diseases (keratinocytes, fibroblasts, neurons, adipocytes, melanocytes, histiocytes, pericytes, endothelial cells, smooth muscle cells, follicular cells, sebocytes, eccrine cells, apocrine cells, etc.).

Direct Immunofluorescence (Dif)



















Diseases Where to biopsy
LE, MCTD, PCT, LP, vasculitis Erythematous border of active lesion/involved skin (avoid old lesions, facial lesions, and ulcers)
Pemphigus group, pemphigoid group, linear IgA Erythematous perilesional skin (avoid bullae, ulcers, and erosions)
DH Normal‐looking perilesional skin (0.5–1 cm away)
Lupus band Uninvolved, non‐photoexposed skin (buttock)

Source: http://www.mayoclinic.org/dermatology‐rst/immunofaqs.html


False positive/negative DIFs:


False negative in BP: (i) low yield of biopsy on distal extremity (esp. legs) (controversial) and (ii) predominantly IgG4 subclass of auto‐antibody (poorly recognized on DIF)


False positive in LE: chronically sun‐exposed skin of young adults


To increase DIF yield: transport in saline (reduces dermal background) – cannot do DIF on formalin‐fixed specimen


Workup Quick Reference Orders (guided by clinical presentation)























































































Acanthosis
nigricans
CBC/CMP, lipid panel, HgA1C, TSH, CEA, LH/FSH
Alopecia
(see “Alopecia Workup, p. 6–9 for further details)
CBC/CMP, Fe/TIBC/Ferritin, TSH, free and total testosterone, 17‐OH progesterone, VDRL,FSH, LH, DHEA‐S, ANA, ESR, prolactin, Vitamin D
Anetoderma CBC, ANA, anti‐dsDNA, anti‐SSA/B, TSH, RPR, Lyme titer, HIV, fasting AM cortisol, C3/C4/CH50, protein C/S, anti‐thrombin III, anti‐cardiolipin abs, lupus anticoagulant, B2‐glycoprotein
Angioedema CBC, C1 est inhib, C1,C2,C4
Hereditary: C1‐nl; C2,C4,C1 est inhib‐ ↓ (C1‐INH levels may be nl but nonfunctional)
Acquired: C1‐↓; C2,C4,C1 est inhib‐ ↓
CTCL CBC with peripheral smear (Sezary Prep), AST/ALT, LDH, CXR, HIV, HTLV‐1, CD4/8 flow cytometry (CD5, CD7, CD45RO, CD26: CTCL protocol)
Dermatitis herpetiformis anti TTG‐IgG, IgA > endomysial ab, anti‐Gliadin ab (IgG and IgA), total IgA, CBC, CMP, Vitamin D
Dermatomyositis Antisynthetase panel: (Anti‐Jo‐1 PL‐7, EJ, OJ
PL‐12), anti‐Mi‐2, CK, aldolase, LDH, CRP, anti‐SRP
PFTs, anti‐aminoacyl‐tRNA synthetases (interstitial lung disease (ILD) association), anti P‐155 (cancer association), anti‐CADM (ILD association), anti‐MDA5 (RA‐like associations)
Flushing 24‐hour urine 5‐HIAA and metanephrines, norepinephrine, VMA, prostaglandin D2, dopamine, tryptase, histamine, plasma VIP, UA, serotonin, calcitonin (if thyroid nodule)
Hypercoagulability and thrombogenic vasculopathy ANA, protein C/S, lupus anticoagulant, anti‐phospholipid ab, β2 glycoprotein ab, anti‐cardiolipin, hepatitis B/C, SPEP/UPEP, Factor V Leiden, prothrombin gene mutation, homocysteine level, MTHFR gene mutation
Hyperhidrosis (diffuse/sudden) CBC, HbA1c, cortisol, TSH, GH, serotonin, urine 5‐HIAA, urine 24‐hour catecholamines
LCV ROS neg: CBC, CMP, UA, ANA, HBV/HCV, Skin Bx +/‐ DIF
ROS pos: add ANCA, Cryo, ASO, HBV, ESR, RF, Complement, age‐appropriate cancer screening
MCTD Anti‐U1RNP, anti‐Ku, ANA, RF, CRP
PCOS Total and free testosterone, DHEA‐S, LH/FSH, sex hormone‐binding globulin, β‐HCG
PCT/
pseudoporphyria
HCV, Fe, 24‐hour urine porphyrins (Uro:copro> 8:1), CBC, LFT, lead levels, quantitative plasma porphyrins, stool porphyrins
Photosensitivity ANA, ENA (SSa/b)
Pruritus CBC/CMP, LFTs, TSH, bilirubin, CXR, UA, hepatitis B/C, peripheral blood smear, Fe, β‐HCG, ESR, HIV
SPEP/UPEP, stool ova and parasite, age‐appropriate cancer screening
Purpura CBC w/ peripheral smear, CMP, TSH, ANA, PT/PTT, bleeding time, c‐ANCA, p‐ANCA, SPEP/UPEP, cryoglobulins, vitamin K level, D‐dimer
Pyoderma gangrenosum CBC/CMP, UA, peripheral smear, ANA, RF, SPEP/UPEP, ANCA, antiphospholipid ab, RF, colonoscopy, Hep B/C
Recurrent furunculosis/carbunculosis Skin culture w/ gram stain, CMP, blood glucose, HIV, hepatitis B/C, CH50, peripheral smear, SPEP, IgG/IgM/IgE, nitroblue tetrazolium (if concern for CGD)
Sarcoidosis CBC, CMP, Ca+, Serum ACE level, 1,25 Vit D, PTH, Alk Phos, ESR, ANA, CXR, QuantiFERON Gold
Scleroderma/CREST syndrome Anti‐Scl‐70, ANA, anti‐Jo‐1, anti‐centromere, RNA, polymerase I/III, RF, esophageal motility, PFTs, BUN/creatinine
Sjogren’s syndrome ANA, anti‐Ro/La, CRP, RF, anti‐alpha‐fodrin ab
Syphilis RPR/VDRL – primary; FTA‐ABS – secondary
SLE CBC/CMP, ANA, anti‐smith, dsDNA, UA, BUN/creatinine, ESR, ENA panel, C3/C4/CH50
TEN Check for IgA deficiency if Tx = IVIG as GammaGard needed (IgA depleted):
IVIG 2–4 g/kg (total dose, divided over 2–5 d, see TEN protocol pg. 227
Urticaria CBC, IgE, anti‐FcεRI (CUI), sinus X‐ray, hepatitis B/C, TSH, anti‐TPO, anti‐thyroglobulin, H. pylori, cryoglobulins
In children often due to strep: Check ASO, Rapid Strep
Urticarial vasculitis ESR, C4/CH50, anti‐FcεRI (CUI), anti‐C1q, ASO, RF, ANA, UA, SPEP, Hep B/C, CRP, C3/C4/CH50
Vitiligo CBC, TSH/Free T4, anti‐thyroid peroxidase (TPO), fasting blood glucose, 25‐OH Vitamin D, B12/folic acid, anti‐parietal gastric cell antibody (APGC)

Source: Adapted from Comprehensive Laboratory Disease Workups. Graham PM, Wilchowski S and Fivenson D. Directions in Residency. Spring 2016, pp.1–4.

Diagram for management of acne displaying boxes labeled comedonal; papular/pustular; mixed: comedonal and papular/pustular; and cystic/scarring and boxes for their corresponding treatments.

Alopecia Workup






























Hair Duration % of hair Microscopic/hair pull
Anagen 2–6 yr 85–90 Sheaths attached to roots
Catagen 2–3 wk <1 Intermediate appearance (transitional)
Telogen 3 mo 10–15 Tiny bulbs without sheaths, “club” root
Exogen Active shedding of hair shaft
Kenogen Rest period after shedding telogen; empty follicle


  1. Associations

    1. Medications? Telogen effluvium associated medications: anticonvulsants, anticoagulants, chemotherapy, psychiatric medications, antigout, antibiotics, and beta‐blockers
    2. Hormones (pregnancy, menstruation, and OCPs)?
    3. Hair care/products?
    4. Diet (iron or protein deficiency)?
    5. Systemic illness/stress?

  2. Cicatricial or non‐cicatricial?

    1. Non‐cicatricial: Is hair breaking off or coming out at the roots? Is hair loss focal or diffuse?














      Breakage Coming out at roots
      Hair shaft defects, trichorrhexis nodosa, hair care (products, traction, and friction), tinea capitis, trichotillomania, anagen arrest/chemotherapy Telogen effluvium, alopecia areata, androgenetic, syphilis, loose anagen, OCPs
      Focal loss Diffuse loss
      Hair care (traction), tinea capitis, trichotillomania, alopecia areata, syphilis, hair shaft defects Telogen effluvium, anagen effluvium, androgenetic alopecia, hair shaft defects

    2. Cicatricial: Is biopsy predominately lymphocytic, neutrophic, or mixed?

      Classification of cicatricial alopecia












      Lymphocytic Neutrophilic Mixed


      • Lichen planopilaris/LPP (including classic, frontal fibrosing, Graham‐Little)
      • Central centrifugal cicatricial alopecia (CCCA)
      • Alopecia mucinosa
      • Keratosis follicularis spinulosa decalvans
      • Chronic cutaneous LE
      • Pseudopelade (Brocq)


      • Folliculitis decalvans
      • Dissecting cellulitis/ folliculitis


      • Folliculitis/acne keloidalis
      • Folliculitis/acne necrotica
      • Erosive pustular dermatosis

      Source: Adapted from Olsen EA, et al. North American Hair Research Society Summary of Sponsored Workshop on Cicatricial Alopecia. J Am Acad Dermatol. 2003;48:103–110.


  3. Associated hair fragility?

    Structural hair abnormalities by hair fragility










    Increased fragility No increased fragility
    Trichorrhexis invaginata (bamboo)
    Monilethrix
    Trichorrhexis nodosa
    Trichothiodystrophy
    Pili torti
    Loose anagen
    Pili annulati
    Uncombable hair (spun‐glass)
    Woolly hair
    Pili bifurcati
    Pili multigemini
    Acquired progressive kinking

    Source: Adapted from Hordinsky MK. Alopecias. In: Bolognia JL, Jorizzo JL, Rapini RP. Dermatology Vol. 1, Mosby; London. 2003, p. 1042.


  4. Pull test and hair mount

    1. Pull test – Telogen hairs in telogen effluvium, Anagen hairs in loose anagen syndrome. Helpful in identifying active areas in cicatricial alopecia or alopecia areata.
    2. Hair mount







































    Disorder Hair mount findings
    Monilethrix Beaded, pearl necklace, knots
    Trichorrhexis nodosa Fractures, paint brushes
    Trichorrhexis invaginata Bamboo/golf tee hair
    Trichothiodystrophy Trichoschisis, tiger‐tail on polarization
    Loose anagen Anagen hairs with ruffled cuticles and curled ends and lacking root sheaths
    Pili torti Flattened, 180° irregularly spaced twists
    Uncombable hair Pili canaliculi et trianguli, triangular in cross‐section
    Pili annulati Abnormal dark bands on polarization, air bubbles in cortex
    Elejalde Pigment inclusions
    Griscelli Pigment clumping
    Menkes Multiple – pili torti, trichorrhexis nodosa, trichoptilosis

  5. Hair count – helpful in quantifying hair loss

    1. Daily hair count: collect all hairs before shampooing (Normal <100)
    2. 60‐second hair count: comb for 60 seconds (Normal 10–15 hairs)

  6. Biopsy – helpful in persistent alopecia, may help determine if cicatricial alopecia

    1. 4 mm punch biopsy for horizontal sectioning

      1. Hair count: Caucasians should have ~40 total hairs (20–35 terminal, 5–10 vellus) while African‐Americans should have fewer (18 terminal, 3 vellus)* – assess catagen vs. telogen at the isthmus level and terminal vs. vellus at the infundibular level
      2. Look at terminal to vellus** hair ratio: Normal >4 (~7–10T: 1V) Androgenic <2–4T: 1V
      3. Look for characteristic findings: Alopecia areata: lymphocytes around anagen bulbs

        Trichotillomania: pigment casts, trichomalacia, catagen hairs, dermal hemorrhage


        Androgenetic alopecia: miniaturized follicles


  7. Labs – TSH, CBC, iron, TIBC, ferritin; consider RPR, ANA Check hormones (testosterone, DHEAS, and prolactin) – if irregular menses, infertility, hirsutism, severe acne, galactorrhea, or virilization

    Consider checking “nutrition labs” – Vitamin D, thiamine, zinc, total protein


Ethnic differences in hair
























Hair shaft structure Hair shaft cross‐section Others
African‐American Coiled, curved Elliptical, flattened Lowest water content, slower growth, fewer cuticular layers at minor axes (only 1–2 not 6–8), longer major axis, less dense, large follicles
Asian Straight Circular Largest follicular diameter; fewer eyelashes with lower lift‐up/curl‐up angles and greater diameter
Caucasian In between In between, oval More dermal elastic fibers anchoring hair

*Vellus hairs – true vellus hairs (small and lack melanin) and miniaturized terminal hairs – histologically identical.


Telogen effluvium – workup and treatment



  1. History: Medical/surgical; Stressors (stress scale 1–10), drugs, pregnancy, diet, weight loss/gain, metabolic/nutritional deficiency, endocrine dysfunction

    1. Drugs: majority of drugs implicated, important to determine change in dose, and history of adverse reaction

  2. Etiology:

    1. Normal hair cycle is asynchronous – each follicle is independent
    2. TE – altered follicular growth cycle shedding:

      1. Telogen shed > 35% loss – common
      2. Anagen shed > 80% loss – rare

    3. Immediate release – seen in fever, drugs, and stress
    4. Delayed release – prolongation of anagen phase, then synchronized telogen phase in postpartum female

  3. Labs: CBC, CMP, TSH, DHEAS, free and total Testosterone, Ferritin, Zinc, Vitamin D, Vit A, ANA, microsomal AB
  4. Physical exam/Bx:

    1. Look at scalp, eyebrow, eyelash, and body hair
    2. Hair pull test: pull 40–60 hairs at 3 areas, <6–10 pull is positive
    3. Look for nail changes
    4. Bx: >7–35% telogen hairs

  5. Treatments:

    1. Treat seb derm (healthy skin, healthy hair) – ketoconazole shampoo
    2. Treat deficiency: Biotin forte 3 with zinc, Vit D, iron supplement
    3. High DHEAs – use spironolactone
    4. Find and remove triggers
    5. Minoxidil 5% liquid or foam

Androgenic alopecia – workup and treatment



  1. Autosomal dominant – 23–28% prevalence
  2. Androgen influence on hair follicle and sebaceous glands

    1. Alopecia: scalp – change from terminal to vellus hair
    2. Hirsutism: increase sexual terminal hairs
    3. Acne: increase sebaceous gland

  3. Risk of androgen excess – PCOS, infertility, hyperlipid, metabolic syndrome, insulin resistance, and diabetes
  4. Labs: DHEA‐s, testosterone (total and free), androstenedione, and prolactin
  5. Treatment

    1. Minoxidil – 5% more effective in both men and women but may cause facial hair growth in women
    2. Finasteride (Propecia) 1 mg PO QD.

      1. Effective in men
      2. Effective in young women with SAHA (seborrhea, acne, hirsutisum, and alopecia), Finesteride 0.5 mg/d. Must use with OCP
      3. Avoid in pregnant females (causes ambiguous genitalia in male fetus)
      4. Not effective in postmenopausal women

    3. Spironolactone may be helpful in women with hyperandrogenism – dose 50–300 mg/d (Preg category D)
    4. OCP – suppress gonadotrophins, reduce testosterone
    5. Cyproterone acetate – Progestin, high anti‐andorgen activity. Usually combined with estrogen (Preg category D). Increase risk of venous thromboembolism
    6. Metformin – 500–1000 mg/d in combination with spironolactone
    7. Weight loss – decrease insulin and testosterone
    8. Healthy scalp/healthy hair – consider ketoconazole/zinc pyrithione, green tea

Alopecia areata – workup and treatment


Associated with nail pitting, exclamation point hair, and yellow dots on dermoscopy


No approved FDA treatment. Guided by age of pt, location of loss, disease extent, disease activity, other medical issues, and pt choice










Patchy AA Extensive AA
Topical or IL corticosteroid
Steroid in shampoo
Minoxidil
Anthralin
Topical immunotherapy
Topical, IL, Oral corticosteroids
Anthralin
Minoxidil
Immunotherapy
Phototherapy/Excimer laser
Immunosuppressive‐MTX, CSA
Biologics



  1. Watchful waiting
  2. Intralesional kenalog 2.5–10 mg/cc (preferred 5 mg/ml, max 3 ml). Use 0.1 ml per injection site about 1 cm apart; every four to six weeks. Response 71%; relapse rate 29% in focal AA, 72% in totalis.
  3. Topical steroid. Class I–II BID × three weeks, week off, then QD alternate week on and week off for two months. Response rate 75%; relapse 37–63%.
  4. Oral steroid – reserve for rapid onset/acute progression, high relapse
  5. Monoxidil 5% solution – use in conjunction with above treatments
  6. Anthralin ointment or cream (0.5–1%) to affected area daily, start with 5–15 minutes, then wash off with soap or remove with mineral oil on cotton ball. Increase time by five minutes per night to two hours max as tolerated. Stop application if irritated until skin returns to normal. Need to produce mild irritation to be effective.
  7. Immunotherapy with squaric acid dibutylester (SADBE) or diphenylcyclopropenone (DPCP)

    1. Initial sensitization to 2% (2 × 2 cm area to scalp)
    2. Apply lowest concentration 0.001% to scalp every one to three weeks to produce a mild eczematous rxn.
    3. If no rxn, increase to 0.01%, then 0.1, 0.5, 1, and 2%.
    4. If no regrowth after 6–12 months, treatment is discontinued.

  8. Methotrexate – 15–25 mg weekly dose, takes three months to see regrowth. Response 57% along, 63% if used with low‐dose oral steroid. Relapse 57%.
  9. Cyclosporin – Response 25–76%, relapse rate up to 100%
  10. JAK inhibitors (oral tofacitinib) – off‐label use. Response rate 50–65%. Consider topical JAK inhibitor: Tofacitinib 2% in Versabase.
  11. Simvastatin/ezetimibe 40 mg/10 mg (Vytorin) – off‐label use. Anti‐inflammatory effect, modulate JAK pathway. Variable response rate.
  12. Fexofenadine (Allegra) 60 mg BID – H1 receptor antagonist decrease IFN‐g and ICAM‐1. Variable response rate.

Other alopecia treatments



  1. Central centrifugal cicatricial alopecia (CCCA)/Folliculitis decalvans

    1. Noninflammatory: potent topical steroid + Tetracycline
    2. Inflammatory: Rifampin 300–600 BID and Clindamycin 150–300 BID × 10–12 weeks

  2. Discoid lupus

    1. Sun avoidance/physical sunblock such as zinc oxide
    2. High‐potency topical steroid and IL kenalog 10 mg/ml q4–6 weeks
    3. Hydroxychloroquine 200 mg BID
    4. Acitretin/isotretinoin for recalcitrant and/or hyperkeratotic disease

  3. Dissecting cellulits of the scalp

    1. Tetracycline + IL kenalog
    2. Isotretinoin – 0.5–1.5 mg/kg/d – variable response
    3. Rifampin 300–600 BID and Clindamycin 150–300 BID
    4. Surgical – incision and drainage, CO2 laser

  4. Erosive pustular dermatosis

    1. Topical steroid and topical psoriatic medications
    2. Avoid traumatic manipulation and phototherapy – may aggravate condition

  5. Lichen planopilaris

    1. Corticosteroid – intralesional kenalog 3–10 mg/ml; oral prednisone
    2. Tetracycline
    3. Hydroxychloroquine 200 BID
    4. Mycophenolate mofetil 500 BID × 4 weeks, then 1 g BID
    5. Compounded tacrolimus 0.1% solution

Aphthosis Workup and Treatment


Adapted from Letsinger et al. J Am Acad Dermatol. 2005 Mar;52(3 Pt 1):500–508.


Morphologic classification



  • Minor aphthae: single to few, shallow ulcers (<1 cm) which spontaneously heal in ~ one to two weeks
  • Major aphthae (Sutton’s, periadenitis mucosa necrotica recurrens): single to few, deep ulcers (>1 cm) which heal over weeks – months and scar
  • Herpetiform aphthae: 10–100, clustered, small (≤3 mm) ulcers which heal in days–weeks, may scar (not associated with HSV)

Classification by cause



  • Simple aphthae: recurrent minor, major, or herpetiform aphthae, often in healthy, young patients
  • Complex aphthae: >3, nearly constant, oral aphthae OR recurrent genital and oral aphthae AND exclusion of Behcet and MAGIC syndrome

    • Primary: idiopathic (stress, trauma, hormonal changes, acidic foods, EBV, and CMV potential cause)
    • Secondary: IBD, HIV, cyclic neutropenia, FAPA (fever, aphthous stomatitis, pharyngitis, and adenitis), gluten sensitivity, ulcus vulvae acutum, vitamin deficiencies (B1, B2, B6, and B12, folate), iron, and zinc deficiencies, and drugs (NSAIDS, alendronate, beta‐blockers, and nicorandil)

Workup for complex apthae



  • HSV PCR/Cx
  • CBC
  • Iron, folate, vitamin B12, and zinc
  • UA
  • Consider HIV, HLA‐B27, and antigliadin/antiendomysial Ab
  • Consider biopsy
  • Consider GI, Rheum, Ophtho, and Neuro consults
  • If considering dapsone, check G6PD

Local factors promoting aphthae: chemical/mechanical injury, sodium lauryl sulfate‐containing dental products, inadequate saliva, and cessation of tobacco


Treatment



  1. Avoid trauma (soft foods, atraumatic brushing, and avoid acidic foods)
  2. Topical:

    • Corticosteroids (hydrocortisone hemisuccinate pellets 2.5 mg; triamcinolone dental paste, betamethasone sodium phosphate 0.5 mg tablet dissolved in 15 cc water for mouth rinse)
    • Anesthetics for pain
    • Tacrolimus
    • Tetracycline rinses (doxycycline 100 mg or tetracycline 500 mg dissolved in 10 cc of water) QID may reduce severity of ulcers
    • Other mouth rinses (chlorhexidine, betadine, salt water, and hydrogen peroxide)
    • B complex vitamins

  3. Systemic: colchicine, dapsone, and thalidomide (HIV)

Dermatologic Signs








































































































































































































































































Sign Disease association Site
Albright’s dimpling Albright’s hereditary osteodystrophy Dimpling over knuckles, enhanced by fist clenching
Albright’s Nevoid BCC syndrome/Gorlin’s Short fourth metacarpal digits
Asboe–Hansen +: in pemphigus and other blistering dx (BP, DH, EBA, CP, DEB, bullous drug, SJS/TEN)
−: usually for Hailey–Hailey and Staph scalded Skin
Existing blister, extension to adjacent unblistered skin with mechanical pressure on top of bulla
Auspitz Plaque psoriasis, but also Darier’s disease and actinic keratosis Red, glossy surface with pinpoint bleeding on removal of the scale by scraping or scratching
Battle’s Basal skull fracture Discoloration at mastoid process
Blue dot Torsion of testicular epididymis and appendices Blue or black nodule visible under the skin on the superior aspect of the testis or epididymis and area will be tender
Butterfly Lupus erythematosus on face; atopic dermatitis on upper back Erythema over the malar eminence and nasal bridge; butterfly‐shaped area of sparing observed over the upper central back, corresponding to the zone that is difficult to reach by hands
Buttonhole Cutaneous neurofibraomas, but also syphilitic chancre and old pigmented nevi Invaginate the tumor into the underlying dermal defect with digital pressure
Cluster of jewels Early stage of chronic bullous disease of childhood New lesions at margin of older ones, aka “string of pearls, “rosettes sign”
Corn‐flake Kyrle’s and Flegel’s diseases Polygonal irregular configuration of lesions that tend to occur over the lower extremities
Crowe’s Type II neurofibromatosis Axillary freckling, may occur in perineum, typically appears later than café au lait macules
Darier’s Condns with increased mast cells in the dermis (urticaria pigmentosa, systemic mastocytosis, insect bite reactions, neurofibroma, juvenile xanthogranuloma, acute neonatal lymphoblastic leukemia) Whealing, circumferential erythema, and localized pruritis elicited by scratching or rubbing of a lesion
Deck chair Cutaneous Waldenstrom’s macroglobulinemia Widespread erupton of erythematous papules that coalesce into rectangular plaques. Sparing of the natural skin folds, resembling the slats of a deck chair
Dimple Dermatofibromas Lateral compression with the thumb and index finger leads to depression of the lesion. This dimpling is secondary to the lesion being attached to the subcutaneous fat
Dirty neck Chronic atopic dermatitis Reticulate pigmentation of the neck with the anterolateral aspects of the neck typically affected secondary to melanin incontinence
Doughnut Scleromyxedema Central depression surrounded by an elevated rim of skin on the extended proximal interphalagneal joint
Dubois’ Dermatitis artefacta Produced by corrosive liquids. Patterned burned areas correspond to the areas of dripping of the liquid when applied by the patient
Ear lobe Contact dermatitis Substance applied with the hand to the face and neck leads to sparing of the diagonal crease of the ear lobe on the ipsilateral side, whereas the contralateral side is affected. Secondary to hand‐sweeping movement made during application of the substance
Enamel paint Kwashiorkor Sharply demarcated hyperpigmented desquamating patches and plaques resembling enamel paint occur on the skin, predominantly in areas of pressure and irritation
Exclamation mark hair Alopecia areata Proximal tapering of hair where the dot represents the remains of the bulb
Flag Nutritional deficiencies (kwashiorkor) intermittent high dosage of methotrexate or following chemotherapy and ulcerative colitits Horizontal alternating bands of discoloration in the hair shafts corresponding to periods of normal and abnormal hair growth. Discoloration may be reddish, blonde, gray, or white depending on the original hair color
Forchheimer’s Rubella Enanthem of red macules or petechiae confined to the soft palate
Frank’s Coronary disease and coronary artery disease or retinopathy in DM type II Diagonal groove across the ear lobe in adults
Gorlin’s Ehlers–Danlos syndrome Ability to touch the tip of the nose with the extended tongue
Gottron’s Dermatomyositis, but also systemic lupus Symmetric confluent macular violaceous erythema occurring over the knuckles, hips, knees, and medial ankles
Grey Turner’s Acute hemorrhagic pancreatitis and other causes of retroperitoneal hemorrhage Induration and bruising seen on the skin over the costovertebral angle secondary to the spread of blood from anterior pararenal space
Groove Lymphogranuloma venereum in heterosexual males Inflammatory mass of femoral and inguinal nodes separated by a depression or groove made by Poupart’s (inguinal) ligament
Hair collar Neural tube closure defects on the scalp (such as aplasia cutis, encephalocele, meningocele, or hetertropic brain tissue) Ring of dark coarse hair surrounding a malformation. Defect is typically midline and the occipital or parietal scalp is typically affected
Hanging curtain Pityriasis rosea When the skin is stretched across the long axis of the herald patch, the scale is noted to be finer, lighter, and attached at one end, which tends to fold across the line of the stretch
Heliotrope Dermatomyositis Violaceous erythema involving the periorbital skin
Hertoghe’s Atopic dermatitis, trichotillomania, ectodermal dysplasia, alopecia areata, alopecia mucinosa, leprosy, syphilis, ulerythema ophryogenes, systemic sclerosis and hypothyroidism Lack of hair at the outer 1/3 of the eyebrows
Hoagland’s Infectious mononucleosis Early and transient bilateral upper lid edema
Holster Dermatomyositis Pruritic, macular, violaceous erythema affecting the lateral aspects of the hips and thighs
Hutchinson’s nail Subungual melanoma Periungual extension of brown‐black pigmentation onto the proximal and/or lateral nail folds
Hutchinson’s nose Herpes zoster Presence of vesicles occurring on the tip of the nose
Jellinek’s Hyperthyroidism Hyperpigmentation of the eyelid
Leser–Trelat Internal malignancy (typically adenocarcinomas, lung cancer, melanoma, and mycosis fungoides) Sudden eruption of multiple seborrheic keratoses, which are often pruitic
Muehrcke’s Nephritic syndrome, GN, liver disease, and malnutrition Paired, transverse, narrowed white bands that run parallel to the lunula of the nails and are seen in patients with hypoalbuminemia or those receiving chemotherapy agents
Neck Scleroderma Ridging and tightening of the neck forming a visible and palpable tight band that lies over the platysma in the hyperextended neck
Necklace of casal Pellagra Hyperpigmentation on the neck extending as a broad collar‐like band around the entire circumference of the neck
Nikolsky’s Pemphigous foliaceus Pulling the ruptured wall of the blister it is possible to take off the horny layer for a long distance on a seemingly healthy skin and rubbing off of the epidermis between the bullae by slight friction without breaking the surface of the skin and leaving moist surface of the granular layer
Nose Airbone contact dermatitis, severe atopic dermatitis, and exfoliative dermatitis Sparing of the nose in the eruption distribution
Oil drop Psoriasis Translucent, yellow‐red discoloration and circular areas of onycholysis in the nail bed that fail to reach the free border and look like oil drops underneath the nail
Panda Laser therapy complication Nevus of Ota in the periorbital location
Pastia Preeruptive stage of scarlet fever Pink or red transverse lines found in the antecubital fossae and axillary folds
Pathergy Pyoderma gangrenosum or Behcet’s syndrome Elicitation of new lesions or worsening of existing lesions by superficial trauma
Racoon Basilar skull fracture Periorbital ecchymosis from subconjunctival hemorrhage
Romana’s Chagas’ disease First clinical sign of sensitization response to the bite of the Trypansoma cruzi insect presenting as severe unilateral conjunctivitis and palpable, painless lid edema
Rope Interstitial granulomatous dermatitis with arthritis Inflammatory indurations appearing like cords that extend from the lateral trunk to the axillae
Round fingerpad Scleroderma Disappearance of the peaked contour on the fingerpads and progression to a hemisphere‐like finger contour
Russell’s Bulimia nervosa Lacerations, abrasions, and callosities that are found on the dorsum of the hand overlying the metacarpophalangeal and interphalangeal joints due to repeated contact of the incisor teeth with the skin during self‐induced vomiting
School chair Contact dermatitis to nickel Rash occurring over the posterior thighs, corresponding to contact with a school chair
Shawl Dermatomyositis Vonfluent, symmetric, macular violaceous erythema on the posterior shoulders and neck, giving a distinctive shawl‐like appearance
Slapped cheek Children with fifth disease Confluent, erythematous, edematous plaques on the cheeks
Sternberg’s thumb Arachnodactyly and Marfan syndrome Completely opposed thumb in the clenched hand projects beyond the ulnar border
Tent Benign appendageal tumor pilomatricoma Solitary, asymptomatic, firm nodule. When the overlying skin is stretched, the lesion appears to be multifaceted and angulated, giving a “tent” appearance. The tent sign is due to calcification occurring in the lesion
Thumbprint Disseminated strongyloidosis Periumbilical purpura resembling multiple thumbprints
Tin‐tack Discoid lupus erythematosus Hyperkeratotic scale extending into the follicular infundibulum creates keratotic spikes when viewed from the scale’s undersurface, resembling a carpat tack
Tripe palms Internal malignancy (carcinoma of the stomach and lung) Rugose thickening of the palmar surface of the hands, with accentuation of the normal dermatoglyphic ridges, thus resembling the ridging of the interior surface of a bovine foregut
Trousseau’s Visceral malignancy (predominantly pancreatic cancer) Development of successive crops of tender nodules in affected blood vessels secondary to intravascular low‐grade hypercoagulation usually affecting upper extremities or trunk
Ugly duckling Melanoma A nevus that does not resemble a patient’s other nevi
V Dermatomyositis Erythema secondary to photosensitivity seen in the V area of the upper chest
Walzel Acute and chronic pancreatitis Livedo reticularis
Winterbottom’s Gambian form of African trypanosomiasis Occasionally visible enlargement of lymph nodes in the posterior cervical group

Source: Adapted from Freiman et al. J Cutaneous Med Surg 2006; 10(4).


Folliculitis




































Type Clinical presentation Treatment
Staph Multiple follicular‐based erythematous papules/pusules Mupirocin cream to nares
Chlorhexidine wash
Dicloxacillin or cephalexin for MSSA
Trimethoprim/sulfamethoxazole, clindamycin, or doxycycline for MRSA
Gram‐negative Multiple small pustules in the perinasal region, chin, and cheeks. Classic scenario: acne patient treated with long‐term antibiotics Isotretinoin
Ampicillin, trimethoprim/sulfamethoxazole, and ciprofloxacin
Pseudomonas Exposure to contaminated water in pools/hot tub Usually resolve without treatment in 7–10 d
Ciprofloxacin for severe cases
Demodex Rosacea‐like papules and pustules with periorificial accentuation on a background of erythema. Facial perifollicular scaling. Permetherin 5% cream
Metronidazole
Ivermectin
Pityrosporum Very pruritic small monomorphous papules and pustules on upper trunk. Commonly found in hot and humid environment or with immunocompromised patient or those on long‐term antibiotics Ketoconazole cream/shampoo
Selenium sulfide shampoo
May need systemic antifungals
Eosinophilic folliculitis

  1. Ofuji – in Asian descent, discrete papules and pustules that coalesce to form circinate plaques with central clearing on the face, back, and arms
  2. HIV positive/immunocompromised – persistent papules and pustules favoring face, scalp, and upper trunk.
  3. Infantile – male, self‐limiting. Cyclic course. Scalp and eyebrows
Tacrolimus 0.1% ointment
Cyclosporin
Indomethacin 25–75 mg qd for 1–8 wk
Isotretinoin
Metronidazole
Phototherapy
EGFR induced Four stages of eruption – dysesthesia, erythema, edema; erythematous papules and pustules; purulent crusting; telangiectasia. Lesions can be painful and pruritic. Doxycycline 200 QD prescribed with EGFR inhibitor to prevent folliculitis

Melasma


(From Sheth VM and Pandya AG. JAAD 2011;65: 689–697)



  1. Etiology/pathogenesis

    1. Skin type – Melasma is more common in Fitz III and IV.
    2. Genetics – highly reported incidence in family members
    3. UV exposure – induces melanocyte proliferation, migration, and melanogensis. Increase production of IL‐1, endothelin‐1, a‐MSH, and ACTH which upregulates melanocyte proliferation and melanogensis.
    4. Hormones – no definitive association of serum hormone levels to melasma. Definite association of melasma with OCP and pregnancy. If pt notes onset/worsen with OCP, should stop OCP when possible.
    5. Vascular component – bx of melasma skin show greater vascular endothelial growth factor expression

  2. Differential diagnosis

    1. PIH
    2. Solar lentigines
    3. Ephelides
    4. Drug‐induced pigmentation (i.e. MCN pigmentation)
    5. Actinic lichen planus
    6. Acathosis nigricans
    7. Frictional melanosis
    8. Acquired nevus of Ota (Hori’s nevus)
    9. Nevus of Ota

  3. Assessment tools

    1. Melasma Area and Severity Index (MASI) MASI = 0.3A (D + H) + 0.3A (D + H) + 0.3A (D + H) + 0.1A (D + H)

      [Forehead] [L malar] [R malar]  [chin]


      Score range 0–48



      1. Divide face into four areas – forehead (30%), L malar area (30%), R malar area (30%), and chin (10%).
      2. Area of involvement (A) from 1 (<10%) to 6 (90–100%)
      3. Darkness of pigment (D)
      4. Homogeneity of pigment (H)

    2. Quality of life assessment – MelasQoL

Principles of melasma therapy



  1. Set realistic expectations

    • Melasma is a chronic skin disease
    • Recurrence is common
    • Requires daily commitment
    • Rotational regimen based on flare and remission

  2. Avoid triggers

    • Broad‐spectrum sunscreen – UVA and UVB protection SPF 30 + physical blocker – improves melasma and enhances efficacy of HQ.
    • Wear protective hats and clothing
    • Iron oxide sunscreen and makeup (tinted) – protect from high‐energy visible (HEV) light, esp. important for Fitz IV–VI.

      • Avene, Femme Couture and Get Corrected, Elta MD.
      • Visible light may play a role – visible light (400–700 nm) and UVA1 (340–400 nm) induce hyperpigmentation in Type V skin (Mahmoud JID 2010).
      • Iron oxide improves MASI in conjunction with HQ4% (Bissonnette Derm Surg 2008; Castanedo‐Cazares PPP 2014).

    • Camouflage makeup – Dermablend, Covermark, and CoverFx
    • OCP – If onset associated with OCP and no family history, consider stopping OCP.

  3. Topicals

    • Triple combination cream – first line for eight weeks (more effective than HQ alone)

      • Kligman: HQ 5%, tretinoin 0.1%, and dexamethasone 0.1%
      • Triluma: HQ 4%, tretinoin 0.05%, and fluocinolone 0.01%

    • For resistant melasma (adapted from Dr. Alison Tam)

      • Start with compounded cream (i.e. HQ8%/Kojic acid 6%, vitC, HC 2.5%) BID dosing
      • Take photos prior to initiation of therapy, followup in six to eight weeks
      • If no improvement, titrate HQ by 2–4%
      • If improved, decrease usage frequency from BID → QD → QOD → TIW. Give drug holiday.

  4. Resistant cases

    • Tranexamic acid – synthetic lysine analog (available in 650 mg in the United States)

      • 250 mg BID or 650 mg break in half BID × three months
      • FDA approved for menorrhagia, off‐label for melasma
      • Blocks plasminogen activator/plasmin pathway
      • SE: nausea, diarrhea, GI upset, and oligomenorrhea
      • Must assess risk of thromboembolism in patient: ask about personal and family history of DVT/PE, stroke, miscarriages, complications of pregnancy

    • Chemical peels
    • Lasers

      • Vascular component of melasma, consider PDL
      • IPL, Fraxel, and Q‐swithced Nd:YAG have been used for melasma

  5. Maintanence therapy

    • Decrease HQ concentration to 2% or off HQ to avoid risk of exogenous ochronosis
    • Azelaic acid 20% (off‐labeled), similar efficacy as HQ 2%

      • Direct cytotoxic effect on hyperactive melanocytes
      • Can be used during pregnancy/breastfeeding
      • Does not cause depigmentation in normal skin

    • Kojic acid combination with lower strength HQ

      • More irritating than HQ, use with steroid

    • Lignin peroxidase/Melanozyme (Elure)
    • Other agents: Soy, Arbutin, Green tea, Ascorbic acid, and Niacinamide
    • Polypodium leucotomos – Heliocare, may be photoprotective

IMMUNOLOGY AND IMMUNOLOGIC DISEASE


Lupus Erythematosus


Systemic lupus erythematosus criteria (4 of 11)


Adapted from the American College of Rheumatology 1982 revised criteria


Mucocutaneous



  1. Malar rash (tends to spare nasolabial folds)
  2. Discoid lesions
  3. Photosensitivity
  4. Oral ulcers (must be observed by physician)

Systemic



  1. Arthritis – nonerosive arthritis of 2+ joints
  2. Serositis – pleuritis, pericarditis
  3. Renal disorder – proteinuria > 0.5 g/d or 3+ on dipstick
  4. Neurologic – seizures or psychosis
  5. Hematologic

    1. hemolytic anemia with reticulocytosis
    2. leukopenia (<4 K) on 2 occasions
    3. lymphopenia (<1.5 K) on 2 occasions
    4. thrombocytopenia (<100 K)

  6. Immunologic – anti‐dsDNA, anti‐Sm, false positive RPR
  7. ANA+

Acute cutaneous lupus erythematosus


Clinical findings: transient butterfly malar rash, generalized photosensitive eruption, and/or bullous lesions on the face, neck, and upper trunk.


Associated with HLA‐DR2, HLA‐DR3


DIF: granular IgG/IgM (rare IgA) + complement at DEJ


Subacute cutaneous lupus erythematosus


Clinical findings: psoriasiform or annular non‐scarring plaques in a photodistribution.


Associated with:



  • HLA‐B8, HLA‐DR3, HLA‐DRw52, HLA‐DQ1
  • SLE, Sjögren, RA, C2 deficiency
  • Medications: HCTZ, Ca+ channel blocker, ACE inhibitors, griseofulvin, terbinafine, anti‐TNF, penicillamine, glyburide, spironolactone, piroxicam

DIF: granular pattern of IgG/IgM in the epidermis only (variable)


Chronic cutaneous lupus erythematosus


Discoid lupus

Clinical findings: erythematous plaques which progress to atrophic patches with follicular plugging, scarring, and alopecia on sun‐exposed skin.


Progression to SLE: 5% if above the neck; 20% if above and below the neck


DIF: granular IgG/IgM (rare IgA) + complement at DEJ, more likely positive in actively inflamed lesion present × 6–8 weeks


Lupus panniculitis

Clinical findings: deep painful erythematous plaques, nodules, and ulcers involving proximal extremities and trunk. Overlying skin may have DLE changes.


Progression to SLE: 50%


DIF: rare granular deposits at the DEJ. May have deposits around dermal vessels.


Tumid lupus

Clinical findings: erythematous indurations of fat with no scale or follicular plugs.


DIF: nonspecific


Lupus band: strong continuous antibody deposits at the DEJ on nonlesional skin; found in >75% of SLE patients on sun‐exposed skin and 50% SLE patients on non‐sun‐exposed skin


Autoantibody


Autoantibody sensitivities and specificities


























































































































































































Condition Autoantibody Sensitivity (%) Specificity (%)
SLE ANA 93–99 57
Histone 60–80 50
dsDNA* 50–70 97
U1‐RNP 30–50 99
Ribosomal‐P 15–35 99
Sm 10–40 >95
SS‐A 10–50 >85
SS‐B 10–15
SCLE ANA 67
SS‐A 60–80
SS‐B 25–50
DLE ANA 5–25
SS‐A ≪̸10
Drug‐induced LE ANA >95
Histone >95
dsDNA
1–5
Sm 1
Neonatal lupus SS‐A** 95
SS‐B 60–80
MCTD ANA 100
U1‐RNP >95
Scleroderma ANA 85–95 55
Scl‐70 15–70 100
U3‐RNP 12 96
Centromere <10
CREST Centromere >80
Scl‐70 15
Progessive systemic sclerosis Scl‐70 50
Centromere <5
Sjögren ANA 50–75 50
SS‐A 50–90 >85
SS‐B 40 >90
RF 50
Polymyositis (PM) ANA 85 60 (DM/PM)
Jo‐1 25–37
Dermatomyositis (DM) ANA 40‐80 60 (DM/PM)
Rheumatoid arthritis CCP 65–70 90–98
RF 50–90 >80
ANA 20–50 55
Histone 15–20
Secondary Raynaud ANA 65 40

Sensitivity and specificity for different antibiodies varies depending on the assay used. The % reported here are estimated averages from the referenced text below.


* Correlates with SLE activity and renal disease.


** Risk of neonatal lupus among babies of SS‐A+ mothers: 2–6%.


ANA titers of 1:80, 1:160, and 1:320 are found in 13, 5, and 3%, respectively, of healthy individuals. Among healthy elderly patients, ANA titers of 1:160 may be seen in 15%.


Sheldon J. Laboratory testing in autoimmune rheumatic disease. Best Pract Res Clin Rheumatol. 2004 Jun;18(3): 249–269.


Lyons et al. Effective use of autoantibody tests in the diagnosis of systemic autoimmune disease. Ann N Y Acad Sci. 2005 Jun;1050:217–228.


Kurien BT, Scofield RH. Autoantibody determination in the diagnosis of systemic lupus erythematosus. Scand J Immunol. 2006 Sep;64(3):227–235.


Habash‐Bseiso et al. Serologic testing in connective tissue diseases. Clin Med Res. 2005 Aug;3(3):190–193.


Autoantibodies in connective tissue diseases














































Autoantibody or target Activity Clinical association
LAC, β2‐glycoprotein I, Prothrombin, Cardiolipin, Protein S, and Annexin AV Phospholipids Antiphospholipid antibody syndrome*
Rheumatoid factor Fc portion of IgG Low level nonspecific (SLE, SSc, MCTD, neoplasm, chronic disease)
High level – associated with erosive RA
Ku DNA end‐binding repair protein complex Overlap DM/PM, SSc, LE
U2‐RNP
Overlap DM/PM, SSc
Alpha‐fodrin Actin‐binding protein Specific for Sjögren
Jo‐1/PL‐1 Histidyl‐tRNA synthetase DM/PM** (20–40% sensitive) – increased risk of ILD, but no increased rate of malignancy
Mi‐2 Nuclear helicase DM with malignancy, better prognosis than anti‐synthetase
PDGF
SSc, cGVHD
SRP Signal recognition protein Anti‐SRP syndrome (rapidly progressive necrotizing myopathy); association with cardiac disease not confirmed
155 K‐EB antigen Transcriptional intermediary factor‐1 DM (20% sensitive in adult‐onset classical form), may be associated with internal malignancy

Source: Adapted from Jacobe H et al. Autoantibodies encountered in patients with autoimmune connective diseases. In: Bolognia J, et al. Dermatology. Philadephia: Elsevier; 2003. pp. 589–599.


* Antiphospholipid antibody (APA) syndrome – Primary (50%), SLE (35%); Skin: livedo reticularis, ulcers, gangrene, and splinter hemorrhages.


Diagnosis requires at least one clinical criterion:



  • Clinical episode of vascular thrombosis
  • Pregnancy complication: unexplained abortion after week 10, premature birth at or before week 34, or ≥3 unexplained, consecutive SAB before week 10

And at least one lab criterion: anticardiolipin, lupus anticoagulant, or anti‐β2‐glycoprotein I Abs on 2 occasions six weeks apart.


** Polymyositis/Dermatomyositis – ≥0% ANA+, 90% auto‐Ab. Anti‐synthetase syndrome (tRNA): ILD, fever, arthritis, Raynaud disease, and machinist hands.


Anti‐nuclear antibodies


(Sn: sensitive Sp: specific)


































































Pattern Antibody target Disease Notes
Homogenous Histone Drug‐induced LE* (>90% Sn), SLE (>60% Sn), Chronic Dz
dsDNA SLE (60% Sp), Lupus nephritis IC in glomeruli = nephritis, follows disease activity, test performed on Crithidia luciliae
Peripheral nuclear (Rim) Nuclear lamins SLE, Linear Morphea
Nuclear pore PM
Centromere/true speckled Centromere CREST (50–90% Sn), SSc, Primary billiary cirrhosis (50% Sn), Idiopathic Raynaud, PSS
Speckled/particulate nuclear
(ENA)
U1RNP Mixed connective tissue disease (near 100% Sn)
SLE (30% Sn), DM/PM, SSc, Sjögren, RA
Titer > 1:1600 in 95–100% MCTD
Smith (snRNP) SLE (99% Sp but only 20% Sn)
Ro/SS‐A (E3 ubiquitin ligase, TROVE2) SCLE (75–90% Sn), Sjögren, Neonatal LE, Congenital Heart Block, C2/C4 deficient LE Photosensitivity workup
La/SS‐B (binds RNA newly transcribed by RNA Pol III) Sjögren, SCLE
Nucleolar SCL‐70 (Topoisomerase I) SSc (diffuse) Poor prognosis
Fibrillarin (U3‐RNP) SSc (localized > diffuse)
PM‐SCL PM/SSc overlap syndromes Machinists hands, arthritis, Raynaud, and calcinosis cutis
RNA Pol I SSc Poor prognosis, renal crisis

*Drug‐induced (“Dusting Pattern”): Allopurinol, aldomet, ACE‐I, chlopromazine, clonidine, danazol, dilantin, ethosuximide, griseofulvin, hydralazine, isoniazid, lithium, lovastatin, mephenytoin, mesalazine, methyldopa, MCN, OCP, para‐amino salicylic acid, penicillamine, PCN, phenothiazine, pheylbutazone, piroxicam, practolol, procainamide, propylthiouracil, quinidine, streptomycin, sulfasalazine, sulfonamides, tegretol, and TCN.


ANCA (Anti‐neutrophil cytoplasmic antibodies)







































Granulomatosis with polyangiitis (formerly Wegener’s) Microscopic polyangiitis Churg–Strauss syndrome
ANCA (% sensitivity) C‐ANCA (85%) > P‐ANCA (10%) P‐ANCA (45–70%) > C‐ANCA (45%) P‐ANCA (60%) > C‐ANCA (10%)
Classic features Upper respiratory (sinusitis, oral ulcers, rhinorrhea), glomerulonephritis (GN), saddle‐nose, strawberry gingiva, ocular Necrotizing GN (segmental and crescentic), pulmonary hemorrhage (esp. lower), neuropathy Asthma, allergies, nasal polyps, eosinophilia, PNA, gastroenteritis, CHF, mononeuritis multiplex
Skin Palpable purpura, SQ nodules, pyoderma gangrenosum‐like lesions Palpable purpura Palpable purpura, SQ nodules
Pathology Perivascular necrotizing granulomas, LCV No granulomas, LCV with few/no immune depositis Eosinophils, extravascular granulomas, LCV
Respiratory Upper and lower respiratory, fi xed nodular densities Lower respiratory, alveolar hemorrhage Patchy, transient interstitial infi ltrates
Treatment High‐dose corticosteroids; Cytotoxic agents if severe (no controlled trial demonstrating benefi ts) High‐dose corticosteroids; Cytotoxic agents if severe (no controlled trial demonstrating benefi ts) High‐dose corticosteroids combined with cytotoxic agent (cyclopohsphamide) with proven benefi t in survival

C‐ANCA = cytoplasmic (IIF) = proteinase 3.


P‐ANCA = perinuclear (IIF) = myeloperoxidase.


Other conditions which may be ANCA positive: SLE, RA, chronic infection (TB, HIV), digestive disorders (infl ammatory bowel disease, sclerosing cholangitis, primary biliary cirrhosis, autoimmune hepatitis), drugs (propylthiouracil, hydralazine, methimazole, minocycline, carbimazole, penicillamine), silica/occupational solvents


Titers might indicate disease activity, relapse.


Treatment of ANCA‐associated vasculitis



  • Induction: Cyclophosphamide 2 mg/kg/d, Prednisolone 1 mg/kg/d tapered to 0.25 mg/kg/d by 12 weeks
  • Maintenance: Azathioprine 2 mg/kg/d, Prednisolone 7.5–10 mg/d

Frequent life‐severe adverse events with cyclophosphamide (Cytoxan), nitrogen mustard, and alkylating agent:



  1. Hemorrhagic cystitis (10%) and risk of bladder cancer (5% at 10 years, 16% at 15 years): minimize by using copious fluids, mesna, acetylcysteine and not using h.s. dosing.
  2. Bone marrow suppression: Onset 7 days, nadir 14 days, recovery 21 days.
  3. Infection
  4. Infertility

Vasculitis


Initial workup: Detailed history, physical exam, ROS, skin biopsy ± DIF, CBC, ESR, BMP, UA, consider drug‐induced vasculitis.


Further studies guided by ROS and type of vasculitis suspected: CRP, SPEP, UPEP, cryo, LFT, HBV, HCV, RF, C3, C4, CH50, ANA, ANCA, ASO, CXR, guaiac, cancer screening, HIV, ENA, echo, electromyogram, nerve conduction, biopsy (nerve, respiratory tract, kidney)


Small vessel vasculitis






















































Disease Symptoms Etiology Associations Treatment
Cutaneous small vessel vasculitis Palpable purpura, lower legs/ankles/dependent areas, +/– livedo reticularis, urticaria, edema, ulcers, +/– pruritic, painful/burning, fever, arthralgias Drugs, infections, connective tissue diseases, and neoplasms Usually self‐limited, rest, elevation, compression, NSAIDs, anti‐histamines, corticosteroids, colchicine, dapsone, and immunosupressants
Henoch–Schönlein purpura Palpable purpura on extensors and buttocks, pts 4–7 yrs old polyarthralgia (75%), GI bleeding, fever, hematuria, edema, renal dysfunction, pulmonary hemorrhage, and headache 1–2 weeks after respiratory infection, allergens/food, drugs; usually unknown Primarily supportive. corticosteroids, other immunosuppressants, dapsone, factor XII
Acute hemorrhagic edema of infancy Large, annular, purpuric plaques and edema on face, ears, extremities, usually in patients <2 yo Infections (especially respiratory), drugs, vaccines; usually unknown Self‐resolving
Urticarial vasculitis Painful >pruritic, lasts >24 h, post‐inflammatory hyperpigmentation, +/– bullae, systemic dz in hypocomplementemic version (anti‐C1q precipitin, F > M, ocular, angioedema, COPD), F > M Autoimmune/CTD (30% of Sjogren,20% of SLE pts), drugs (serum sickness), infections (HBV, HCV, EBV), neoplasms, Schnitzler syndrome Oral corticosteroids, antimalarials, dapsone, colchicine, anti‐histamines, and NSAIDs
Hyperimmuno‐globulinemia D syndrome Periodic fever, arthralgia, GI sxs, LAN, erythematous macules/papules/nodules/urticaria on extremities, onset <10 yo, ↑ IgD and IgA levels AR; Mevalonate kinase deficiency NSAIDs, anti‐IL‐1 Ab, and corticosteroids
Familial mediterranean fever Periodic fever, arthritis, serositis, erysipelas‐like rash on legs, myalgias, AA amyloidosis, renal failure, PID sxs; unlike Hyper‐IgD, no LAN and nl IgD level AR; Pyrin deficiency Colchicine, anti‐IL‐1
Erythema elevatum Diutinum Yellow/brown/red papules, plaques, and nodules over joints Various associations: hematologic diseases, HIV, IBD, CTD, and streptococcal infections Dapsone, niacinamide, and topical/intralesional corticosteroids
Granuloma faciale Brown/red plaques on face
Middle‐aged, M > F, Caucasian
Unknown Treatment‐resistent, intralesional steroids, dapsone, and surgery
Serum sickness Fever, lymphadenopathy, arthralgias, urticaria, maculopapular, scarlatiniform, purpura, and myalgias Type III hypersensitivity, commonly following streptokinase, IVIG, Abx (cefaclor, PCN, MCN, rifampin, and cefprozil) Avoidance, anti‐histamines, anti‐pyretics, and corticosteroids

Medium (± small) vessel vasculitis



























Polyarteritis nodosa (systemic) SQ nodules on legs, livedo reticularis, “punched‐out” ulcers, digital gangrene, p‐ANCA positive, universal multisystemic involvement: myocardial/GI/renal infarction, polyneuritis, CNS, arthralgias, weight loss, HTN, (renal) microaneurysms, orchitis (esp. with HBV) Various infections/inflammatory conditions: streptococcus, HBV, HCV, CMV, HIV, SLE, IBD, and hairy cell leukemia Corticosteroids, cyclophosphamide
Polyarteritis nodosa (cutaneous) SQ nodules, starburst pattern of livedo reticularis, mild fever, nerve and muscle involvement As above (cPAN represents 10% but is most common form in children, more often strep) Topical/intralesional steroids, PCN
Microscopic polyangiitis Palpable purpura, ulcers, splinter hemorrhages, crescentic necrotizing segmental GN, fever, weight loss, myalgias, neuropathy, HTN, p‐ANCA (60%); c‐ANCA (40%)
Corticosteroids, cyclophosphamide
Granulomatosis with polyangiitis (formerly Wegener’s) Respiratory, renal, sinus, ocular, otologic, CNS, cardiac, joints, nasal nodules/ulcers/saddle nose, pulmonary infiltrates/nodules, SQ nodules, and c‐ANCA (85%) Unknown – distinguish from lymphomatoid granulomatosis – severe EBV+ angioinvasive B‐cell lymphoma of skin and lungs Corticosteroids, cyclophosphamide (treat staph infection and nasal carriage to minimize relapse)
Churg–Strauss syndrome (Allergic granulomatosis) Asthma, sinusitis, allergic rhinitis, eosinophilia, arthritis, myositis, CHF, renal/HTN, mononeuritis multiplex, palpable purpura, infi ltrated nodules, p‐ANCA (60%) Vaccination, leukotriene inhibitors, desensitization therapy, rapid steroid taper Corticosteroids, cyclophosphamide

Large vessel vasculitis













Giant cell arteritis (temporal) Tender, temporal artery, polymyalgia rheumatica, unilateral HA, jaw claudication, blindness, F > M, Northern European Unknown Corticosteroids
Takayasu arteritis Constitutional sxs, pulselessness, signs/sxs of ischemia, EN‐like nodules, and pyoderma gangrenosum‐like lesions Associations: RA, other CTD Corticosteroids, cyclophosphamide, surgical revascularization

Other causes of vasculitis: Infections (bacterial – meningococcemia, gonnococcemia, strep, mycobacterial; viral – HSV; fungal), Rheumatoid vasculitis, drug‐induced, Lupus, Paraneoplastic, Buerger, and Mondor.


Lymphocytic vasculitis: Pityriasis lichenoides, Pigmented purpuras, Gyrate erythemas, Collagen vascular dz, Degos, Perniosis, Rickettsial, TRAPS


Neutrophilic dermatoses: Sweet, Marshall (+ acquired cutis laxa), Behcet, Rheumatoid, Bowel‐associated dermatosis–arthritis syndrome.


Vasculo‐occlusive/Microangiopathies: Cryos, Anti‐phospholip syndrome, Atrophic blanche/Livedoid, DIC, Purpura fulminans, Coumadin necrosis, TTP, Sneddon (livedo reticularis + cerebrovascular ischemia), Cholesterol emboli, CADASIL, Calciphylaxis, and Amyloid.


Cryoglobulinemia






























Cryoglobulinemia type Monoclonal or polyclonal Immunoglobulins Diseases
1 (“Simple/Single”) Single monoclonal IgM > IgG > IgA or light chain Associations: Lymphoproliferative disorders: lymphoma, CLL, myeloma, and Waldenstrom macroglobulinemia
Manifestations: Retiform necrotic lesions, acrocyanosis, Raynaud phenomenon, cold urticaria, livedo reticularis, retinal hemorrhage, and arterial thrombosis
2 (“Mixed”) Monoclonal and polyclonal Monoclonal IgM (RF) complexed to polyclonal IgG Associations: HCV > other autoimmune (Sjögren, SLE, and RA), infections (CMV, EBV, HIV, HBV, and HAV), and lymphoproliferative disorders
Manifestations: LCV with palpable purpura, arthralgias/arthritis involving PIPs, MCPs, knees and ankles, diffuse GN
3 (“Mixed”) Polyclonal IgG and/or IgM Associations: HCV, other autoimmune (Sjögren, SLE, and RA), infections (CMV, EBV, HIV, HBV, and HAV), and lymphoproliferative disorders
Manifestations: LCV with palpable purpura, arthralgias/arthritis PIP, MCP, knees and ankles, and diffuse GN

Rheumatoid factor = Antibody against Fc portion of IgG = Cryoglobulinemia Types 2 (monoclonal RF) and 3 (polyclonal RF)


Meltzer Triad = Purpura, arthralgia, and weakness


Workup: Serum specimen must be obtained in WARM tubes. Immunoglobulins precipitate at cold temperature. Type 1 precipitates in 24 hours, Type 3 may require 7 days.


Cryoglobulinemia: Immunoglobulins which reversibly precipitate on cold exposure


Cryofibrinogen: Fibrinogen, fibrin, and fibronectin which precipitate in the cold


Cold agglutinins: IgM antibodies which promote agglutination of RBCs on exposure to cold, triggering complement activation and lysis of RBCs.


All three groups cause occlusive syndromes in the skin triggered by cold exposure.


Bullous Disorders


Intracorneal/subcorneal



  • Impetigo – PMNs + bacteria
  • SSSS – Epidermolytic/exfoliative toxins cleave Dsg 1 (160 kd) (ETA – chromosomal, ETB – plasmid‐derived), strain type 71 of phage group II, organisms not usually present on bx, kids <six years or immunosuppressed/renally insufficient adults
  • Staphylococcal toxic shock – superantigens activate T‐cell receptor through Vβ
  • Streptococcal toxic shock – grp A including (strep pyogenes), 60% have + blood cx (unlike Staphylococcal toxic shock)
  • P. foliaceous – Dsg 1 (160 kd) (upper epidermis), may have “grains”‐like dyskeratotic cells in granular layer of older lesions

    • Endemic – fogo selvagem
    • DIF – intercellular IgG/C3

  • P. erythematosus (Senear–Usher) – Features of lupus + PF

    • DIF – intercellular IgG/C3 + lupus band

  • Subconeal pustular dermatosis (SPD) (Sneddon–Wilkinson)

    • Distinguish Sneddon–Wilkinson from pustular psoriasis and IgA pemphigus – IgA Pemphigus has two variants: SPD variant (Ab’s to desmocollin 1) and intraepidermal neutrophilic (IEN) variant (AB’s to Dsg 1 or 3), 20% IgA monoclonal gammopathy, intercellular IgA (upper epidermis in SPD type but less restricted in IEN type)

  • Infantile acropustulosis
  • Erythema toxicum neonatorum – eosinophils, may be intraepidermal
  • Eosinophilic pustular folliculitis
  • Transient neonatal pustular melanosis – neutrophils
  • AGEP – β‐lactams, cephalosporins, macrolides, and mercury
  • Miliaria crystalline

Intraepidermal



  • Palmoplantar pustulosis
  • Viral blistering diseases
  • Friction blister – Acral, just beneath SG
  • EBS – May be suprabasilar
  • Amicrobial pustulosis associated with autoimmune disease (APAD)
  • Coma blisters – May be subepidermal, sweat gland necrosis (EM‐like)

Suprabasilar


Acantholysis – P. vulgaris, P. vegetans, Hailey–Hailey, and acantholytic AK


Acantholysis + dyskeratosis – Darier, Grover, paraneoplastic pemphigus, and warty dyskeratoma


Other blistering diseases with acantholysis – SSSS, P. foliaceous



  • P. vulgaris – Dsg 3 (130 kd), ~50% also have Ab to Dsg 1 (160 kd), “tombstoning” with adnexal involvement unlike Hailey–Hailey, DIF: intercellular IgG/C3, IIF: 80–90% positivity, fishnet on monkey esophagus (more sensitive than Guinea pig)
  • P. vegetans – Dsg 3 (130 kd), Dsg 1 (160 kd), Histo: eos > pms (esp. in early pustular lesions), DIF = P. vulgaris,

    Two types of P. vegetans:



    • Neumann type – more common, starts erosive and vesicular, then becomes vegetating
    • Hallopeau type – starts pustular, more benign course

      Should distinguish P. vegetans from pyodermatitis–pyostomatitis vegetans – associated with IBD, DIF‐


  • Hailey–Hailey (Benign familial pemphigus) – Dilapidated brick wall, DIF–
  • Darier – Acantholytic (more than PV) dyskeratosis (less than H–H)
  • Grover – Four histo patterns: Darier‐like, H–H‐like, PV‐like, and spongiotic
  • EBS
  • Pemphigus‐like blisters + PPK – Case report with Ab to Desmocollin 3, BPAg1, LAD

Subepidermal with little inflammation



  • EB

    • EBS – fragmented basal layer at base of blister, floor: BP Ag, Col IV, laminin, and PAS+ BM
    • JEB – subepidermal, cell‐poor, roof: BP Ag; floor: Col IV, laminin, PAS+ BM
    • DEB – subepidermal, cell‐poor, roof: BP Ag, Col IV, laminin, PAS+ BM
    • EB types may also demonstrate supepidermal blisters with eos

  • EBA – Ab to Col VII (290 kd), DIF: linear IgG/C3 at BMZ, EBA variant may also demonstrate supepidermal blisters with PMNs
  • PCT/pseudo‐PCT
  • Burns and cryotherapy
  • PUVA‐induced
  • TEN
  • Suction blisters
  • Bullous amyloidosis
  • Kindler
  • Vesiculobullae over scars
  • Bullous drug

Subepidermal with lymphocytes



  • EM
  • Paraneoplastic pemphigus – Can demonstrate suprabasaliar acantholysis or subepidermal clefting, dyskeratosis, basal vacuolar change, band‐like dermal infiltrate, DIF: intercellular IgG/C3 + IgG/C3 at BMZ (~P. erythematosus), IIF: intercellular staining on rat bladder
  • LS&A
  • LP pemphigoides
  • Fixed drug
  • PMLE
  • Bullous tinea

Subepidermal with eosinophils



  • BP – DI: linear BMZ + IgG/C3, Abs to BPAg1 (230 kd, 80% of patients) and/or BPAg2 (180 kd, contains Col 17 and NC16A domain, 30% of patients)
  • Pemphigoid gestationis (herpes gestationis) – DIF similar to BP, BPAg2 – placental matrix antigen
  • Arthropod bite – esp. with chronic lymphocytic leukemia

Subepidermal with neutrophils



  • DH – IgA endomysial ab, DIF: IgA at the dermal papillae (perilesional and uninvolved skin)
  • Linear IgA – Various antigens including 97 kd (ladinin) or 120 kd (LAD‐1) = BPAg2 degradation products (in lamina lucida form), DIF: linear IgA at BMZ (non‐lesional skin)
  • CP (benign mucosal pemphigoid)
  • Brunsting–Perry = localized form, head/neck, w/o mucosa
  • Deep lamina lucida (anti‐P105) pemphigoid
  • Anti‐P200 pemphigoid
  • Bullous LE – Clinically, may be similar to DH or have large hemorrhagic bullae, Ab to Col VII (like EBA), Histo: like DH and often lacks vacuolar change of other forms of LE
  • Sweet
  • Orf – May have eos, DIF: C3/IgG at DEJ, IIF: anti‐BMZ IgG (binding dermal side of SSS)
image

Subepidermal with mast cells



  • Bullous mastocytosis

From JL Bolognia, JL Jorizzo, RP Rapini [Editors], Dermatology. Elselvier, 1st Edition, 2003. p. 436, Figure 30.2, with permission.


Epidermolysis bullosa


Simplex (“epidermolytic EB”) – split basal layer tonofilament clumping in basal layer on EM, 40% of EB patients, sxs worse in summer/heat, typically no scarring and not severe (except Dowling–Meara and AR forms)



  • Mutations: KRT5 or 14, plectin, mainly AD (99%)
  • IF: Col IV, laminin, BPAg on floor of blister

Localized forms:



  1. Weber–Cockayne (AD) – most common, hyperhidrosis, palms/soles, usually due to KRT5 or 14 mutations, rarely may be due to ITGB4 (integrin β4) mutations
  2. Kallin (AR) – anodontia/hypodontia, hair/nail anomalies
  3. Autosomal recessive EBS (AR) – KRT14

Generalized forms:



  1. Koebner (AD) – mild, (–) Nikolsky, mucous membrane and nails are nl
  2. Dowling–Meara (AD) – herpetiform pattern, hemorrhagic bullae, milia, oral involvement, dystrophic/absent nails, alopetic areas, confluent PPK, improves at ~10 years‐old and in adulthood (becomes more restricted to acral/pressure sites)
  3. Ogna (AD) – hemorrhagic blister and bruising, plectin defect but no MD, closely linked to glutamic pyruvic transaminase
  4. Mottled pigmentation (AD) – reticulated hyperpigmentation
  5. Muscular dystrophy (AR) – plectin defect, blisters at birth with scarring, neuromuscular dz
  6. Pyloric atresia (AD, AR) – plectin defect, may be lethal, single family reported (J Invest Dermatol. 2005 Jan;124(1):111–115)

Junctional – split lamina lucida, defect in hemidesmosome, <10% of EB patients, oral lesions, absent/dystrophic nails, dysplastic teeth, usually no scarring/milia



  • Mutations: laminin 5, α6β4 (ITGA6, ITGB4), BPAg2, all AR except Traupe–Belter–Kolde–Voss
  • IF: Col IV, laminin on floor; BPAg on roof


  1. Herlitz (EB letalis or gravis) – defect: laminin 5, very severe generalized dz – may be fatal (often during infancy or childhood), manifest at birth, stereotypical stridor/cry, nonhealing erosions (often large and zygomatic), GI, gallbladder, corneal, vaginal, laryngeal (>esophageal), and bronchial lesions, dystrophic/absent nails, exuberant granulation tissue and bleeding
  2. Non‐Herlitz (non‐lethal) – defect: laminin 5, moderately severe generalized dz worse pretibially, bullae smaller and healing, dystrophic nails, risk of SCC, large acquired melanocytic nevi (seen in JEB > DEB or EBS; asymmetric, irregular)
  3. JEB with pyloric atresia – defect: α6β4, severe mucocutaneous fragility and gastric outlet obstruction, manifest at birth, polyhydramnios during pregnancy
  4. Generalized atrophic benign EB – defect: COL XVIIA1 (BPAg2), moderately severe generalized dz + enamel defects/oral lesions and atrophic alopecia (~ male‐pattern), survive to adulthood, dystrophic nails, “Localized Atrophic” variant also due to COL XVII mutations
  5. JEB letalis with congenital muscular dystrophyEur Neurol 1993;33(6):454–460.
  6. Laryngo–Onycho–Cutaneous/Laryngeal and Ocular Granulation tissue in Children from the Indian subcontinent (LOGIC)/Shabbir – hoarse cry as newborn, erosions and bleeding at tramatic sites, onychodystrophy, conjunctival and laryngeal chronic granulation tissue, symblepharon, blindness, dental enamel hypoplasia, and anemia
  7. Others: Acral, Inversa, Cicatricial, Late‐Onset/Progressiva.

Dystrophic (“dermolytic EB”) – split sublamina densa (papillary dermis), >50% of EB patients, defective anchoring fibers, scars and milia.



  • Mutation: Col VII*
  • IF: Col IV, laminin, BPAg on roof

Dominant dystrophic EB: manifest at birth, bullae on extensor surfaces, (+) Nikolsky, (onion) scars and atrophy, milia on ears, hands, arms, and legs, mucous membrane/esophagus involved, nail dystrophy, scarring tip of tongue, improve w/ time.



  1. Albopapuloid (Pasini, Pretibial with lichenoid features) – white papules on trunk not preceded by bullae, more severe, present in adolescence
  2. Cockayne–Touraine – hypertrophic scars, more limited
  3. Bart – aplasia cutis (legs), blisters, and nail deformities, rarely with JEB
  4. Dominant transient bullous dermolysis of the newborn – vesiculobullae at birth, recover by four months, no scars
  5. Pruriginosa ‐ pruritis, prurigo‐like lesions, nail dystrophy, and may have albopapuloid lesions, may be AR
  6. EBD with subcorneal cleavage = EBS‐superficialis

Recessive dystrophic EB



  1. Generalized – mitis (non‐Hallopeau–Siemens) – severe blisters, generalized, esophageal strictures, ±digital cicatricial pseudosyndactyly
  2. Generalized – gravis (Hallopeau–Siemens) – very severe, generalized, skin and mucous membrane bullae as newborn, high risk of SCC (primary cause of death), mitten deformity, esophageal stricture, anemia, cardiomyopathy, and fatal amyloidosis (AA type)
  3. Others: Inversa (axilla, groin), Centripetal, Recessive Transient Bullous Dermolysis of the Newborn

*Tumorigenesis in RDEB is increased with production/retention of Col VII containing the NC1 domain (in laminin five‐dependent process).


Non‐EB genodermatoses with infantile bullae: Kindler, Ichthyosis Bullosa of Siemens, BCIE, Gunther


Major bullous diseases – clinicopathologic findings












































































































Disease Manifestation Antigen(s) Size (kD) Path DIF Rx
Pemphigus foliaceus Crusted, scaly erosions, seborrheic distribution, positive Nikolsky, non‐mucosal Dsg 1
Plakoglobin
160
85
Acantholysis in upper epidermis, split in SG or right below SC Intercellular IgG/C3, often superficial, may be thoughout epidermis Topical steroids if mild, systemics similar to PV if generalized
Pemphigus vegetans Flaccid bullae, erosions, fungoid vegatations, intertriginous, head, mucous membrane, two subtypes: Neumann – severe, Hallopeau – mild Dsg 3
Dsg 1
Plakoglobin
130
160
85
Like PF Like PF Like PF
Pemphigus vulgaris
Drug‐induced (usually PF‐like): penicillamine, IL‐2, PCN, thiopurine, rifampin, ACE‐I
Flaccid bullae, mucous membrane, + Nikolsky, + Asboe–Hansen Dsg 3–100%
Dsg 1–~50%
Plakoglobin
130
160
85
Suprabasilar acantholysis can follow hair, + tombstones Intercellular IgG (also C3, IgM, and IgA) thoughout epidermis.
Follow progression with IIF (Dsg 3) (monkey esophagus)
Prednisone, azathioprine, cyclophosphamide, mycophenolate mofetil, and CSA
IgA pemphigus Flaccid vesicles, superficial pustules in annular/serpentine patterns, trunk (axilla, groin), proximal extremities SPD variant – Desmocollin 1; IEN variant – Dsg 1/3 105, 115 Pustules: subcorneal or suprabasilar, no acantholysis, PMNs IgA in upper epidermis (intercellular), no IgG Dapsone, sulfapyridine, etretinate, UV, and steroids
Pemphigus erythematosus
(Senear–Usher)
Erythematous, crusted, erosions, often malar, originally PE = PV + LE Dsg 1
Plakoglobin
160
85
Like PF Intercellular and DEJ IgG/C3+ lupus band sometimes Prednisone
Paraneoplastic pemphigus
Associations: NHL, CLL, Castleman, sarcoma, and thymoma
Bullae, erosions, EM‐like, lichenoid, SJ‐like in mucous membranes Plectin
Desmoplakin 1
BPAg1
Envoplakin
Desmoplakin 2
Periplakin

Dsg 1,3
500
250
230
210
210
190
170
160, 130
Suprabasilar acantholysis, dyskeratotic keratinocytes, sometimes basal layer degeneration/band‐like infiltrate Intercellular IgG/C3 in
epidermis and at BMZ

IIF: IgG rat bladder
Treat‐associated neoplasm


May die from bronchiolitis obliterans
Epidermolysis bullosa acquisita
Associations: myeloma, colitis, DM2, leukemia, lymphoma, amyloid, and cancer
Fragile skin, blisters with trauma, atrophic scars, milia, and nail dystrophy Col VII (also an antigen in bullous LE) 290/145 Noninflammatory subepidermal bullae, PMN > Eos IgG/C3 linear BMZ
IIF anti‐BMZ
Salt split skin: immunoreactants on dermal side, type IV collagen on roof
Immunosuppression, wound care
Bullous pemphigoid
Drug‐induced: lasix, PCN, ACE‐I, sulfasalzine, and nalidixic acid
Large, tense bullae on trunk and extremities BPAg1
BPAg2

BPAg2 worse prognosis.
230
180
Subepidermal bullae, eosinophils in superficial dermis (more likely acral in infants) Linear IgG/C3 at BMZ
Salt split skin: immunoreactants on epidermal side, type IV collagen on base
Topical steroids, prednisone, MTX, mycophenolate mofetil, azathioprine, nicotinamide, TCN, sulfapyridine, dapsone
Herpes gestationis/gestational pemphigoid
Associations: HLA‐DR 3,4, B8
Pruritic, urticarial plaques on trunk, starts near umbilicus, flares with delivery/OCP, increased risk of prematurity/SGA, 10% of newborns with skin lesions BPAg1
BPAg2
230
180
Subepidermal bullae, eosinophils, perivascular infiltrate Linear C3 ± IgG at BMZ
IIF: anti‐BMZ IgG by complement‐added IIF.
Topical/oral steroids
Dermatitis herpetiformis Grouped, pruritic papules and vesicles on extensors,
HLA‐B8, DR3, and DQ2
Endomysial Ag (tissue transglutaminase)
Anti‐gliadin
Subepidermal bullae, PMNs in dermal papillae Granular IgA ± C3 (tips of papillae) Gluten‐free diet, dapsone, sulfapyridine, TCN, nicotinamide, and colchicine
Linear IgA
Drug‐induced: vancomycin, lithium, amiodarone, ACE‐I, PCN, PUVA, lasix, IL‐2, oxaprozin, IFN‐γ, dilantin, diclofenac, and glibenclamide
DH‐like vesicles (crown of jewels), BP‐like bullae, 50% mucous membrane involvement, children: self‐limited Ladinin
LAD‐1
BPAg1
BPAg2
Col VII
97
120
230
180
290/145
Subepidermal bullae, PMNs in dermal papillae ± Eos Linear IgA at BMZ, maybe IgG, no C3 Dapsone, steroids, TCN, nicotinamide, IVIg, and colchicine
Cicatricial pemphigoid (benign mucosal pemphigoid)
Drug‐induced: penicillamine, clonidine
Primarily mucous membrane, vesicles, erosions, ulcers, scars, erosive gingivitis, and chronic BPAg1
BPAg2
Laminin‐6
Epiligrin (Lam‐5)
Integrin β4
230
180
165, 220, 200
165, 140, 105
200
Like BP plus scarring in upper dermis C3/IgG at BMZ in 80%;
IIF+ in 20%, usually IgG
Topical steroids, dapsone, cyclophosphamide, oral steroids, and surgery.

Complement











































Complement type Action
C1q Binds antibody, activates C1r
C1r Activates C1s
C1s Cleaves C2 and C4
C2 Cleaves C5 and C3
C3a Basophil and mast cell activation
C3b Opsonin, component at which classical and alternative pathways converge
C4a Basophil and mast cell activation
C4b Opsonin
C5a Basophil and mast cell activation
C5b, 6, 7, 8, 9 Membrane attack complex
C5, 6, 7 PMN chemotaxis
C5b Basophil chemotaxis

Classical pathway: C1qrs, C1 INH, C4, C2, C3


Activated by: antibody–antigen complex


IgM > IgG (except IgG4 does not bind C1q)


Alternative pathway: C3, Properdin, factor B, D


Activated by: pathogen surfaces


Lectin pathway: Mannan‐binding lectin and ficolins serve as opsonins, analogous to C1qrs. Leads to activation of the classical pathway without antibody.


Activated by: pathogen surfaces


Membrane attack complex: C5–9


C3NeF: Autoantibody that stabilizes bound C3 convertase (C3Bb). IgG isotype against Factor H, inhibits its activity to also drive complement activation. Associated with mesangiocapillary GN and/or partial lipodystrophy.


Angioedema and complement levels





















































C1 C1 INH C2 C3 C4
HAE – 1 Nl Nl
HAE – 2 Nl Nl/↑ (but nonfunctional) Nl
HAE – 3* Nl Nl Nl Nl Nl
AAE – 1** Nl/↓
AAE – 2*** Nl/↓
ACEI‐induced Nl Nl Nl Nl Nl

*HAE‐3 = estrogren‐dependent form


**AAE‐1 = associated w/ B‐cell lymphoproliferation


***AAE‐2 = autoimmune form, Ab against C1‐INH


Treatments:



  • Acute: C1‐INH concentrate, FFP, epinephrine, and terbutaline
  • Severe Rxn: steroids, antihistamines (H1 and H2 blocker)
  • Hereditary angioedema: androgens for acute attacks (stanozolol or danazol), antifibrinolytics (epsilon‐aminocaproic acid or tranexamic acid)

Complement deficiencies


Most are AR, except hereditary angioneurotic edema (HAE) which is AD































Complement deficiency Disease
Early classical pathway (C1, C4, C2) SLE without ANA, increased infections (encapsulated organisms)
C1 esterase HAE
Decreased C1q SCID
C2 Most common complement deficiency, SLE (sometimes HSP, JRA)
C3 Infections, SLE, partial lipodystrophy, Leiner disease
C4 SLE with PPK
C3, C4, or C5 Leiner disease (diarrhea, wasting, and seborrheic dermatitis)
C5–9 Recurrent Neisseria infections

GVHD (Graft vs. Host Disease)


Biopsy for GVHD vs. lymphocyte recovery vs. drug eruption



  • In general, path is indistinguishable between GVHD, lymphocyte recovery, and drug eruption except high‐grade GVHD.
  • Lymphocyte recovery occurs in the first two weeks after transplant.
  • Acute GVHD occurs between 3 weeks and 100 days (or longer in persistent, recurrent, or late‐onset forms).
  • Chronic GVHD classically was considered to occur after 40 days but has no time limit.
  • Eosinophils may be found in both drug eruption and acute GVHD.

Marra, DE, et al. Tissue eosinophils and the perils of using skin biopsy specimens to distinguish between drug hypersensitivity and cutaneous graft‐versus ‐host disease. JAAD 2004, 51(4): 543–545.


Zhou, Y et al. Clinica significance of skin biopsies in the diagnosis and management of graft vs host disease in early postallogeneic bone marrow transplantation. Arch Derm 2000, 136(6): 717–721.


HLA associations



















































































































































































































Disease Associated HLA(s)
Abacavir‐induced hypersensitivity syndrome B*5701
Actinic prurigo DR4 (DRB1*0401), DRB1*0407
Acute generalized erythematous pustulosis B5, DR11 and DQ3
Allopurinol‐induced SJS/TEN
– Han Chinese B*5801
Alopecia areata
– all types – HLA‐DQB1*0301 (DQ7), HLA‐DQB1*03 (DQ3), and HLA‐DRB1*1104 (DR11)
– severe alopecia totalis/universalis – DRB1*0401 (DR4) and HLA‐DQB1*0301 (DQ7)
Behçet’s disease B51
Bullous pemphigoid
– Caucasians – DQB1*0301
– Japanese – DRB1*04, DRB1*1101, and DQB1*0302
Carbamazepine‐induced SJS/TEN
– Asians and East Indians – B*1502
– Europeans – A*3101
Chronic urticarial DR4, DQ8
Dermatitis herpetiformis DQ2, B8
Dermatomyositis
– Juvenile – DR3, B8
– with anti‐JO antibodies – DR52
– with anti‐Mi‐2 antibodies – DR7, DRw53
– adults with dermatomyositis overlap – B14, B40
– Japanese with juvenile dermatomyositis – DRB1*15021
Epidermolysis bullosa aquisita
– Caucasians and African Americans – DRB1*1501, DR5
– Koreans – DRB1*13
Erythema dyschromium perstans
Mexican patients DR4
Erythema multiforme DQw3, DRw53, and Aw33
Generalized granuloma annulare Bw35
Granulomatosis with polyangiitis
 (formerly Wegener’s) DPB1*0401
Henoch–Schonlein purpura
With renal disease B35
Juvenile idiopathic arthritis
– Type II oligo/pauciarticular arthritis – B27
– Enthesitis‐related arthritis – B27
Leprosy
– Lepromatous form – DQ1
– Tuberculoid form – DR2, DR3
Lichen planus
– Oral and cutaneous – DR1
– Oral
– English patients – B27, B51, and Bw57
– Japanese and Chinese patients – DR9
– HCV patients – DR6
Mixed connective tissue disease DR4, DR1, and DR2
Mucous membrane pemphigoid DQw7
Pemphigoid gestationis DR3, DR4
Pemphigus vulgaris
– Caucasians
– Japanese
– DRB1*0402, DRB1*1401 and DQB1*0302
– DRB1*14 and DQB1*0503
Psoriasis
– Early onset Cw6 (also in late‐onset), DRB1*0701/2
Relapsing polychondritis DR4
– Negatively associated w/ organ involvement DR6
Rheumatoid arthritis DR1, DR4, and DRB1
Sacroiliitis
– Psoriasis
– Crohns
– UC
– SAPHO
– Reactive arthritis B27
Sarcoidosis 1, B8, DR3, DRB1, and DQB1
Stevens–Johnson syndrome
With ocular complications DQB1*0601
Still’s disease, Adult‐onset B14, B17, B18, B35, Bw35, Cw4, DR2, DR7, DR4, and Dw6
Subacute cutaneous lupus erythematosus B8, DR3
Systemic lupus erythematosus A1, B8, and DR3

Adapted from Bolognia JL, Jorizzo JL, Schaffer JV. Dermatology. 3rd Edition. Elsevier; 2012.


Th profiles
























Th profile Cytokines Associated diseases
Th1 IL‐2, IFN‐γ, IL‐12 Tuberculoid leprosy, Cutaneous leishmaniasis, Erythema nodosum, Sarcoidosis, Behcet, and MF
Th2 IL‐4, IL‐5, IL‐6, IL‐10, IL‐9, IL‐13 Atopic dermatitis, Lepromatous leprosy, Disseminated leishmaniasis, and Sezary
Th17* IL‐6, IL‐15, IL‐17, IL‐21, IL‐22, IL‐23, TGFβ Psoriasis, ACD, and Hyper‐IgE
T regulatory IL‐10 or TGFβ (also CD25+ and FOXP3+) IPEX

* Th17 and Treg differentiation are both TGFβ‐dependent, but retinoic acid inhibits Th17 and promotes Treg differentiation.


SPECIAL SITES: GLANDS, NAIL, BONE, MUCOSA


Glands

















































Glands Apocrine Eccrine Sebaceous
Derivation Ectodermal (~weeks 16–24) Ectodermal (~week 14) Ectodermal (~week 14)
Secretion Decapitation Merocrine Holocrine
Innervation Sympathetic adrenergic Sympathetic cholinergic and cholinergic Androgenic hormones (not innervated)
Purpose Pheromones Temperature regulation Lubricate, waterproof
Locations Axillary, breast (mammary), external ear (ceruminous), anogenital, eyelid (Moll)
Nevus sebaceous
Widespread (especially soles) excluding vermilion border, labia minora, glans, nail beds, and inner prepuce Everywhere except palms and soles
Associated with hair follicles except on mucosa
Montgomery tubercles – nipples, areola
Meibomian – deep eyelid; granuloma
Glands of Zeis – superficial eyelid
Tyson – foreskin, labia minora
Fordyce spots – vermilion, buccal
Secretion contents Fatty acids, cholesterol, triglycerides, squalene, androgens, ammonia, iron, carbohydrates, antimicrobial peptides NaCl, potassium, bicarbonate, calcium, glucose, lactate, urea, pyruvate, glucose, ammonia, enzymes, cytokins, and Ig’s Ceramides, triglycerides, free fatty acids, squalene, sterol and wax esters, free sterols
Stains * GCDFP, EMA, CEA, keratins CEA, S100, EMA, keratins (CAM 5.2, AE1) EMA, CK15, lipid stains
Nonneoplastic conditions

  • Fox Fordyce (apocrine miliaria)
  • Apocrine chromhidrosis – ochronosis, stained undershirts
  • Axillary bromhidrosis – (E)‐3‐methyl‐2‐hexanoic acid, Micrococcus or Corynebacterium, M>F, postpuberty, more common than eccrine bromhidrosis except during childhood


  • Neutrophilic eccrine hidradenities: chemo, palmoplantar (pediatric), pseudomonas
  • Syringolymphoid hyperplasia with alopecia
  • Miliaria
  • Lafora – PAS+ granules
  • Bromhidrosis – drugs (bromides, PCN), food, metabolic, or bacterial degradation of softened keratin
  • Uremia – small eccrine glands
  • PAS+ granules in hypothyroidism
  • Degeneration in lymphoma, heat stroke, coma blister
  • Ebola particles


  • Acne
  • Vernix caseosa
  • Juxtaclavicular beaded lines
  • Chalazion – granuloma involving Meibomian glands
  • Internal hordeolum (stye) – infection/inflammation of Meibomian glands
  • External hordeolum (stye) – infection/inflammation of Zeiss or Moll (apocrine)

* Specificity of apocrine vs. eccrine stains is controversial.


Nail terminology


























































































































































































Sign Definition/due to Associated conditions
Nail plate/nail shape abnormalities
Anonychia Absence of nail plate or nail unit
Angel wing deformity Central portion of nail is raised and lateral portions are depressed. Due to nail plate thinning Lichen planus
Beau line Transverse (horizontal) ridges affecting all nail plates due to intermittent injury to the nail matrix Acute systemic illness
Brachyonychia Short, wide nails (racquet nails) Rubinstein–Taybi
Clubbing Bulbous fusiform enlargement of the distal portion of the digit with exaggerated curvature of the nail and flattening of the angle between the proximal nail fold and nail plate Idiopathic (pahcydermoperiostosis, familial clubbing, hypertrophic osteoarthropathy); Secondary (systemic disease)
Koilonychia Concave, spoon‐shaped nails Normal variant, iron deficiency anemia (Plummer–Vinson associated with esophageal webbing), diabetes, protein deficiency, connective tissue disease, and acitretin
Habit tic deformity Longitudinal furrow with multiple transverse parallel lines in the center Habitual picking of the proximal nail fold, most common the thumb
Longitudinal groove Central longitudinal groove/median canaliform dystrophy Growth at the nail matrix such as myxoid cyst or wart
Longitudinal splitting Extension of ridging Lichen planus, psoriasis, darier, and fungal infection
Median nail (canaliform) dystrophy Central longitudinal ridge with feathering, like branches of a Christmas tree Unknown, trauma may play a role
Onychocryptosis Ingrown nail with granuloma Aggravated by oral retinoids
Onychorrhexis Longitudinal ridging Lichen planus, psoriasis, darier, and fungal infection
Onychogryphosis Thick curved nail plate (ram’s horn) Aging, psoriasis, trauma, and ill‐fitting shoes
Onychomadesis Transverse full thickness break in the nail from temporary growth arrest of the nail plate (unlike Beau line – partial thickness) Viral infection such as hand–foot–mouth disease
Onychauxis Thick nail plate Psoriasis, trauma, and fungal nail infection
Onychoschizia Splitting/brittle nail Water damage
Pincer nail Transverse over‐curvature of the nail plate, sometimes causing pain at the lateral nail plates curving into the nail bed/fold Psoriasis, SLE, Kawasaki disease, cancer, and paronychia congenita
Pitting Inflammatory condition affecting the nail matrix or bed Alopecia areata, eczema, and psoriasis
Trachyonychia Rough opaque nails Lichen planus, Twenty nail dystrophy (if all nails affected), alopecia areata, atopical dermatitis, and psoriasis
Transverse ridging Eczema, paronychia, and psoriasis
Nail discoloration
Blue nail Wilson disease (blue lunula), argyria, oral medications (minocycline, AZT, HIV, antimalarials, and busulfan)
Green nail Striking blue‐green color to 1 or 2 nails Pseudomonas or candida infection
Yellow nail syndrome Yellow, hard, hypercurved (classic hump), thickened nail Due to lymphatic obstruction associated with lymphedema, pleural effusion, and ascites. Biotin 10 mg qd and fluconazole may be helpful
Yellow nail Yellow discoloration Funal nail infection, yellow nail syndrome, and quinacrine (fluorescent on black light)
Oil drop sign Salmon colored “oil” spots in the nail bed. Caused by exudation of a serum glycoprotein in psoriasis Psorasis
Orange streak Orangish/yellow patch Dermatophytoma (dermatophyte abscess)
Brown nail Staining (nicotine, potassium permanganate, nail varnish, and podophyllin); chemotherapy, hyddroxyurea
Leukonychia (white nail) White spots or white discoloration (see also Mee lines and Muehrcke lines) Trauma (especially to the cuticle that does not follow contour of the matrix), superficial onychomycosis (T. mentagrophytes in immunocompetent; T. rubrum in HIV and kids)
Transverse leukonychia Multiple parallel white lines Manicuring, associated with beau lines
Mee lines Partial leukonychia. Transverse white bands on several nails (follows the contour of lunula because of matrix growth) These grow out Arsenic, thallium, or other heavy metal poisoning, systemic disease, chemotherapy, thallium and antimony intoxication, and etretinate therapy
Muehrcke lines Apparent leukoychia – Double band
Disappears with digital pressure
Hypoalbuminemia, correlates with serum albumin below 2.2 g/100 ml
Half and half nail (Lindsay nail) Apparent leukonychia: white proximal nail, brown or pink distal nail Renal failure
Terry nail White proximal nail (about 2/3), reddened distal nail Liver cirrhosis
Onycholysis Lifting of the distal nail plate. Appears white or yellow. Idiopathic, trauma, contact dermatitis, photoonycholysis (tetracycline, psoralens) and drug reaction (5FU, doxorubicin, captopril, etretinate, isotretinoin, indomethacin, isoniazid, and griseofulvin). Partial onycholysis can occur in psoriasis, thyrotoxicosis, and candida infection.
Melanonychia striata/Longitudinal melanonychia Longitudinal hyperpigmented band(s) extending from the proximal nail plate to the distal end of the nail plate Normal physiologic variant, trauma, pregnancy, Addison disease, post inflammatory hyperpigmentation, Laugier–Hunziker, and Peutz–Jeghers. Can be associated with doxorubicin, 5FU, AZT, and psoralen. Can occur in benign melanocytic nevi and malignant melanoma (Hutchinson sign – extension of the hyperpigmentation through the lunula to the proximal nail fold and cuticle)
Candida can sometimes cause candida black melanocyhia at the lateral edge. Exposure to hydroquinone and vitamin C can cause multiple melanonychia that scrapes off
Erythronychia (Red nail) Longitudinal thin red/brown line beneath the nail plate

  • Single nail: Most common – onychopapilloma (V nicking, longitudinal streak, and spincter hemorrhoage), glomus tumor, wart, Bowen’s disease, BCC, and melanoma
  • Multiple nails = inflammation/systemic disease such as subacute bacterial endocarditis (SLE), rheumatoid arthritis, antiphospholipoid syndorome, malignancy, OCP use, pregnancy, psoriasis, and trauma
Splinter hemorrhage (Red nail) Multiple longitudinal thin red/brown lines beneath the nail plate Multiple nails = inflammation/systemic disease; SLE, rheumatoid arthritis, antiphospholipoid syndorome, malignancy, OCP use, pregnancy, psoriasis, and trauma
Abnormalities of the cuticle, lunula, and nail fold
Pterygium V formation scarring from the proximal nail outward Due to scarring in the nail matrix. Seen in lichen planus, Stevens–Johnson, after trauma.
Ragged cuticle Connective tissue disease, parakeratosis pustulosa
Blue lunula Wilson disease (dark blue); Diabetes (pale blue)
Red lunula Cardiovascular disease, collagen vascular disease, and hematologic malignancy
Absent lunula Anemia or malnutrition
Nail fold telangiectasia Dilated capillaries at the ponychium (just proximal to the cuticle) Connective tissue disease (SLE, rheumatoid arthritis, dermatomyositis, and scleroderma)

Disorders or drugs associated with nail, bone, or ocular findings























































































































































































































































































































































































































































































































































































































Ocular Skeletal/oral Nail
5‐FU, AZT, Phenophthalein, antimalarials, Hydroxyurea, MCN Blue lunulae (also argyria, Wilson, Hgb M dz)
Acitretin Koilonychia, onychocryptosis (ingrown/unguis incarnatus, granuloma)
Acne fulminans Osteolytic lesions (clavicle, sternum, long bones, ilium)
Albright hereditary osteodystrophy Short stature, brachydactyly, subcutaneous ossifications
Alkaptonuria Osler sign (blue/gray slerae) Arthritis, blue/gray ear cartilage, calcified cartilage
Alezzandrini Unilateral retinitis pigmentosa, retinal detachment
Alopecia areata Asx punctate lens opacities Pitting, trachyonychia, red spotted lunulae
Antimalarials Retinopathy Blue lunulae
Apert Hypertelorism, exophthalmos Craniosynostosis Brittle nails, fusion of nails
Argyria Blue/gray sclera Blue/gray gums Azure lunulae
Arsenic Garlic breath, intra‐abdominal radio‐opacities (acute) Mees lines
Ataxia‐Telangiectasia (Louis–Bar) Bulbar telangiectasia, strabismus, nystagmus
Behçet Retinal vasculitis, uveitis, hypopyon, optic disc hyperemia, macular edema Arthritis, oral ulcers
Buschke–Ollendorff Osteopoikolosis
Carbon monoxide poisoning, Polycythemia, CTD, CHF Red lunulae
CHIME Retinal colobomas
Cicatricial pemphigoid Conjunctivitis, symblepharon, synechiae, ankyloblepharon Oral ulcers, hoarseness, dysphagia
Cirrhosis, CHF Terry nails
Cholesterol emboli Hollenhorst plaque
Cockayne Salt and pepper retinal pigmentary degeneration, optic atrophy, cataracts, strabismus, nystagmus, sunken eyes Dwarfism, dental caries, osteoporosis, overcrowded mouth
Coffin–Siris Bushy eyebrows Hypoplastic/absent fifth distal phalanges, microcephaly Hypoplastic/absent fifth nail
Congenital erythropoietic porphyria Conjunctivitis, scleromalacia perforans Erythrodontia, acro‐osteolysis, osteoporosis Nail dystrophy
Congenital syphilis Keratitis Osteochondritis, saddle nose, mulberry molars, Hutchinson teeth, saber shins
Connective tissue disease, Trauma Pterygium inversum unguis
Conradi–Hünermann syndrome Striated cataracts, microphthalmus, optic nerve atrophy Asymmetric limb shortening, chondrodysplasia punctata – stippled epiphyses (also in CHILD)
Cooks syndrome Absent/hypoplastic distal phalanges, brachydactyly fifth finger Anonychia/onychodystrophy
Darier–White Longitudinal red and white bands and ridging, V‐shaped notches, subungual hyperkeratosis
Dermochondrocorneal dystrophy (Francois) Corneal dystrophy, central opacities Acral osteochondrodystrophy, contractures, subluxations, gingival hyperplasia
Drug (azidothymidine, tetracycline), Ethnicity, Laugier–Hunziker, Peutz–Jeghers Longitudinal melanonychia
Dyskeratosis congenita Blepharitis, conjunctivitis, epiphora Dental caries, loss of teeth, premalignant leukoplakia, dysphagia Longitudinal ridging, thinning, pterygium
Ehlers–Danlos VI Fragile sclerae/cornea, keratoconus, hemorrhage, retinal detachment, blue sclerae, angioid streaks Kyphoscoliosis
Ehlers–Danlos VIII Periodontitis, loss of teeth
Ehlers–Danlos IX Occipital horns, elbow and wrist defects
Endocarditis, trauma, trichinosis, cirrhosis, vasculitis Splinter hemorrhages
Epidermal vevus syndrome Lipodermoids, colobomas, choristomas Kyphoscoliosis, abnormal skull shape, limb hypertrophy/asymmetry, rickets
Fabry disease Circular corneal opacities (cornea verticillata), tortuous vasculature, spoke‐like cataracts Oral angiokeratoma (tongue), osteoporosis
Fanconi anemia Strabismus, retinal hemorrhages Radius and thumb defects
Fever, stress, meds (chemo) Beau lines
Gardner Congenital hypertrophy of retinal pigmented epithelium Osteomas, dental abnormalities
Gaucher Pingueculae Erlenmeyer flask deformity, osteopenia, osteonecrosis
Goldenhar (Facioauriculovertebral sequence) Epibulbar choristomas, blepharoptosis or narrow palpebral fissures, eyelid colobomas, lacrimal drainage system anomalies Ipsilateral mandibular hypoplasia, ear anomalies, vertebral anomalies
Goltz Retinal colobomas, microphthalmia, nystagmus, strabismus Osteopathia striata, lobster claw deformity, cleft lip/palate, hypo/oligodontia, oral papilloma, enamel hypoplasia
Gorlin Cataracts, strabismus, iris colobomas Odontogenic cysts, fused/bifid ribs, spina bifida occulta, kyphoscoliosis, calcified falx cerebri, frontal bossing
Hallermann–Streiff syndrome Microopthalmia, congenital cataracts, strabismus Bird‐like facies, natal teeth, hypodontia
Hemochromatosis Angioid streaks Koilonychia
Homocystinuria Ectopia lentis (downward) Marfanoid habitus, genu valgum, osteoporosis
Huriez Scleroatrophy of hands, sclerodactyly, lip telangiectasia Hypoplasia, ridging, white, clubbing
Hyperimmunoglobulin E syndrome Osteopenia, fractures, scoliosis, hyperextensible joints, candidiasis Chronic candidiasis
Hypoalbuminemia Muehrcke lines
HSV, varicella Dendritis, keratitis
Incontinentia pigmenti (Bloch‐Sulzberger) Strabismus, cataracts, optic nerve atrophy, retinal vascular changes, detached retina, retinal/iris colobomas Peg/conical teeth, partial adontia, late dentition Nail dystrophy, grooving, painful subungual dyskeratotic tumors
Iron deficiency, Syphilis, Thyroid Dz Koilonychia
Iso‐Kikuchi Index finger hypoplasia, brachydactyly Hypoplastic index finger nail
JXG Ocular JXG, hyphema, glaucoma
KID Keratoconjunctivitis, blepharitis, photophobia, corneal defects Nail dystrophy
Kindler Cicatricial pseudosyndactyly (between MCP and PIP), leukoplakia, caries Nail dystrophy
Lamellar Ichthyosis Ectropion, corneal damage Phalangeal reabsorption
LCH: Hand‐Schuller‐Christian Exophthalmos Bone lesions (esp. cranium)
LEOPARD Hypertelorism
Leprosy Madarosis, lagophthalmos, keratitis, episcleritis, corneal anesthesia, blindness Digital resorption, malaligned fractures, diaphyseal whittling, saddle nose Longitudinal melanonychia, longitudinal ridging, subungual hyperkeratosis, rudimentary nail
Lichen planus Pterygium
Linear morphea Melorheostosis (of Leri; “flowing candle wax”)
Lipoid proteinosis (Urbach‐Wiethe) Eyelid beading/moniliform blepharosis Calcifications in hippocampus (suprasellar, “bean‐shaped”), thick tongue, hoarseness
Mafucci Enchondromas, chondrosarcoma
Marfan Ectopia lentis (upward) Marfanoid habitus
McCune–Albright Polyostotic fibrous dysplasia
MEN IIb Conjunctival neuroma Plexiform neuromas (oral mucosa, tongue), nodular lips, marfanoid habitus
MEN III Marfanoid habitus
Menkes Blue irides, strabismus, aberrant eyelashes, iris stromal hypoplasia Wormian bones of skull, metaphyseal spurring of long bones
Multicentric reticulohistiocytosis Mutilating arthritis
Myxoid cyst, verruca vulgaris Median canaliform dystrophy
Naegeli–Franceschetti–Jadassohn Periocular hyperpigmentation Syndrome enamel defects, perioral hyperpigmentation Malaligned great toenails
Nail–Patella Lester iris, heterochromia irides Patella aplasia, posterior iliac horns, elbow arthrodysplasia Triangular lunulae, micro/anonychia
Necrobiotic xanthogranuloma Scleritis, episcleritis
NF‐1 Lisch nodules, congenital glaucoma, optic glioma Sphenoid wing dysplasia
NF‐2 Cataracts, retinal hamartomas
Nicotine, chemotherapy, potassium permanganate, podophyllin, hydroxyurea (streaks) Brown nails
Niemann–Pick Cherry red spots, macular haloes
Noonan Hypertelorism, ptosis, epicanthic folds, downward palpebral fissures, epicanthic folds, refractive errors, strabismus, amblyopia Pectus carinatum superiorly, pectus excavatum inferiorly, scoliosis, short stature, cubitus valgus, joint hyperextensibility
Old age Diminished or absent lunulae, longitudinal ridging, onychogryphosis
Olmsted Corneal anomalies Osteoporosis, joint laxity, leukoplakia, periorifical keratotic plaques Nail dystrophy
Orofaciodigital 1 Colobomas Bifid tongue, accessory frenulae, lip nodules/pseudoclefting, supernumerary teeth, frontal bossing, syndactyly
Osteogenesis imperfecta Blue sclera Brittle bones
Pachyonychia congenita Corneal dystrophy Oral leukokeratosis, natal teeth Thickened nails, pincer nails, paronychia
Papillon–Lefévre Dural calcifications, periodonitis, gingivitis (+ acro‐osteolysis and onychogryphosis in Haim‐Munk)
Phenylketonuria Blue irides Osteopenia
Porphyria cutanea tarda Photo‐onycholysis
Progeria Delayed/abnormal dentition, high‐pitched voice, acro‐osteolysis, short stature, osteoporosis, persistent open fontanelles
Pseudomonas (Pyocyanin) Green nails
Psoriasis Nail pits, oil spots
PXE (Gronblad–Strandberg) Angioid streaks (also Paget’s Dz of bone, sickle cell, thalassemia, Pb poisoning, HFE, ED6) Oral yellow papules
Refsum Salt and pepper retinitis pigmentosa Epiphyseal dysplasia
Relapsing polychondritis Conjunctivitis, scleritis, uveitis, corneal ulceration, optic neuritis Arthritis (truncal), aphthosis
Renal disease Lindsay nails
Retinoids, indinavir, and estrogen Isotretinoin – DISH‐like hyperostotic changes (bones spurs, calcified tendons, and ligaments) Pyogenic granuloma
Richner–Hanhart Pseudoherpetic keratitis Tongue leukokeratosis
Rothmund–Thomson Cataracts Anomalies of radius and hands, hypodontia Nail dystrophy
Rubinstein–Taybi Long eyelashes, thick eyebrows, strabismus, cataracts Broad thumb‐great toe, clinodactyly of fourth toe and 4th–5th fingers, short stature Racquet nails
SAPHO Osteomyelitis
Schnitzler Bone/joint pain (iliac/tibia), hyperostosis, osteosclerosis
Schopf–Schulz–Passarge Eyelid hidrocystomas Hypodontia Nail hypoplasia, dystrophy
Sjögren–Larsson Retinitis pigmentosa, glistening dots Short stature
Sturge–Weber Glaucoma, retinal malformations Tram‐track calcifications (skull X‐ray)
Sweet syndrome Conjunctivitis, episcleritis, iridocyclitis Arthritis, arthralgias
Tricho‐dento‐osseus Caries, periodontitis, small teeth, enamel defects, tall stature, frontal bossing Brittle nails
Trichorhinophalangeal Cone‐shaped epiphyses, shortened phalanges and metacarpals, thin upper lip Nail dystrophy
Trichothiodystrophy Cataract, conjunctivitis, nystagmus Osteosclerosis, short stature Koiloynchia, ridging, splitting, leukonychia
Tuberous sclerosis Retinal hamartomas (mulberry appearing), hypopigmented spots on iris Dental pits, gingival fibromas, bone cysts, osteosclerosis Koenen tumor
Vitamin A deficiency Night blindness, unable to see in bright light, xerophthalmia, Bitot spots, keratomalacia Growth retardation, excessive periosteal bone (decreased osteoclastic activity) Brittle nails
Vitamin B2 (Riboflavin) deficiency (Oral–ocular–genital) Eye redness, burning, fatigue, sandiness, dryness, photosensitivity to light, cataracts Cheilosis, red sore tongue
Vitiligo Uveitis, depigmented retina
Von Hippel Lindau Retinal hemangioblastoma
Waardenburg Dystopia canthorum, heterchromia irides Caries, cleft lip/palate, scrotal tongue
Werner Cataract, glaucoma Sclerodactyly, osteoporosis, high‐pitched voice
Wilson Kayser‐Fleischer ring Blue lunulae
Witkop Retained primary teeth Nail dystrophy (toe>finger)
X‐linked chthyosis Posterior comma‐shaped corneal opacities (Descemet’s membrane)
Yellow nail syndrome Yellow nails, thick, slowed growth Yellow lunulae – consider insecticides/weed killers (dinitro‐orthocresol, diquat, and paraquat), tetracycline, smoking

Source: Adapted from Benjamin A. Solky, MD and Jennifer L. Jones, MD. Boards’ Fodder – Bones, Eyes, and Nails.


Genital ulcers














































Infection Organism Incubation Presentation Treatment Notes
Chancroid Haemophilus ducreyi 3–10 d Painful, soft, ragged edges; tender, and unilateral LAN Azithromycin, ceftriaxone, ciprofloxacin, and erythromycin “School of fish” gram stain
Primary syphilis (Chancre) Treponema pallidum 2–4 wk Painless, indurated, sharp, and raised edges; bilateral and nontender LAN Penicillin Rubbery, “ham‐colored base”
Genital HSV HSV 3–7 d Painful, grouped Antivirals
Lymphogranuloma venereum Chlamydia trachomatis serovars L1–3 3–12 d Painless, soft, tender LAN Doxycycline “Groove sign” – tender nodes around Poupart’s ligament
Donovanosis/granuloma inguinale Calymmatobacterium/Klebsiella granulomatis 2–12 wk Non‐ or mildly painful, beefy red, bleeding TMP‐SMX, doxycycline, erythromycin, and ciprofloxacin “Safety pin” Donovan bodies

Other infectious causes of genital ulcers: EBV, Amebiasis, Candida, TB, and Leishmaniasis.


Non‐Infectious causes of genital ulcers: Behcet/Apthous, Crohn, Lichen Planus, Tumor, Lichen Sclerosis, Contact, Trauma, Factitial, Fixed drug (NSAIDs, metronidazole, sulfonamide, acetaminophen, TCN, phenytoin, OCPs, phenolphthalein, and barbiturates), Other meds (all‐trans‐retinoic acid, foscarnet), MAGIC syndrome, Cicatricial/Bullous pemphigoid, Hemangioma, EM/SJS/TEN.


INFECTION AND INFESTATIONS


Fungal Disease / Mycoses


Laboratory tests


Direct microscopy:



  • KOH: softens keratin, clearing effect can be acclerated by gentle heating
  • DMSO: softens keratin more quickly than KOH alone in the absence of heat
  • Chlorazole Black E: chitin specific, stains hyphae green
  • Parker Black Ink: stains hyphae, not chitin specific
  • Calcofluor White: stains fungal cell wall (chitin) and fluoresces blue/white or apple/green using fluorescent microscopy
  • India Ink: capsule excludes ink (halo effect) – best for Cryptococcus neoformans
  • Gram Stain: stains blue
  • PAS: stains red
  • GMS: stains black
  • Mucicarmine: pink = capsule; red = yeast
  • AFB: + if nocardia
  • Lactophenol cotton blue: use for mounting and staining fungal colonies

Cultures



  • Sabouraud’s Dextrose Agar: standard medium for fungal growth + chloramphenicol: inhibits bacteria

    • + cycloheximide: use to recover dimorphic fungi and dermatophytes. Inhibits crypto, candida (not albicans), Prototheca, Scopulariopsis, Aspergillus

  • Dermatophyte test medium (DTM): use to recover dermatophytes

    • Turns medium from yellow to red (pH indicator)

Superficial mycoses


White piedra: Trichosporon. Soft mobile nodules, face, axilla, pubic, and tropical.



  • Tx: Shave hair. Systemic antifungal if relapse.

Black piedra: Piedraia hortae. Hard nonmobile nodules, face, scalp, pubic, and temperate.



  • Tx: Shave hair. Systemic antifungal if relapse.

Tinea nigra: Phaeoannellomyces (Hortaea) werneckii. Brown macules on the palms.



  • Tx: Topical iodine, azole antifungal, terbinafine for two to four weeks beyond resolution to prevent relapse. Resistant to griseofulvin.

Tinea versicolor: Malassezia furfur/Pityrosporum ovale. Hypo/hyperpigmented macules on trunk and extremities.



  • KOH: “spaghetti and meatballs” – hyphae and spores
  • Tx: Topical ketoconazole cream, selenium sulfide shampoo, oral ketoconazole.

DDx superficial bacterial infection



  • Erythrasma: Corynebacterium minutissima (coproporphyrin III)
  • Trichomycosis axillaris: Corynebacterium tenuis
  • Pitted keratolysis: Micrococcus sedentarius

Cutaneous mycoses


Dermatophytes by sporulation characteristics


















Trichophyton Microsporum Epidermophyton
Macroconidia
Shape
Wall
Rare
Cigar/pencilThin/smooth
ManySpindled/taperedThick/echinulate Many, Grouped
Club/bluntThin/smooth
Microconidia Many Few None

Dermatophytes by mode of transmission

Zoophilic and geographic dermatophytes elicit significant inflammation















Anthrophilic Humans T. rubrum, T. tonsurans, E. floccosum, T. concentricum, T. mentagrophytes var. interdigitale
Zoophilic Animals T. mentagrophytes var. mentagrophytes, M. canis, T. Verrucosum
Geographic Soil M. gypseum

Most common dermatophytes























Tinea corporis, tinea cruris, tinea mannum, tinea pedis T. rubrum, T. mentagrophytes, E. floccosum
Tinea pedis Moccasin: T. rubrum, E. floccosum
Vesicular: T. mentagrophytes var. mentagrophytes
Onychomycosis Distal subungual: T. rubrum
Proximal white subungual (HIV): T. rubrum
White superficial: T. mentagrophytes (adults);
T. rubrum (children). Also molds: Aspergillus, Cephalosporium, Fusarium, Scopulariopsis
Tinea barbae Usually zoophilic dermatophytes (especially T. mentagrophytes var. mentagrophytes and T. verrucosum) or T. rubrum
Tinea capitis US: T. tonsurans > M. audouinii, M. canis
Europe: M. canis, M. audouinii
Favus: T. schoenleinii > T. violaceum, M. gypseum
Tinea imbricata/Tokelau T. concentricum
Majocchi granuloma Often T. rubrum > T. violaceum, T. tonsurans

Dermatophytes invading hair












Ectothrix Fluorescent (pteridine) M. canis, M. audouinii, M. distortum, M. ferrugineum, and M. gypseum
Nonfluorescent T. mentagrophytes, T. rubrum, T. verrucosum, T. megninii, M. gypseum, and M. nanum
Endothrix (black dot) T. rubrum, T. tonsurans, T. violaceum, T. gourvilli, T. yaoundie, T soudanense, and T. schoenleinii (fluoresces)


M. gypseum may or may not fluoresce; T. rubrum may be ecto‐ or endothrix


E. floccosum and T. concentricum do NOT invade scalp hair


Fungal Disease ‐ Clinical Presentation and Management
















































































































































Disease Etiology In Vivo/KOH (Tissue phase) Culture (Mold phase) Clinical Tx
Subcutaneous mycoses
Sporotrichosis Sporothrix schenckii Cigar‐shaped budding yeast, Splendore–Hoeppli phenomenon Hyphae with daisy sporulation Florist, gardener, farmer‐ (rose thorn, splinter), Zoonotic (cats)
Sporotrichoid spread (fixed if prior exposure)
DDx for sporotrchoid spread: leishmaniasis, atypical mycobacteria, tularemia, nocardia, and furunculosis
Itraconazole, SSKI
Chromoblastomycosis Fonsecaea (most common), Cladosporium, Phialophora, Rhinocladiella Copper pennies/ Medlar bodies/Sclerotic bodies Small pink warty papule → expands slowly to indurated verrucous plaques with surface black dots Itraconazole, surgical excision
Phaeohyphomycosis Exophiala jeanselmei, Wangiella dermatitidis, Alternaria, Bipolaris, Curvularia, Phialophora Like chromo but with hyphae Solitary subcutaneous draining abscess Surgical excision, itraconazole
Lobomycosis (Keloidal Blastomycosis) Loboa loboi (Lacazia loboi) Lemon‐shaped cell chains with narrow intracellular bridges
Maltese crosses – polarized light
Not cultured Bottle nose dolphins and rural men in Brazil
Confluent papules/ verrucous nodules that ulcerates/crusts
Fibrosis may resemble keloids
Surgical excision
Zygomycosis Conidiobolus coronatus Rhinofacial subcutaneous mass
Rhinosporidiosis (protozoan) Rhinosporidium seeberi Giant sporangia (raspberries)
Stains with mucicarmine
Not cultured Stagnant water, endemic in India and Sri Lanka
Nasopharyngeal polyps – may obstruct breathing
Surgical excision
Protothecosis (algae) Prototheca wickerhamii Morula (soccer ball) Olecranon bursitis
Actinomycotic mycetoma (bacterial) Actinomadura pelletierii (red)
Actinomadura madurae (white)
Streptomyces (yellow)
Actinomyces israeli
Botryomycosis
Nocardia (white‐orange)
Volcano‐like ulcer and sinus tracts
Sulfur grains – yellow, white, red, or brown
Tissue swelling
Early bone and muscle invasion
Antimicrobial
Eumycotic mycetoma (fungal) Pseudallescheria boydii (most common, white‐yellow)
Madurella grisea
Madurella mycetomi (brown‐black)
Exophilia jeanselmei
Acremonium spp. (white‐yellow)
Small ulcer with sinus tracts
Sulfur grains (white or black)
Tissue swelling
Lytic bone changes occur late; rare muscle invasion
Antifungal rarely effective; surgical excision
Systemic mycoses
Coccidiomycosis (San Joaquin Valley Fever) Coccidioides immitis/C. posadasii Large spherules,
Splendore–Hoepli phenomenon
Boxcars: barrel‐shaped arthroconidia alternating with empty cells Southwestern US, Mexico, Central America
Primary pulmonary infection (60% asx)
Dissemination to CNS, bone
Skin lesions more verrucous. May develop EN or EM lesions
Itraconazole, fluconazole, amphoB
Paracoccidiomycosis (South American Blastomycosis) Paracoccidioides brasiliensis Mariner’s wheel (thin‐walled yeast with multiple buds) Oval microconidia indistinguishable from Blastomyces South America, Central America
Chronic granulomatous pulmonary disease
Disseminates to liver, spleen, adrenals, GI, nodes
Skin: granulomatous oral/ perioral lesions
*Men ≫̸ women: estrogen may inhibit growth
Ketoconazole
Blastomycosis (Gilchrist disease, North American Blastomycosis) Blastomyces dermatitidis Broad‐basedbbudding yeast with thick walls Lollipop spores Southeast US and Great Lakes
Primary pulmonary infection
Disseminates to CNS, liver, spleen, GU, long bones
Skin: verrucous lesion with “stadium edge” borders
Itraconazole, amphoB
Histoplasmosis (Darling disease) Histoplasmosis capsulatum/
H. duboisii
Intracellular yeasts in macrophages (parasitized histiocytes, may see halo unlike Leish) Tuberculate macroconidia Mississippi/ Ohio river valley basin – bird/bat droppings
Most common: pulmonary infection (80–95%)
Dissemination to liver, BM, spleen, and CNS
Skin: molluscum‐like lesions in AIDS
Itrazconaozle, amphoB
Opportunistic mycoses
Candidiasis Candida albicans Pseudohyphae or true septate hyphae Part of normal enteric flora
Infection is due to predisposing factors: impaired epithelial barrier: burns, maceration, wounds, occlusion, foreign bodies (dentures, catheters), and antibiotics
Constitutional disorders: DM2, polyendocrinopathy, and malnutrition
Immunodeficiency: cytotoxic agents, neutropenia, agranulocytosis, HIV, and chronic granulomatous disease
Topicals: nystatin, miconazole, clotrimazole

Systemic: SAF
Cryptococcosis Cryptococcus neoformans Encapsulated yeasts with surrounding clear halo, “tear drop budding”
Stain with mucicarmine, PAS, GMS, or India ink
Bird droppings – usually via pulmonary infection then hematogenous spread to lungs, bones, and viscera. Predilection for CNS.
Skin: nasopharygeal papules/pustules, subQ ulcerated abscess
AmphoB
fluconazole
Aspergillosis Aspergillus flavus
A. fumigatus
A. niger
Phialides with chains of conidia (broom brush)
Septate hyphae 45° branching
Infection from inhalation of conidia → pulmonary aspergillosis
Allergic bronchopulmonary aspergillosis: hypersensitivity, no tissue invasion
Invasive/disseminated aspergillosis: angioinvasive
Allergic: steroid
Invasive: SAF
Zygomycosis/Mucormycosis Hyphae broad ribbon like with 90° branching Most commonly respiratory portal of entry → rhinocerebral infection
Associated with diabetic ketoacidosis
AmphoB, surgical excision
Rhizopus

Mucor
Absidia
Rhizoid opposite sporangia
No rhizoids
Rhizoids between sporangia
Penicilliosis Penicillium marneffei Histo‐like intracellular yeasts Southeast Asia
Umbilicated lesions, 85% of affected patients have skin lesions
AmphoB, fluconazole

SAF – systemic antifungal: amphoB, liposomal amphoB, fluconazole, itraconazole, voriconazole, and caspofungin.


Viruses and diseases























































































Family Examples Replication site Genome (+ sense; – antisense)
DNA Poxviridae Molluscipox: Molluscum
Orthopox: Vaccinia, smallpox, and cowpox
Parapox: Orf, milker’s nodule
Cytoplasm dsDNA
Papillomaviridae Human papilloma virus Nucleus dsDNA
Herpesviridae HHV1: HSV1
HHV2: HSV2
HHV3: VZV
HHV4: EBV
HHV5: CMV
HHV6: Roseola infantum, reactivation increases drug‐induced hypersensitivity syndrome severity
HHV7: associated with Pityriasis rosea
HHV8: Kaposi sarcoma
Nucleus dsDNA for all
Hepadnaviridae HBV Nucleus w/ RNA intermediate* Gapped dsDNA
Adenoviridae Human adenovirus Nucleus dsDNA
Parvoviridae Erythema infectiosum Nucleus ssDNA
RNA Paramyxoviridae Measles, Mumps Nucleus ssRNA
Togaviridae Rubella, Chikungunya Cytoplasm +ssRNA
Rhabdoviridae Rabies Nucleus ssRNA
Retroviridae HIV, HTLV Nucleus +ssRNA (dsDNA intermediate
Picornaviridae Enterovirus (coxsackie; HAV) Nucleus +ssRNA
Flaviviridae HCV, West Nile, Yellow fever, Dengue Cytoplasm +ssRNA
Filoviridae Ebola, Marburg cytoplasm –ssRNA
Bunyaviridae Hantavirus, Rift valley, Congo‐Crimean cytoplasm –ssRNA
Arenaviridae Lassa cytoplasm –ssRNA

* Therefore HBV is susceptible to anti‐HIV medications.


Human papilloma virus












































































Disease Description Associated HPV type
Verruca vulgaris Common warts 1, 2, 4
Myrmecia Large cup‐shaped palmoplantar warts 1
Verruca plantaris/palmaris Plantar warts 1, 2, 27, 57
Butcher’s wart Warty lesions from handling raw meat 2, 7
Verrucous carcinoma, foot Epithelioma cuniculatum 2, 11, 16
Verruca planae Flat warts 3, 10
Epidermodysplasia verruciformis Inherited disorder of HPV infection and SCCs 3, 5, 8, 12, many others
Buschke and Löwenstein Giant condyloma 6, 11
Condyloma acuminata Genital warts LOW RISK: 6, 11
HIGH RISK: 16, 18, 31
Flat condyloma: 42
Oral condyloma: 6, 11
Oral florid papillomatosis (Ackermann) Oral/nasal, multiple lesions, smoking/irradiation/chronic inflammation 6, 11
Recurrent respiratory papillomatosis Laryngeal papillomas 6, 11
Heck disease
(Focal epithelial hyperplasia)
Small white and pink papules in mouth 13, 32
Bowen’s disease SCCIS 16, 18
Bowenoid papulosis Red‐brown papules and plaques on the genital resembling genital warts. Histologically SCCIS/ high‐grade squamous intraepithelial lesion 16, 18
Erythroplasia of queyrat Velvety erythematous plaque on the genital. Histologically SCCIS 16, 18
Stucco keratoses White hyperkeratotic plaques on legs 23b, 9, 16
Ridged wart Wart with preserved dermatoglyphics 60

Other viral diseases




















































































































Viral disease Description Cause
Boston exanthem Roseola‐like morbilliform eruption on face and trunk, small oral ulcerations Echovirus 16
Castleman disease (associated w/ POEMS and paraneoplastic pemphigus) (Angio)lymphoid hamartoma: hyaline‐vascular type, plasma cell, and multicentric/ generalized types HHV‐8
Dengue fever (virus may cause Dengue fever, Dengue hemorrhagic fever, or Dengue shock syndrome) Rash in in 50% of patients, flushing erythema within 1–2 d of symptom onset, then 3–5 d later a generalized often asx maculopapular eruption with distinct white “islands of sparing,” 1/3 mucosal lesions, may be ecchymotic or petechial, incubation 3–14 d Dengue flavivirus
Eruptive pseudoangiomatosis Fever, transient hemangioma‐like lesions, usually children, often with halo Echovirus 25 and 32
Erythema infectiosum (Fifth disease) Children aged 4–10 yr, “slapped cheeks,” reticular exanthem, usually extremities, arthropathy in adults, anemia/hydrops in fetus, persistent in Sickle Cell Parvovirus B19
Gianotti–Crosti syndrome (Papular acrodermatitis of childhood) Children (often ≤4 yo) with acute onset of often asymptomatic, lichenoid papules on face and extremities, less on trunk Various: HBV most common worldwide, EBV most common in the United States
Hand‐Foot‐and‐Mouth Brief mild prodrome, fever, erosive stomatitis, acral and buttock vesicles, highly contagious, mouth hurts, skin asymptomatic Various Coxsackie viruses, Coxsackie Virus A16, Enterovirus 71
Herpangina Fever, painful oral vesicles/erosions, no exanthem Coxsackie Groups A and B, various echoviruses
Hydroa vacciniforme Vesiculopapules, photosensitivity, pediatric with resolution by early adulthood EBV (when severe, EBV‐associated NK/T‐cell lymphoproliferative disorders)
Infectious mononucleosis (Glandular fever) Two peaks: 1–6 yo and 14–20 yo; fever, pharyngitis, (cervical) lymphadenopathy, HSM, eyelid edema, 5% rash, leukocytosis, elevated LFTs; 90% get maculopapular exanthema with ampicillin/amoxicillin EBV (also causes nasopharyngeal carcinoma, posttransplant lymphoproliferative disorder, African Burkitt lymphoma)
Kaposi sarcoma Vascular tumors HHV‐8
Kaposi varicelliform eruption (Eczema herpeticum) Often generalized, crusted, vesiculopustular dermatitis; may be umbilicated*; fever, malaise, lymphadenopathy HSV, may also occur with coxsackie, vaccinia, and other dermatitides
Lichen planus Purple, Polygonal, Planar, Pruritic, Papules HCV
Measles (Rubeola) Prodrome – cough, coryza, conjunctivitis, Koplik spots. Then maculopapular rash spreads craniocaudally. Incubation 10–14 days Paramyxovirus
Milker’s nodules Similar to Orf
From infected cows
Paravaccinia/Parapoxvirus
Molluscum Contagiosum Umbilicated papules in children and HIV, or as STD Poxvirus; 4 MCV subtypes: MCV 1 is most common overall,
MCV 2 in immunocompromised
Monkeypox Smallpox‐like but milder and lesions may appear in crops, with prominent lymphadenopathy, and without centrifugal spread Monkeypox/Orthopoxvirus (smallpox vaccination is protective)
Oral hairy leukoplakia Nonpainful, corrugated white plaque on lateral tongue in HIV or other immunosuppressed patients, + smoking correlation EBV
Orf (Ecthyma Contagiousum) Umbilicated nodule after animal contact, six stages; sheep, goats, reindeer; self‐limiting in ~5 weeks Orf/Parapoxvirus
Papular/Purpuric stocking‐glove syndrome Young adults, mild prodrome, enanthem, edema, erythema, petechiae, purpura, burning, pruritus on wrists/ankles Various: Parvovirus B19, Coxsackie B6, HHV‐6
Pityriasis rosea Usually asymptomatic papulosquamous exanthem Possibly HHV‐7
Ramsey hunt Vesicular lesions following geniculate ganglion on external ear, tympanic membrane, with ipsilateral facial paralysis and deafness, tinnitus, vertigo, oral lesions VZV
Roseola infantum
(Exanthum subitum, Sixth disease)
Infants with high fever (×3 days) followed by morbilliform rash, 15% have seizure HHV‐6B, rarely HHV‐6A or HHV‐7
Rubella (German measles) Mild prodrome, tender LAN, pain with superolateral eye movements, morbilliform rash, spreads craniocaudally, petechial enanthem (Forschiemer spots), incubation 16–18 days Togavirus
Smallpox 7–17 day incubation, 2–4 day prodrome (fever, HA, and malaise), then centrifugal vesiculopustular rash, lesions are all the same stage, respiratory spread Variola/Orthopoxvirus
STAR complex Sore throat, elevated Temperature, Arthritis, Rash Various: HBV, Parvovirus B19, Rubella
Unilateral laterothoracic exanthem Age <4 years, morbilliform or eczematous, often starts in axilla, unilateral then spreads Various: EBV, HBV, Echovirus 6

* Umblicated lesions DDx: molluscum, pox viruses, HSV, histoplasmosis, cryptococcosis, penicilliosis, perforating disorders, leprosy, and GA.


Adapted from Benjamin A. Solky, MD and Jennifer L. Jones, MD. Boards’ Fodder – Viruses.


Infections/Bugs


Vector‐borne diseases
























































































































































































































































Disease Cause Vector/transmission Treatment
Acrodermatitis chronica atrophicans
(Pick‐Herxheimer disease)
Borrelia afzelii,
Borrelia garinii
Ixodes ricinus, Ixodes hexagonus,
Ixodes persulcatus
Amoxcillin, doxycycline, cefotaxime, penicllin G
African tick‐bite fever Rickettsia africae Amblyomma hebraeum,
Amblyomma variegatum
Doxycycline
African trypanosomiasis (sleeping sickness)
–Winterbottom sign (posterior cervical LAN)
–Kerandel’s sign (hyperesthesia)
Trypanosoma brucei gambiense (West Africa) Tsetse fly (Glossina morsitans) Pentamidine isethionate (hemolytic stage)
Melarsoprol or eflornithine (CNS involvement)
Trypanosoma brucei rhodesiense (East Africa) Tsetse fly (Glossina morsitans) Suramin (hemolytic stage)
Melarsoprol (CNS involvement)
Bacillary angiomatosis Bartonella henselae, Bartonella quintana Cat flea (Pediculus humanus) Erythromycin, doxycycline
Brazilian spotted fever Rickettsia ricketsii Ixodid tick Amblyomma cajennense
RESERVOIR: Capybara
Doxycycline
Carrion disease
(Bartonellosis, Oroya fever, Verruga peruana)
Bartonella bacilliformis Sandfly (Lutzomyia verrucarum) Chloramphenicol (due to frequent superinfxn with salmonella)
Cercarial dermatitis (Swimmer’s itch) Cercariae of animal schistosomes Snail Topical corticosteroids
Chagas disease (American trypanosomiasis) Trypanosoma cruzi Reduviid bug (assassin bug, kissing bug) Benznidazole, nifurtimox
Cutaneous larva migrans (Creeping eruption) Ancylostoma braziliense, Ancylostoma caninum Animal feces Albendazole, ivermectin OR
Thiabendazole topically
Cysticercosis Taenia solium Contaminated pork Albendazole, praziquantel
Dengue fever Flavivirus Aedes aegypti or albopticus Supportive Tx
Dracunculiasis Dracunculus medinensis (Guinea fire worm) Cyclops water flea ingestion Slow extraction of worm + wound care
Oral metronidazole facilitates removal
Ehrlichiosis, human monocytic (HME) Ehrlichia chaffeensis Amblyomma americanum Doxycycline, rifampin (pregnancy)
Ehrlichiosis, human granulocytic (HGE), and human granulocytic anaplasmosis (HGA) Ehrlichia ewingii (HGE),
Anaplasma phagocytophilum (HGA)
Ixodes persulcatus and Dermacentor variabilis Doxycycilne, rifampin (pregnancy)
Elephantiasis tropica (Lymphatic filariasis) Wuchereria bancrofti,
Brugia malayi, Brugia timori
Culex, Aedes, and Anopheles mosquitos Diethylcarbamazine
Erysipeloid (of Rosenbach) Erysipelothrix rhusiopathiae Fish, shellfish, poultry, and meat Penicillin G, Cipro, erythromycin/rifampin
Glanders (Farcy) Burkholderia (Pseudomonas) mallei Horses, mules, and donkeys Augmentin, doxycycline, TMP‐SMX
Kala‐azar
(Visceral leishmaniasis)
L. donovani, L. infantum (Old World)
L. chagasi (New World)
Phlebotomus sand fly
Lutzomyia sand fly
Pentavalent antimony (sodium stibogluconate) or amphotericin
Leishmaniasis, New World (Muco) Cutaneous (Chiclero Ulcer, Uta, Espundia, Bay Sore) L. mexicana, L. braziliensis Lutzomyia sand fly Pentavalent antimony (sodium stibogluconate) or amphotericin
Leishmaniasis, Old World Cutaneous (Oriental/Baghdad/Dehli Sore) L. tropica; L. major; L. aethiopia, L. infantum Phlebotomus sand fly
RESERVOIR: Rodents
Pentavalent antimony (sodium stibogluconate)
Loiasis (Calabar, Fugitive swelling) Loa loa Tabanid (horse/mango) fly,
Chrysops (red, deer) fly
Diethylcarbamazine
Lyme disease US: Borrelia burgdorferi


EUROPE: B. garinii and B. afzelli
NE/GREAT LAKES: Ixodes scapularis/dammini
WEST US: I. pacificus
EUROPE: I. ricinus
Doxycycline
Amoxicillin if pregnancy or <9 yo
Mediterranean spotted fever
(Boutonneuse fever)
Rickettsia conorii Rhipicephalus sanguinous (dog tick) Doxycycline, chloramphenicol, and floroquinolone
Melioidosis (Whitmore disease) Burkholderia (Pseudomonas) pseudomallei Tropical soil, water IV ceftazidime (high‐intensity phase) then TMZ‐SMX and Doxycycline
Myiasis Dermatobia hominis (botfly),
Cordylobia anthropophaga (tumbu fly), Phaenicia sericata (green blowfly)
Mosquito (for Dermatobia hominis) Removal of larvae and treatment with abx for superinfection
Onchocerciasis (River blindness) Onchocerca volvulus Simulium species (black fly) Ivermectin
Plague (Bubonic) Yersinia pestis Xenopsylla cheopis (rat flea) Streptomycin, gentamicin
Q Fever Coxiella burnetii Dried tick feces inhalation Doxycycline
Rat‐bite fever (Haverhill, Sodoku) Spirillium minus (Asia/Africa),
Streptobacillus moniliformis (US)
Rat bite, scratch, excrement, contaminated food Penicillin
Relapsing fever – Louse‐borne Borrelia recurrentis (Africa, South America) Pediculosis humanus, Doxycycline
Relapsing fever – Tick‐borne Borrelia duttonii, Borrelia hermsii (Western US) Ornithodorus genus (soft bodied ticks) Doxycycline
Rickettsialpox Rickettsia akari Allodermanyssus (Liponyssoides) Sanguineus (house mouse mite)
RESERVOIR: Mus musculus – domestic mouse
Doxycycline
Rift valley fever Phlebovirus, bunyavirus Aedes Supportive Tx, ribavirin (investigational)
Rocky mountain spotted fever Rickettsia rickettsii Dermacentor andersoni, Dermacentor variabilis Doxycycline
Schistosomiasis/Bilharziasis
(Cercarial dermatitis, Katayama fever, late allergic dermatitis, perigenital granulomata, extragenital infiltrative)
Schistosoma mansoni (GI),
S. japonicum (GI),
S. haematobium (urinary system)
Snail Praziquantel
Scrub typhus (Tsutsugamushi fever) Rickettsia/Orientia tsutsugamushi Larval stage of trombiculid mite (chigger, Trombicula/Leptotrombidium akamushi) Doxycycline
South African tick‐bite fever Rickettsia conorii Rhipicephalus simus, Haemaphysalis leachii, Rhipicephalus mushamae Doxycycline
Sparganosis Spirometra (dog and cat tapeworm larvae) Application/ingestion of infected frog, snake, or fish Surgical removal
Toxoplasmosis Toxoplasma gondii Cat feces, undercooked meat, milk Pyrimethamine and sulfadiazine
First trimester: spiramycin
Trench (Quintana) fever Bartonella quintana Pediculus humanus corporis Doxycycline, erythromycin
Trichinosis Trichinella spiralis Undercooked pig, wild game Steroids for severe symptoms and
mebendazole or albenazole
Tularemia (Deer fly fever, Ohara disease) Francisella tularensis Rabbit, Dermacentor andersonii,
Amblyomma americanum,
Chrysops discalis (deer fly), domestic cats
Streptomycin
Typhus, endemic; Murine/Flea‐borne typhus Rickettsia typhi Xenopsylla cheopis (rat flea) Doxycycline
Typhus, epidemic; Brill‐Zinsser disease/relapsing Louse‐Borne typhus) Rickettsia prowazekii Pediculus humanus, squirrel fleas
RESERVOIR: Glaucomys volans‐flying squirrel
Doxycycline
Weil disease (leptospirosis) Leptospira interrogans icterohaemorrhagiae Rat urine Doxycycline, penicillin, ampicillin, and Amoxicillin
West Nile fever Arbovirus Aedes, culex, and anopheles Supportive Tx
Yellow fever Arbovirus Aedes aegypti Supportive Tx

Source: Adapted from Benjamin A. Solky, MD and Jennifer L. Jones, MD. Boards’ Fodder – Bugs and their Vectors. Treatment adapted from The Medical Letter 2004; 46(1189).


Creatures in dermatology


































































































































































































































































































Creature Scientific name Special features
Spiders
Brown recluse spider Loxosceles reclusa

  • VENOM: Sphingomyelinase‐D, hyaluronidase
  • Violin‐shaped marking on back
  • Painless bite but with extensive necrosis
  • Red, white, and blue sign
  • Viscerocutaneous loxoscelism: fever, chills, vomit, joint pain, hemolytic anemia, shock, and death
  • Tx: steroid, ASA, antivenom. Avoid debridement
Black widow spider Latrodectus mactans

  • VENOM: Α‐lactotoxin
  • Hourglass‐shaped red marking on abdomen
  • Painful bites but no necrosis
  • Neurotoxin causes chills, GI sxs, paralysis, spasm, diaphoresis, HTN, and shock
  • Tx: IV Ca gluconate, muscle relaxant, antivenom
Jumping spider Phidippus formosus

  • VENOM: Hyaluronidase
  • Dark body hairs and various white patterns
  • Very aggressive spider
  • Painful with toxin venom but no systemic sxs
Wolf spider Lycosidae

  • VENOM: Histamine
  • Lymphangitis, eschar
Sac spider Chiracanthium

  • VENOM: Lipase
  • Yellow colored
Hobo spider Tegenaria agrestis

  • Herringbone‐striped pattern on abdomen
  • Painless bite with fast onset induration then eschar
  • Aggressive spider
  • Funnel‐shaped web
Green lynx spider Peucetia viridans

  • Green with red spots
  • Painful bite with tenderness and pruritus
Tarantula Theraphosidae

  • Hairs cause urticaria
  • Ophthalmia nodosa – if hair gets into eyes→ chronic granuloma formation
Caterpillers Lepidoptera (urticaria after contact with hairs)
Puss/Asp Megalopyge opercularis

  • Brown woolly flat
  • Checkerboard eruption
Iomoth Automeris io

  • Green with lateral white strip from head to toe
Gypsy/Tent moth Lymantria dispar

  • Histamine in lance‐like hair
  • Windborne can cause airborne dermatitis
Saddleback Sibine stimulea

  • Bright green saddle on the back
Hylesia moth Hylesia metabus

  • Caparito/Venezuela itch
Lonomia caterpillar Lonomia achelous/obliqua

  • Latin America moth, fatal bleeding diathesis
Flies
Black fly Simulium

  • VECTOR: Onchocerciasis
Sand fly Phlebotomus

  • VECTOR: L. donovani, L. tropica, L. infantum, L. major, and L. aethiopia
Lutzomyia

  • VECTOR: L. mexicana, L. braziliensis, and Bartonellosis
Tsetse fly Glossina

  • VECTOR: African trypanosomiasis
Deer fly Chrysops

  • VECTOR: Loiasis, tularemia
Botfly larvae Dermatobia hominis, Callitroga americana (US)

  • Myiasis when larvae (maggot) infest skin
  • Other flies whose larvae cause myiasis: Cordylobia anthopophaga (tumbu fly, moist clothing) and Phaenicia sericata (green blowfly, US)
Mosquitoes Culicidae

Anopheles

  • VECTOR: Malaria, filariasis

Aedes

  • VECTOR: Yellow fever, dengue, and filariasis, Chikungunya

Culex

  • VECTOR: Filariasis, West Nile
Fleas Siphonaptera
Human flea Pulex irritans

  • May play role in plague, affects other mammals
Cat flea Ctenocephalides felis

  • VECTOR: Bartonella hensalae → cat scratch disease and bacillary angiomatosis
  • PARINAUD: oculoglandular syndrome – granulomatous conjunctivitis and preauricular LAN
Rat flea Xenopsylla cheopis


  • VECTOR: R. typhi → endemic typhusYersinia pestis → bubonic plaque
Sand/Chigoe flea Tunga penetrans

  • Tungiasis
  • Give tetanus px when tx (surgery or ivermectin)
Beetles
Rove beetle Paederus eximius

  • Nairobi eye
  • TOXIN: Pederin
Blister beetle Lytta vesicatoria/Spanish fly

  • Source of cantharadin
  • Blister if squished on skin
Carpet beetle Attagenus megatoma and A. scrophulariae

  • ACD with larvae
Lice
Pubic (Crab) Pthirus pubis

  • Shortest and broadest body with stout claws
  • Maculae ceruleae (blue macules) on surrounding skin from louse saliva on blood products
Head lice Pediculus capitis

  • Six legs, long narrow body
Body lice Pediculus humanus corporis


  • Narrow, longest body
  • Lives in folds of clothing not directly on host
  • VECTORS: Bartonella quintana → trench feverBorellia recurrentis → relapsing fever
    Rickettsia prowazekii → epidemic typhus
Mites
Scabies Sarcoptes scabiei hominis

  • Classic burrows along webspaces, folds
  • Skin scraping for eggs, feces, and mites
  • Tx: Permethrin, lindane, and ivermectin
Straw itch mite Pyemotes tritici

  • Found on grain, dried beans, hay, and dried grasses
  • Salivary enzymes are sensitizing
  • May cause systemic sx: fever, diarrhea, and anorexia
Demodex Demodicidae

  • Associated with acne rosacea, demodex folliculitis
  • Lives in human hair follicles
Grain mite Acarus siro

  • Causes baker’s itch
Cheese mite Glyciphagus

  • Causes grocer’s itch
  • Papular urticaria or vesicopapular eruption
Grocery mite Tyrophagus

  • Papular urticaria or vesicopapular eruption
Harvest mite (Chigger) Trombicula alfreddugesi

  • Intense pruritus on ankles, legs, and belt line
  • VECTOR: R. tsutsugamushi→ scrub typhus
Dust mite Dermatophagoides
Euroglyphus


  • Atopy
House mouse mite Allodermanyssus sanguineus

  • VECTOR: R. akari → rickettsialpox
Walking dander Cheyletiella

  • Walking dandruff on dogs/cats
  • Pet is asx; human gets pruritic dermatitis
Fowl mite Ornithonyssus,
Dermanyssus


  • Bird handlers most commonly bitten
  • VECTOR: Western equine encephalitis
Copra Itch Tyrophagus putrescentiae

  • Causes itching to dried coconut handlers
  • Resembles scabies on hand but no burrows
Others
Scorpions Centruroides sculturatus and C. gertschi

  • Neurotoxin causes numbness distally
  • Systemic: convulsion, coma, hemiplegia, hyper/hypothermia, tremor, restlessness
  • Arrhythmia, pulmonary edema, hypertension
  • Local wound care, ice packs, antihistamine
Bedbugs Cimex Lectularius

  • Flat with broad bodies, 4–5 mm in length
Bees, wasps, hornets, ants Hymenoptera

  • May cause angioedema
  • VENOM of honeybee: Phospholipase A
Fire ant Solenopsis

  • VENOM: Solenopsin D (piperidine derivative)
Reduviid bug Hemiptera

  • Kissing/Assassin bugs
  • VECTOR: Trypanosoma cruzi → Chagas disease
  • Primary lesion: chagoma
  • Romana’s sign: unilateral eyelid swelling
  • Acute: 1–2 weeks, fever, LAN, arthralgia, and myalgia
  • Chronic: progressive heart, megacolon
Centipedes Chilopoda

  • Carnivores: venomous claws causes painful bites with two black puncture wounds 1 cm apart
Millipedes Deplopoda

  • Vegetarians, emit toxin which burns, blister
Water Creatures
Leeches

  • Medicinal use associated with Aeromonas hydrophila wound infection
Sea urchin

  • Foreign body reaction to spines, use hot water and vinegar for pain relief and inactivating toxins
  • Black sea urchin = Diadema setosa
Sea cucumber

  • Toxin holothurin causes conjunctivitis
Dolphins

  • Lobomycosis – keloidal blastomycosis, Loboa loboi
Schistosomes (Flukes)
– nonhuman host


  • Swimmers itch/Clam Diggers itch (uncovered skin)
  • Cercarial forms of flatworm penetrates skin in fresh or salt water (Northern US/Canada), causes allergic reaction
  • Schistosomes of ducks and fowls (nonhuman)
Schistosomes (Flukes)
– human host


  • S. mansonii, S. japonicum, S. hematobium → Schistosomiasis
  • Cercarial forms penetrates skin and enters the portal venous system to the lungs, heart, and mesenteric vessels
Stronglyoides stercoralis (Threadworm)

  • Cutaneous larva currens
  • Serpiginous urticarial burrow on buttocks, groin, and truck
  • May penetrate basement membrane to affect lungs and GI tract (chronic strongyloidiasis, Loefler’s syndrome)
  • FAST migration (5–10 cm/h)
  • Tx: Ivermectin
Ancylostoma caninum,
A. braziliense (Hookworm)


  • Cutaneous larva migrans
  • Hookworm penetrates skin on foot on sandy beaches
  • Cannot penetrate basement membrane (dead‐end host)
  • Larvae deposited by dogs and cat feces
  • Serpiginous vesicular burrow
  • SLOW migration (2–10 mm/h)
  • Tx: Thiabendazole or ivermectin
Cnidarian Jellyfish, Portuguese man of war, sea anemone, coral, and hydroids. Stingers (nematocytes) break through skin causing pain and potential systemic symptoms. Use 3–10% acetic acid or vinegar to fix nematocytes to prevent firing and toxin release
Box jellyfish

  • Toxic stings may lead to shock
Portuguese Man of War

  • Painful stings may cause hemorrhagic lesions with vesicles
Sea anemone (Edwardsiella lineate)
Thimble jellyfish (Linuche unguiculata)


  • Seabathers eruption (prurituic papules in areas covered by swimwear)
  • Contact with cnidarian larvae in salt water (Southern US/Caribbean), larvae trapped beneath swimsuit
Exotic pets, others
Iguana

  • Salmonella, Serratia marcescens, and Herpes‐like virus
Hedgehog

  • Trichophyton mentagrophytes, Salmonella, and atypical mycobacteria
Cockatoo, Pigeon

  • Cryptococcus neoformans, avian mites
Chincilla

  • Trichophyton mentagrophytes, Microsporum gypseum, Klebsiella, and Pseudomonas
Fish/Fish tank/Swimming pool

  • Mycobacterium marinum
  • Treat with TMP‐SMX, Clarithromycin, and Doxycycline
Flying squirrel

  • Rickettsia prowazekii, Toxoplasma gondii, Staphylococcus
Lambs (lambing)

  • Lambing ears: farmers develop blistering, itching, painful rash at pinnae (resembles juvenile spring eruption/PMLE)

CONTACT AND PLANT DERMATITIS


Patch testing



  • Allergaic contact dermatitis = Type IV delayed‐type hypersensitivity

    • Common location of rash – hands, face, and neck
    • Sensitization process takes 10–14 days. Upon reexposure, rash appears in 12–48 hours
    • Contrast with Irritant Contact Dermatitis – can occur from single application (no prior exposure) or multiple repeated applications. Usually more painful and burning (rather than itchy with ACD). Combination of exogenous irritant and loss of host barrier function.

      • Hand Dermatitis frequently presents with BOTH irritant and allergic contact dermatitis.

    • Contrast with Type I (immediate hypersensitivity) – IgE mediated. RAST test.

  • Product usage – can trigger even if rarely used. Secondary allergy is common (i.e. product used after rash started)
  • Stop immunosuppressive meds:

    • Decrease prednisone < 20 mg/d, ideally stop systemic corticosteroid one to two weeks
    • Stop topical meds 7–14 days prior to patch testing to testing area
    • No sun exposure/phototherapy three weeks prior
    • MTX, TNF‐a, mycophenolate mofetil may be ok to continue (limited data showing patients on these meds have positive patch test)
    • Ok to continue antihistamines (except if contact urticaria is suspected)

  • Adminstration

    • Use uninvolved skin on the upper back if possible (avoid preexisting dermatitis)
    • Shave back hair prior to day of testing
    • Mark patch sites with surgical pen and highlighter
    • Secure with hypoallergenic adhesive tape
    • Take picture of patch test placement

  • Remove patch at 48 hours. Allow transient erythema to subside for 10–15 minutes then mark initial reaction.
  • Followup in three to seven days for final read. Must keep back dry until final reading

    • Early reactors: carba mix, thiuram, and balsam of Peru
    • Late reactors: metals (gold), topical corticosteroid, antibiotics, dyes, formaldehyde‐releasing preservatives, PPD, cocamide diethanolamine

  • Positive reaction does not mean pt’s rash is due to that specific antigen (clinical relevance!)

Reactions
























Negative – no reaction
? Doubtful reaction: Macular erythema only
+ Weak reaction: Nonvesicular – erythema, infiltration, and possibly papules
++ Strong reaction: Edematous or vesicular, erythema and papules
+++ Extreme reaction: Spreading, bullous, and ulcerative
IR Irritant reaction
NT Not tested

T.R.U.E Test (Thin‐layer Rapid Use Epicutaneous Test): 36 chambers



  • 35 allergens (1 negative control #9)
  • True test identifies approximately 70–75% of positive reactions in the NACDG screening series of 70 allergens (see below)




























































































Panel 1.3
Panel 2.3
Panel 3.3
1 Nickel sulfate 13 p‐tert‐Butylphenol formaldehyde resin (PTBP) 25 Diazolidinyl urea
2 Wood alcohols 14 Epoxy resin 26 Quinoline mix
3 Neomycin sulfate 15 Carba mix 27 Tixocortal‐21‐pivalate
4 Potassium dichromate 16 Black rubber mix 28 Gold sodium thiosulfate
5 Caine mix 17 Cl Me Isothizolinone 29 Imidazolidinyl urea
6 Fragrance mix 18 Quarterium 15 30 Budesonide
7 Colophony 19 Methydibromo‐glutaronitrile 31 Hydrocortison‐17‐butyrate
8 Paraben mix 20 p‐Phenylenediamine 32 Mercaptobenzothiazole
9 Negative control 21 Formaldehyde 33 Bacitracin
10 Balsamof Peru 22 Mercapto mix 34 Parthenolide
11 Eithylenediamine dihydrocholoride 23 Thimerasal 35 Disperse Blue 106
12 Colbalt dichloride 24 Thiuram mix 36 2‐Bromo‐2‐nitro‐propane‐1‐3‐diol (bronopol)

Common contact allergens
























































































































































































































































































































































Allergen (standard testing concentration) Uses/products/cross‐reactions (X‐RXN) T.R.U.E test NACDG rank*
Metal
Nickel
(2.5% pet.)
– Jewelry, watches, alloys, coins, buttons and belt buckles, eyelash curlers, kitchen utensils, scissors, razors, canned food, and electronics (phones)
– Dietary nickel: legumes, dark leafy green vegetables, chocolate, and oat
Can have coexisting allergies to chromate and cobalt
*Dimethylglyoxime – to detect nickel (turns pink)
#1 1
Cobalt
(1.0% pet.)
Mixed with metals for strength
– Cement, cosmetics, vitamin B12 injections, pigment in porcelain, paint, crayon, glass, pottery, and blue tattoos
X‐RXN: nickel, chromate
#12 14
Potassium dichromate/chromium
(0.25% pet.)
– Tanned leather, cement, mortar, matches, anti‐rust products, paint, plaster, GREEN dyes/ tattoos (pool/card table felt), metal working, chromic surgical gut suture, and implants
X‐RXN: nickel, cobalt
#4 40
Gold sodium thiosulfate
(0.5% pet.)
– Jewelry, dental restorations, electronics, and glass frames
X‐RXN: nickel, cobalt
#28
Resin/plastics/glue
2‐Hydroxyethyl methacrylate/HEMA
(2% pet.)
– Artificial nails, dental work 30
Epoxy resin/Bisphenol A
(1% pet.)
Allergens: bisphenol A, epichlorohydrin
USES: Resin for adhesive
– Glues, plastics, adhesives, PVC products, electrical insulation, paints, and protective coatings
#14 35
Methyl methacrylate
(2% pet.)
– Artificial nails, dental work, glue for surgical prostheses, and exterior latex house paint 46
Ethyl acrylate
(0.1% pet.)
Resin, plastics, rubber, and denture 51
p‐tert‐Butylphenol formaldehyde resin (PTBP) USES: adhesive
– Glues, shoes/watchband/handbag (glued leather products), plywood, disinfectants, rubber, varnish, printer inks, and fiberglass
may cause depigmentation
X‐RXN: formaldehyde
#13 62
Ethyl cyanoacrylate
(10% pet.)
“Superglue”
– Artificial nails glue, liquid bandage
66
Toulene‐sulfonamide/tosylamide formaldehyde resin
(10% pet.)
Nail lacquer/hardener: eyelid, face, neck, and finger dermatitis 47
Rubber compound
Carba mix
(3% pet.)
USES: Rubber stabilizer, fungicides, and pesticides
– Elastic bands, condoms, shoes, cements, erasers, health‐care equipments (gloves, masks, and tubing)
X‐RXN: thiurams
#15 11
Thiuram mix
(1% pet.)
USES: Rubber additives, prevents degradation of rubber products
– Gloves, adhesive, latex, condoms, neoprene, fungi and pesticides, and Disulfiram
X‐RXN: carba mix, rubber additives
#24 18
Black rubber mix
(0.6%pet.)
Isopropyl PPD, cyclohexyl PPD, and diphenyl PPD
USES: Rubber stabilizer
– Black and gray rubber products: tires, rubber boots, eyelash curlers, scuba suits, and balls
X‐RXN: disperse dyes, hydrochlorothiazide, ester anesthetic (PABA), and sulfonamides
#16 45
Mercapto mix
(1% pet.)
USES: Rubber accelerator
– Rubber products: gloves, makeup sponges, undergarments, and tires
#22 61
Mercapto‐benzothiazole/MBT
(1% pet.)
USES: Rubber accelerator
– Rubber shoes, tires, undergarments, shoes, and neoprene
Co‐sensitizer: rubber additives such as dibutyl and diphenyl thiourea
#32 58
Mixed dialkyl thioureas
(1% pet.)
Rubber antioxidant
– Wet suits, shoe insoles, adhesives, copy paper, and photography
48
Vehicle and cosmetic ingredients
Lanolin/
Wool alcohol
(50% pet.)
USES: Emulsifier
From: sheep sebum (amerchol, cholesterol, lanosterol, agnosterol, and alcohol)
– Cosmetics, soaps, adhesives, and topical agents
X‐RXN: Aquaphor, Eucerin (cetyl or stearyl alcohols)
#2 9
Propylene glycol
(30% aq.)
Dimer alcohol to increase drug solubility
– Vehicle base in topical meds, valium, lubricant jelly; brake fluid, and antifreeze
15
Cocamidopropyl Betaine
(1% aq.)
Nonionic surfactant from coconut oil
Antigens: amidoamine, DMAPA, and CAPB
– Shampoo (“no more tears”), liquid soaps
Usually facial pattern rash
24
Cocamide DEA
(0.5% pet.)
Shampoos, soaps 37
Cocamidopropyl betaine
(1% aq.)
Nonionic surfactant from coconut oil
Antigens: amidoamine, DMAPA, and CAPB
– Shampoo (“no more tears”), liquid soaps
Usually facial pattern rash
24
Benzyl alcohol
(10% pet.)
Solvent, preservative, and anesthetic
– Plants, essential oils, foods, cosmetics, medications, and paints/lacquers
57
Ethylenediamine dihydrochloride
(1% pet.)
Industrial stabilizer
– Topical antibiotic/steroid creams (Mycolog cream); dye, rubber, resin, waxes, fuel additive, corrosion inhibitors, and plastic lubricants
X‐RXN: DETA, epoxy amines, hydroxyzine, aminophylline, and phenothiazine
#11 59
Medicaments
Bacitracin
(20% pet.)
– Triple antibiotics
Risk groups: leg ulcers, post‐op, chronic otitis externa
Co‐sensitivity: neomycin
#33 10
Neomycin sulfate
(20% pet.)
Aminoglycoside group
– Triple antibiotics, ear/eye drops
X‐RXN: aminoglycosides
Co‐sensitivity: bacitracin
#3 17
Chloroxylenol
(1% pet.)
– Carbolated vaseline, personal‐care products, EKG paste, and surgical scrubs 56
Lidocaine
(15% pet.)
Amide anesthetic
Usually allergy due to paraben preservative and not amide
49
Benzocaine
(5% pet.)
PABA derivative, ester anesthetic
X‐RXN: procaine, cocaine, PABA, sulfa meds, thiazide, and PPD
#5: Caine mix 54
Dibucaine
(2.5% pet.)
Amide anesthetic
X‐RXN: lidocaine, bupivicaine
#5: Caine mix 63
Tetracaine
(2% pet.)
PABA derivative, ester anesthetic
X‐RXN: procaine, cocaine, PABA, sulfa meds, thiazide, and PPD
#5: Caine mix
Corticosteroids Four groups based on structure:
A – HC/Prednisone – most allergenic
B – TMC acetonide (also budesonide, desonide)
C – Betamethasone, dexamethasone
D1 – Clobetasone‐17‐propionate
D2 – Hydrocortisone‐17‐butyrate
Tixocortol pivalate (1% pet.) Test for group A corticosteroids
(Hydrocortisone and Prednisone)
– Medicaments, nasal spray
#27 19
Budesonide
(0.1% pet.)
Test for group B corticosteroids (TMC and budesonide)
X‐RXN: D2 steroids (hydrocortisone‐17‐butyrate)
#30 42
Desoximetasone
(1% pet.)
Test for group C corticosteroids (Betamethasone)
X‐RXN: none – more hypoallergenic
69
Clobetasol‐17‐propionate
(1% pet.)
Test for group D1 corticosteroids 65
Hydrocortisone‐17‐butyrate
(1% pet.)
Test for group D2 corticosteroids
X‐RXN: group A steroids (hydrocortisone)
#31 68
Fragrances
Fragrance mix I – 8 fragrances
(8.0% pet.)
1. α‐Amyl cinnamic aldehyde
2. Cinnamic alcohol
3. Cinnamic aldehyde (toothpaste, gum, and lipstick)
4. Hydroxycitronellal – synthetic, floral
5. Isoeugenol
6. Eugenol – clove
7. Evernia prunastri – oak moss/lichen extract
8. Geraniol – geranium
Found in personal hygiene products (perfumes, flavoring agents, and soaps), household cleaners, air fresheners, paper products, foods and flavorings, and candles
X‐RXN: colophony, wood tars, turpentine, propolis, benzoin, storax, and balsam of Peru
#6 2
Balsam of Peru – Myroxylon pereirae resin
(25% pet.)
Cinnamic acid, cinnamyl cinnamate, benzyl benzoate, benzoic acid, vanillin, and eugenol
– Fragrances, spices (cloves, cinnamon, and Jamaican pepper), flavoring agent (wine, tobacco, vermouth, and cola), mild antimicrobial properties, and candles
X‐RXN: Colophony, benzoin, propolis, and fragrance mix
#10 3
Fragrance mix II (14% pet.) 1. Citronellol
2. Hexyl cinnamal
3. Citral
4. Coumarin
5. Farnesol
6. Hydroxyisohexyl 3‐cyclohexene
carboxaldehyde (Lyral)
Found in personal hygiene products
8
Cinnamic aldehyde (1.0% pet.) Oral hygiene products (toothpaste)
Allergen is component of Frag mix I and balsam of Peru
13
Colophony – rosin, abietic acid – Adhesives, cosmetics, epilation wax, polish, paint, chewing gum, instrument rosin (violin), topical salves, paper products, wood products (sawdust, wood fillers); from conifer
X‐RXN: wood tars, fragranes, spices, and rosin esters
#7 29
Limonene
(2% pet.)
– Citrus peels, fragrance additive, sanitizers, cleansers, and degreasers 70
Preservatives – formaldehyde releasing
Quaternium‐15
(2% pet.)
Sensitivity may be to formaldehyde
#1 cause of hand dermatitis
– topical medications, soaps, shampoos, moisturizers, industrial polishes, waxes, ink, latex paints, and adhesives
#18 5
Formaldehyde
(1% aq.)
– Ubiquitous – fabric finishes (waterproof, anti‐wrinkle), cosmetics, cleansers, paper products, paint, pressed wood construction material, and embalming fluids
X‐RXN: Formaldehyde‐releasing preservatives: quaternium‐15, imidazolidinyl urea, diazolidinyl urea, and DMDM‐hydantoin
#21 7
Diazolidinyl urea (1% pet.) Germall II
– cosmetics, personal‐care products
X‐RXN: Formaldehyde‐releasing preservatives
20
DMDM hydantoin (1% pet)

  • Cosmetics and personal‐care products

X‐RXN: Formaldehyde‐releasing preservatives

23
Bronopol/2‐Bromo‐
2‐nitropropane‐1,3‐diol
(0.5% pet.)
– Topical medications, cosmetics, and personal‐care products
X‐RXN: Formaldehyde‐releasing preservatives
#36 26
Imidazolidinyl urea/Germall 115/Tristat
(2% pet.)
– Topical medications, cosmetics, skin/hair products, adhesive, and latex emulsions
X‐RXN: Formaldehyde‐releasing preservatives
#25 28
Preservatives – non‐formaldehyde releasing
MCI/MI (Methyl‐choloro‐isothiazinolone)/Kathon CG

(0.01% aq.)
USES: biocide and preservative
– Personal‐care products, cosmetics, hair/skin products (Eucerin), household products (toilet paper, baby wipes), permanent waves, and latex emulsions
#17 4
Iodopropyl butyl carbamate
(0.1% pet.)
– Personal‐care products, baby wipes, and cosmetics 12
Methyldibromo glutaronitrile/MDBGN/Euxyl K400
(1.0 % pet.)
USES: Preservative to prevent chemical change or microbial action
– Cosmetic/personal‐care products, paper towels, cutting oils, and adhesives
#19 16
Paraben mix
(12% pet.)
Methyl, Ethyl, Propyl, Butyl, Benzyl p‐hydroxybenzoate
USES: preservatives in personal‐care products, cosmetics, and medication
X‐RXN: PABA, PPD
*paraben paradox – may only react on involved skin, patch test to normal skin is negative
#8 22
Thimerosal
(0.1% pet.)
Components: thiosalicylic acid and ethyl mercuric chloride
– Preservative/antiseptic/vaccine/eye drops
X‐RXN: piroxicam, mercury
*Frequently allergen is not relevant
#23
Quinoline mix Components: Clioquinol and Chlorquinaldol
– Preservative in antifungals, antibacterial medications, and paste bandage
X‐RXN: vioform, diiodoquin, and quinoloar
#26
Hair care
PPD/p‐Paraphenylenediamine
(1% pet.)
Blue‐black aniline dye
– Permanent hair dyes, henna tattoos, photography solutions, printer inks, oils, gasoline, and black rubber products
X‐RXN: pro/benzocaine, PABA, azo‐ and aniline dyes, sulfas, and para‐aminosalicylic acid
#20 6
Ammonium persulfate
(2.5% pet.)
Bleaching agent
– Hair bleach, flour
Contact urticaria, anaphylactoid rxn
Glyceryl thioglycolate/GTG
(1% pet.)
Acidic perming/permanent wave solutions
Chemical remains in hair shaft for months
Others
Disperse Blue 106
(1% pet.)
Fabrics colored dark blue, brown, black, purple, and green
X‐RXN: Disperse blue 124, para‐phenylenediamine
#35 43
Latex Sap from the rubber tree Hevae brasiliensis
– Gloves, condom, and balloon
High risk: children with spina bifida, health‐care workers
X‐RXN: avocado, banana, chestnut, kiwi, and papaya
RAST test, prick test
Gluteraldehyde
(1% pet.)
Cold sterilizing solution
Health‐care workers, embalming fluid, electron microscopy, and hand cleansers
X‐RXN: formaldehyde
53
Propolis
(10% pet.)
Dimethylallyl ester of caffeic acid
– Bee glue, lipstick, ointments, and mascara
– Organic cosmetics
32
Parthenolide
(3 mcg/cm2)
Plants: daisies, feverfew, and magnolia
– Natural remedies
#34

Source: Adapted from Goldenberg A, et al. Boards’ Fodder – Contact Dermatitis Allergens Summer 2015 and Washaw EM et al. Dermatitis. 2015 Jan–Feb;26(1):49–59.


* NACDG Rank Based on Table 8 Significance‐Prevalence Index Number from Warshaw et al. Dermatitis, 2015; 26:56–57.


Allergic vs. irritant contact dermatitis
























































Allergic contact Irritant contact
Frequency Less common (20%) More common (80%)
Reaction Immunologicl/Type IV delayed‐type hypersensitivity (Th1) Non‐immunologic/Local toxic effect
Symptoms Itchy, common on the hands, face, and neck More painful and burning (rather than itchy)
Presentation Hands, face, and neck
Erythema, edema, vesicles, papules, and lichenification
Erythema, edema, desquamation, and fissures
Onset Hours to days Usually minutes to hour
Distribution May be focal or spread beyond area of exposure, appear in ectopic Lesions restricted to areas where irritant damages the skin
Sensitization Required. Usually takes 10–14 days. Upon reexposure, rash appears in 12–48 hours. No sensitization. Can occur from single application without prior exposure or with multiple repeated applications. Affects everyone
Risk if atopic Decreased Increased
Cross‐reaction Can occur No cross‐reaction
Antigen Requires lipophilic, low‐molecular weight haptens N/A
Allergen‐specific lymphocytes not involved
Concentration Independent – can be low dose Dependent (dose response)
Diagnosis Patch testing History and physical
Negative patch test

Allergens – location specific








































Location Tips Allergens
Hands/arms Common to be combination of ICD and ACD
25–40% Irritant
25–75% ACD


  • Quarternium‐15
  • Nickel sulfate
  • Fragrances, Balsam of Peru
  • Neomycin/Bacitracin
  • Rubber accelarators
Periorbital/eyelids Most common – cosmetics

  • Nickel, gold – transfer from hands
  • Cobalt (blue eye makeup)
  • Fragrance, Balsam of Peru
  • Thimerasol, Neomycin
  • Nail products
Lip (cheilitis)/perioral Should get eval for ACD
85% in females


  • Fragrance, Balsam of Peru
  • Nickel (transfer from hands)
  • Toothpastes, mouthwash, and flavors (spearmint, cinnamal)
  • Lipstick, lip balms – Propolis
Scalp and neck Frequently personal‐use products

  • Fragrance, Balsam of Peru
  • PPD (hair dye and black henna)
  • Glycerol thioglycolate (perm. wave solutions)
  • Nail products
  • Shampoos fragrances, isothiazolinones, Formaldehyde releasers (preservatives), Cocamidopropylbetaine
Axillary Usually deodorants, textile
Or systemic contact derm when feet and groin are also involved
Antiperspirant rarely cause ACD


  • Fragrance in deodorants (Hydroxyisohexyl‐3‐cyclohexene, Carboxaldehyde, Isoeugenol, Cinnamicaldehyde)
  • Natural botanicals
  • Texile: Disperse blue 106, 124, Urea formaldehyde – (permanent press)
Anogenital Topically applied products
44% ACD
21% Irritant to soap and cleansers


  • Cinnamicaldehyde,
  • Dibucaine, benzocaine,
  • Hydrocortisone‐17‐butyrate, budesonide
Feet Consider patch test in patients with unexplained chronic dermatitis in lower extremities, feet, and/or sole
Feet: Rubber chemicals, adhesives, leather in shoes


  • Phenol formaldehyde resin (in adhesives), potassium dichromate, and cobalt chloride
  • Rubber chemicals – carbamates, thiurams, and mercaptobenzothiazole
  • Dialkylthioureas(adhesive)
Legs Consider patch test in patients with unexplained chronic dermatitis in lower extremities, feet, and/or sole
Legs: topically applied products


  • Fragrance/ Balsam of Peru,
  • Neomycin, bacitracin
  • Corticosteroids
  • Lanolin

Features suggestive of specific irritant/toxin















Acne/folliculitis Arsenic, oils, glass fibers, asphalt, tar, chlorinated naphthalenes, and polyhalogenated biphenyls
Miliaria Occlusion, aluminum chloride, UV, and infrared
Alopecia Borax, chloroprene dimers
Granulomatous Silica, beryllium, keratin, talc, and cotton

Plants and Dermatoses


Plants causing non‐immunologic contact urticaria


Urticaceae family (nettle):



  • Urtica spp. (dioica) – stinging nettle
  • Dendrocnide spp. – Australian stinging nettle, may be fatal

Euphorbiaceae family (spurge):



  • Acidoton and Cnidosculus spp.
  • Croton plant

Hydrophyllaceae family (water‐leaf)


Plants causing mechanical irritant dermatitis


Hedera helix – Araliaceae – common ivy


Opuntia spp. – Cactaceae – prickly pear


Tulipa spp. – Liliaceae – tulip


Ficus and Morus spp. – Moraceae – fig, mulberry


Carduus and Cirsium spp. – Asteraceae – thistle


Bidens tripartita – Asteraceae – bur marigold


Other Asteraceae – dandelion, lettuce, chicory (irritant latex)


Plants causing chemical irritant dermatitis

























































Chemical Plant Scientific name
Calcium oxalate Daffodil Narcissus spp. (Amaryllidaceae)
Century plant Agave americana (Agavaceae)
Dumb cane
Philodendrom
Dieffenbachia picta and Philodendron spp. (Araceae)
Pineapple Ananas cosmosus (Bromeliaceae)
Hyacinth Hyacinthus orientalis (Liliaceae)
Rubarb Rheum rhaponticum (Polygonaceae)
Thiocyanates Garlic Allium sativum (Alliaceae)
Black mustard Brassica nigra (Brassicaceae)
Radish Raphanus sativus (Brassicaceae)
Cashew nut shell oil Cashew tree Anacardium occidentale (Anacardiaceae)
Bromelin Pinapple Ananas cosmosus (Bromeliaceae)
Phorbol esters, diterpenes (latex) Poinsetta Euphorbia pulcherrina (Euphorbiaceae)
Protoanemonin Buttercup Ranunculus spp. (Renunculaceae)
Capsaicin Chili pepper Capsicum anuum (Salanaceae)

Phytophotodermatoses


Apiaceae: hogweed (Heracleum sphondylium), celery (Apium gaveolens), parsley (Petroselinum), parsnips, fennel (Foeniculum vulgare)


Rutaceae: lime, orange, lemon, garden rue, Hawaiian lei, gas plant/burning bush


Moraceae: mulberry, fig tree


Fabaceae/Leguminosae: bavachee/scurf‐pea (vitiligo tx)


Plant allergic contact dermatitis
























































Allergen Family Plant (Scientific name)
Urushiol Anacardiaceae Poison ivy/oak/sumac (Toxicodendron vernix)
Cashew nut tree (Anacardium occidentale)
Mango (Mangifera indica)
Cross‐reactions: Ginko biloba, Grevillea Brazilian pepper tree (Schinus terebinthifolius, Florida Holly)
Indian marking tree nut (Semecarpus anacardium)
Japanese lacquer tree (Toxicodendron verniciflua)
Rengas tree (Gluta spp.)
Sesquiterpene lactones
Poisonwood tree (Metopium toxiferum)
Asteraceae (Compositae) Feverfew (Tanacetum parthenium)
Chrysanthemum (X Dendranthema)
Dandelion (Taraxacum officinale)
Sunflower (Helianthus annuus)
Scourge of India (Parthenium hysterophorus, wild feverfew)
Daisy (Leucanthemum spp.)
Ragweed (Ambrosia spp.)
Marigold (Tagetes spp.)
Artichoke (Cynara scolymus)
Lettuce (Lactuca sativa)
Endive (Cichorium endiva)
Chicory (Cichorium intybus)
Chamomile, mugwort (Artemisia spp.)
Yarrow (Achillea millefolium)
Diallyl disulfide Alliaceae Onion (A. cepa)
Garlic (A. sativum)
Leek (A. porrum)
Chive
Tuliposide A Alstromeriaceae and Lillaceae Tulip, Peruvian lily (A. auriantiaca and A. ligtu)
Primin Primulaceae Primrose (Primula obconica)
Lamiaceae Peppermint (menthol), spearmint (carvone), lavender, thyme
D‐limonene Myrtaceae Tea tree (Melaleuca spp.)
Colophony and turpentine/carene Pinaceae Pine tree (Pinus spp.)
Spruce tree (Picea spp.)
Ricin Castor bean Ricinus communis
Abrin Jequirity bean Abrus precatorius
Usnic acid, evenic acid, atronorin Lichens

TUMORS AND INFILTRATES


Cutaneous T Cell Lyphoma


CTCL WHO‐EORTC Classification – Relative Frequency and 5‐year Survival


































































Relative Frequency (%) 5‐Year Survival (%)
Indolent cutaneous T‐cell and NK‐cell lymphoma
 Mycosis fungoides 44 88
 Follicular MF 4 80
 Pagetoid reticulosis <1 100
 Granulomatous slack skin <1 100
 Cutaneous anaplastic CD30+ large cell lymphoma 8 95
 Lymphomatoid papulosis 12 100
 Subcutaneous panniculitis‐like T‐cell lymphoma 1 82
 CD4+ small/medium pleomorphic T‐cell lymphoma 2 75
Aggressive cutaneous T‐cell and NK‐cell lymphoma
 Sézary syndrome 3 24
 Cutaneous aggressive CD8+ T‐cell lymphoma <1 18
 Cutaneous γ/δ T‐cell lymphoma <1
 Cutaneous peripheral T‐cell lymphoma unspecified 2 16
 Cutaneous NK/T‐cell lymphoma, nasal‐type <1

Source: Modified from Willemze R, et al. WHO‐EORTC classification for cutaneous lymphoma. Blood. 2005;105: 3798. Based on 1905 patients with primary cutaneous lymphoma registered at the Dutch and Austrian Cutaneous Lymphoma Group 1986–2002.


Mycosis Fungoides Variants


Alibert‐Bazin – classic type of MF


Follicular MF – 10% of MF, folliculotropic infiltrates, follicular mucinosis, favors head and neck (esp eyebrow), alopecia, mucinorrhea, pruritic, stage as if classical tumor stage. Less responsive to skin‐directed therapies due to the deep follicular localization of MF infiltrate.



  • Primary localized – pediatric, H/N, upper trunk, usu resolve within several mos‐yrs
  • Primary chronic, generalized – adults, concerning for malignant progression
  • Secondary – benign (lupus, LSC, ALHE, drug – adalimumab, imatinib), malignant (MF, KS, Hodgkin)

Woringer‐Kolopp/Pagetoid Reticulosis – <1% of CTCL, localized, solitary hyperkeratotic patch/plaque, slowly progressive. Good prognosis No reports of extracutaneous dissemination or disease‐related deaths.


Ketron‐Goodmann – disseminated pagetoid reticulosis, aggressive.


Granulomatous Slack Skin – pendulous atrophic lax skin, esp. axillae and groin. Associated with MF or Hodgkin lymphoma in 1/3 of cases. Usually indolent, very rare.


Sezary – 5% of MF cases, triad of exfoliative erythoderma, lymphadenopathy, and atypical circulating (“Sezary,” “Lutzner,” or “mycosis”) cells. MF‐like immunophenotype but characteristically CD26‐ and CD3+ but diminished. Change from Th1 to Th2 profile may drive progression to Sezary.


Clonality studies



  • Suspected B‐cell lymphomas: Flow cytometry (provides kappa:lambda ratio, requires fresh tissue in cell culture), immunoglobulin heavy chain gene rearrangement studies (can use paraffin‐embedded tissue), immunohistochemistry for kappa or lambda restriction has low sensitivity (normally κ:λ ratio ~ 3).
  • Suspected T‐cell lymphomas: αβ TCR gene rearrangement studies (more sensitive than γδ TCR gene rearrangement studies, can use paraffin‐embedded tissue), flow cytometry (less useful for suspected T‐cell lymphomas).
  • For detecting CTCL, specificity can be increased by performing TCR rearrangement studies on biopsy specimens from ≥2 anatomic locations looking for a shared clone.

CTCL Workup



  1. Complete skin exam: patch, plaque vs. tumor, % skin involvement, check lymph nodes.
  2. Skin biopsy of most indurated area: immunophenotype CD2, CD3, CD4, CD5, CD7, CD8, CD20, CD30, CD25, CD56, TIA1, granzyme B, βF1, TCR‐CγM1, and TCR gene rearrangement.
  3. Blood tests: CBC with diff, Sezary Prep, LFTs, LDH, CMP.
  4. Optional for T1: Flow cytometry (CD3, CD4, CD7, CD8, CD26 to assess for expanded CD4+ cells with increased CD4/CD8 ratio or with abnormal immunophenotype, including loss of CD7 or CD26).
  5. Radiology: CXR for Stage I and IIa. PET CT chest, abd, pelvis for Stage IIb and above.

CTCL (TNMB) staging














T (Skin) N (Nodes) M (Viscera) B (Blood)
T1 = Patch/plaque < 10%
T1a = patch only
T1b = plaque ± patch
T2 = Patch/plaque > 10%
T3 = Tumor(s)
T4 = Erythroderma >90%
N0 = None
N1 = Palpable nodes, path (−)
N2 = Palpable nodes, path (+), nodal architecture unaffected
N3 = Palpable nodes, path (+), nodal architecture effaced
Nx = Palpable nodes, no histologic confirmation
M0 = None
M1 = Visceral
involvement
B0 = <5% Sezary cells
B1 = >5% Sezary cells, low blood tumor burden
B2 = high blood burden (1000/ml Sezary cells and positive clone)

*Adapted from Kim YH. Mycosis fungoides and the Sezary syndrome. Semin Oncol 1999;26:276–289. Kim YH et al. Long‐term outcome of 525 patients with mycosis fungoides and Sezary syndrome. Arch Dermatol. 2003;139:857–866. Amin, Mahul, et al. AJCC Cancer Staging Manual, 8th Ed. Springer International Publishing, 2017. NCCN Guidelines Version 4.2018.





































Stage Clinical involvement Clinically enlarged nodes Histologically + nodes TNMB 5‐year survival (%)*
IA
IB
Patch/plaque < 10%
Patch/plaque > 10%


T1 N0 M0
T2 N0 M0
96
73
IIA
IIB
Patch/plaque
Tumor(s)
+Nodes
±Nodes
−Path
−Path
T1–2 N1 M0
T3 N0‐1 M0
73
44
IIIA
IIIB
Erythroderma
Erythroderma
−Nodes
+Nodes
−Path
−Path
T4 N0 M0
T4 N1 M0
44
IVA
IVB
Any skin
Visceral involvement
+Nodes + Path T1–4 N2–3 M0
T1–4 N0–3 M1
27

CTCL Treatment Algorithm

































Stage First line Second line Experimental
IA SDT or no therapy
IB, IIA SDT
PUVA, NB/BB UVB
TSEB
Radiotherapy
IFN‐α
PUVA + IFN‐α, Retinoids, or Baxarotene
Low‐dose MTX
HDAC‐inhibitors (vorinostat, romidepsin)
Cytokines (i.e. Il‐2, IL‐12, and IFN‐γ)
Pegylated liposomal doxorubicin
Chlorodeoxyadenosine
IIB TSEB + Superficial radiotherapy
Combination (2 of 3) tx w/ IFN‐α, PUVA, or Retinoids
HDAC‐inhibitors (vorinostat, romidepsin)
Denileukin Diftitox
Baxarotene
IFN‐α
Chemotherapy
Brentuximab vedotin
Autologous PBSCT, mini‐allograft
Zanolimumab
III PUVA ± IFN‐α or Retinoids
ECP ± IFN‐α
MTX
IFN‐α
HDAC‐inhibitors (vorinostat, romidepsin)
TSEB
Denileukin diftitox
Bexarotene
Chemotherapy
Alemtuzumab
Brentuximab vedotin
Autologous PBSCT, mini‐allograft
Zanolimumab
IVA, IVB TSEB or radiotherapy, chemotherapy
HDAC‐inhibitors (vorinostat, romidepsin)
IFN‐α
Bexarotene
Denileukin diftitox
Low‐dose MTX
Alemtuzumab
Brentuximab vedotin
Palliative
Autologous PBSCT, mini‐allograft
Zanolimumab

Source: Modified from: Whittaker SJ, et al. Joint British Association of Dermatologists and U.K. Cutaneous Lymphoma Group guidelines for the management of primary cutaneous T‐cell lymphomas. Br J Dermatol 2003 Dec;149(6):1095–1107 and Trautinger F, et al. EORTC Consensus Recommendations for the Treatment of Mycosis Fungoides/Sézary Syndrome. Eur J Cancer 2006 May; 42(8):1014–1030


SDT: Skin‐directed therapy: Emollients, Topical steroids, Nitrogen mutard (Mechlorethamine/HN2, Carmustine/BCNU), Bexarotene gel, Imiquimod, Topical MTX.


ECP: Extracorporeal photopheresis


TSEB: Total skin electron beam


PBSCT: Peripheral blood stem cell transplant


Denileukin diftitox = IL‐2/Diptheria toxin fusion.


Acitretin = Retinoic acid receptor. 25–50 mg/d


Baxarotene = Retinoid X receptor specific. 300 mg/m2/d


Vorinostat = Suberoylanilide hydroxamic acid, SAHA. Histone deacetylase inhibitor. 400 mg po qd with food. May decrease to 300 QD if intolerant.


Alemtuzumab (Campath) = anti‐CD52


Zanolimumab = HuMax‐CD4


Cutaneous B‐cell lymphoma


























Type Clinical Immunophenotype 5‐year survival
Marginal zone Often solitary lesions on trunk or extremities, possible Borrelia association, tattoo association BCL2+ BCL6− CD10− IRTA1+ >95%
Primary follicle center Often solitary/grouped plaques on scalp/forehead or trunk BCL2− BCL6+ CD10± * >95%
Diffuse large B‐cell 80% on leg of elderly patients, F>M BCL2+ BCL6+ CD10– MUM1/IRF4+ 50%
Other B‐cell lymphomas – Intravascular large B‐cell lymphoma, Lymphomatoid granulomatosis, CLL (ZAP‐70+), Mantle cell lymphoma, Burkitt lymphoma, and B‐lymphoblastic lymphoma.

*Secondary cutaneous follicle center lymphoma – BCL2+ BCL6+ CD10+ with t(14;18)


PREVALENCE: 20–25% of primary cutaneous lymphomas are B‐cell lymphomas, each of the three major types representing ≤10% of cutaneous lymphomas.


Leukemia cutis



  • Affects children > adults
  • Skin involvement rarely precedes systemic dz
  • Except for congenital leukemia, leukemia cutis is a poor prognostic sign, especially with myeloid leukemia
  • Frequently associated with extramedullary involvement
  • Usually p/w asx papules and nodules
  • Other presentations – CLL and HTLV‐1‐associated leukemia may be pruritic; greenish tumors = chloromas, aka granulocytic sarcomas (due to myeloperoxidase); gingival hypertrophy in AML‐M4 and AML‐M5; rarely leonine facies
  • Histologically, often grenz zone (grenz zone DDx = granuloma faciale, lepromatous leprosy, lymphoma/leukemia/pseudolymphoma, acrodermatitis chronica atrophicans, AFX)
  • Common types:

    • AML – 10% of affected patients develop leukemia cutis (especially w/ AML‐M4 and ‐M5)
    • CLL and Hairy cell leukemia – 5–10% of affected patients develop leukemia cutis
    • HTLV‐1‐associated leukemia – very rare type of leukemia (except in Caribbean and Japan) but ~50% of patients may develop leukemia cutis (also get “infective dematitis”)

Monoclonal Gammopathies in Dermatology



  • Types of monoclonal gammopathies by frequency: monoclonal gammopathy of undetermined significance (MGUS) (65%), multiple myeloma (15%), AL amyloidosis (10%), others (10%): plasmacytoma, Waldenstrom, and lymphoma
  • Ig produced by monoclonal gammopathies: IgG (60%), IgM (20%), IgA (15%), extremely rarely IgD or IgE




























































Disease Ig type
Direct cutaneous infiltration of cells causing monoclonal gammopathy or depostion of cell products
 Waldenstrom IgM
 AL amyloidosis IgG
 Multiple myeloma IgG
 Plasmacytoma IgA
 Cryoglobulinemia IgM
Disorders associated with monoclonal gammopathies
 Scleromyxedema IgG λ
 Schnitzler IgM κ
 POEMS IgA > IgG
 Scleredema IgG κ
 Plane xanthoma IgG
 EED IgA
 NXG IgG κ
 Pyoderma gangrenosum IgA
 Sneddon–Wilkinson IgA
 IgA pemphigus IgA
 Sweet IgG

Source: Daoud et al. Monoclonal gammopathies and associated skin disorders. J Am Acad Dermatol. 1999;40(4):507–535.


Tumors and gene associations








































































Tumor Gene Protein Comment
Anaplastic large cell lymphoma, primary systemic NPM‐ALK fustion Nucleophosmin‐anaplastic lymphoma kinase fusion protein T(2:5)(p23;q35); ALK+ systemic anaplastic large cell lymphomas have better prognosis than ALK− systemic large cell lymphomas (primary cutaneous cases are ALK−)
Basal cell carcinoma PTCH2 Patched Somatic and BCNS
Clear cell sarcoma EWS‐ATF1 Fusion of Ewing sarcoma and activating transcriptions factor 1 aka “malignant melanoma of the soft parts”
Dermatofibrosarcoma protuberans COL1A
PDGF
Collagen 1A
Platelet‐derived growth factor
t(17;22)(q22;q13), may have supernumerary ring chromosome
Hypereosinophilia syndrome FIP1L1‐PDGFRA F/P fusion ~Chronic eosinophilic leukemia
Mantle cell lymphoma T(11;14) Fusion of Bcl‐1/Cyclin D1 and immunoglobulin heavy chain Tumor cells originate from the “mantle zone” of the lymph node; associated with men over the age of 60
Mastocytosis KIT C‐kit Adult but not childhood forms
Melanoma* CDKN2A/p16‐INK4A/p14‐ARF, BRAF, KIT, NRAS, MITF, PTEN, AKT, MC1R, APAF‐1
BRAF often mutated in melanoma and benign melanocytic nevi but unusual in Spitz nevi (similar to NRAS but reverse w/ HRAS); BRAF and NRAS mutations are reciprocal; BRAF phosphorylates ERKs/MAPKs; MC1R mutations impair cAMP synthesis; p16‐INK4A inhibits Rb; p14‐ARF inhibits p53 degradation
Merkel cell carcinoma Trisomy 6
Mycosis fungoides CDKN2A, TNFRSF6 (Fas), JUNB P16 (INK4a), P14 (ARF) Largely tumor suppressors
Pilomatricoma CTNNB1 Β‐Catenin Activating mutation; wnt signaling pathway
Seborrheic keratosis FGFR3, PIK3CA FGF receptor 3, Phosphatidylinositol kinase 3, catalytic, alpha Same genes as epidermal nevi
Spitz nevi 11p amplifications HRAS Minority of Spitz have HRAS mutations, but much more often than in melanoma

*Melanomas from skin without chronic photodamage – BRAF and NRAS mutations but nl CDK4 and CCND1 vs. Melanomas from skin with chronic photodamage – increase in number of CDK4 and CCND1 but nl BRAF and NRAS vs. Melanomas from non‐sun‐exposed skin (acral, mucosal) – KIT mutations but nl BRAF and NRAS; Acral MMs have higher degrees of chromosomal aberrations; p53 mutations uncommon in MM except LMM or MM associated with XP‐C or Li‐Fraumeni. CDKN2A mutations also found late in sporadic tumors. BRAF‐positive mutated melanomas can be treated with vemurafenib, dabrafenib, and other agents that may increase survival.


SYSTEMIC AND METABOLIC DISEASES


Amyloidoses


Stains: PAS +/diastase resistant. + Thioflavin T. Purple with crystal violet.


Birefringence with Congo red (absent after treating with potassium permanganate in AA subtype).





































Classification Type Symptoms/Subtypes
Primary systemic AL ≫̸AH 40% have skin involvement: waxy skin‐colored papules (nose, eyes, and mouth), alopecia, carpal tunnel, pinch purpura, shoulder pad sign. Also may deposit in heart, GI tract, and tongue.
Secondary/reactive systemic AA Skin NOT INVOLVED. Deposits in liver, spleen, adrenals, and kidney. Associated with chronic disease: especially TB, leprosy, Hodgkin, RA, and renal cell cancer.
Primary cutaneous AL Nodular amyloid: nodule(s) on extremities, trunk
Keratin Macular amyloid: pruritic macules interscapular region, associated with nostalgia paresthetica
Keratin Lichen amyloid: discrete papules on shins
Secondary cutaneous/tumor associated Keratin Following PUVA and in neoplasms
Familial syndromes AA Hereditary periodic fever syndromes: Familial Mediterranean fever and TNF receptor‐associated periodic syndromes (but not Hyper‐IgD)
AA Cryopyrin‐associated periodic syndromes: Familial cold autoinflammatory, Muckle–Wells, CINCA/NOMID


































































Amyloid subtype
Association
AL Ig light chain Primary systemic, myeloma, plasmacytoma, nodular
AH Ig heavy chain Primary systemic, myeloma
AA (apo) serum AA (SAA) Reactive systemic, TRAPS, FMF, Muckle–Wells, familial cold autoinflammatory
ATTR Transthyretin (prealbumin) Familial amyloid polyneuropathy 1 and 2, Familial amyloid cardiomyopathy, Senile systemic
A β2M β2‐microglobulin Hemodialysis
A β A β precursor protein (AβPP) Alzheimer, Down, Hereditary cerebral hemorrhage with amyloidosis (Dutch)
Keratinocyte tonofilaments Macular and Lichen, MEN IIa, Secondary cutaneous (PUVA, neoplasms)
Apolipoprotein I Familial amyloid polyneuropathy 3
Atrial natriuretic factor Isolated atrial
Calcitonin Medullary thyroid cancer associated
Cystatin Hereditary cerebral hemorrhage (Icelandic)
Fibrinogen α chain Familial fibrinogen associated
Gelsolin Familial amyloid polyneuropathy 4 (Finnish)
Islet amyloid polypeptide Diabetes mellitus II/Insulinoma associated
Lactoferrin Corneal lactoferrin associated
Lysozyme Familial lysozyme associated
Medin/Lactadherin Aortic medial
Prion Protein/ Scrapie Creutzfeld‐Jacob

Histiocytosis









































































































Histiocytosis Onset Clinical features Associations Pathology
Langerhans Cell Histiocytosis 2/3 children age 1–3 yo; 1/3 adults – usually pulmonary, often smokers. New classification by organ of involvement:


  1. Restricted LCH:


  1. Skin only
  2. Monostotic lesions ± diabetes insipidus (DI), LN, rash
  3. Polyostotic lesions ± dDI, LN, rash


  1. Extensive LCH:


  1. Visceral organ involvement w/o dysfunction ± dDI, LN, rash
  2. Visceral organ involvement with dysfunction +/‐ DI, LN, rash
Letterer–Siwe 0–2 yo

  • Acute, disseminated, and multisystem form
  • Resembles seb derm
  • Fever, anemia, LAN, osteolytic lesions, and HSM
ALL, solid tumors

  • CD1a+, S100+, Placental Alk Phos+
  • Reniform, “coffee‐bean” nuclei
  • Birbeck granules
Hand‐Schüller‐Christian 2–6 yo

  • Chronic, multisystem (skin lesions in 1/3)
  • Classic triad: bone lesions (80%, esp. cranium), DI, and exophthalmos
Eosinophilic granuloma Older children/adults

  • Localized, benign
  • May present with spontaneous fracture or otitis
Hashimoto–Pritzker Congenital

  • aka Congenital self‐healing reticulocytosis
  • Widespread, red‐brown papules or crusts
Non‐Langerhans Cell Histiocytosis w/o Malignant Features
Juvenile xanthogranuloma Early childhood

  • Most common histiocytosis, self‐limiting
  • Solitary lesion in 25–60% of cases
  • Head/neck > trunk > extremities
  • May be systemic (CNS, liver/spleen, lung, eye, and oropharynx)
  • Eye = most common extracutaneous site, unilateral


  • NF1
  • Leukemia
  • NF and juvenile CML


  • Small histiocytes, Touton and foreign body giant cells, and foam cells
  • CD68+, factor XIIIa+, and vimentin+
Benign cephalic histiocytosis 0–3 yo

  • 2–‐5 mm, yellow‐red papules on face/neck of infant
  • Self‐limiting
  • Spares mucous membranes and viscera
Probably same as JXG aka Histiocytosis w/ intracytoplasmic worm‐like bodies (on EM)
Generalized eruptive histiocytoma Adults > children

  • Crops of small, red‐brown papules. Widespread axial distrib.
  • Spontaneous resolution

Indeterminate cell histiocytosis Adults > children

  • Clinically identical to generalized eruptive histiocytoma

Antigenic markers of both LCH and non‐LCH
Multicentric reticulohistiocytosis Adults (F > M) 30–50 yo

  • Joints, skin, mucous membranes (50%)
  • Papules/nodules – head, hand, elbow, and periungual “coral beads”
  • Often misdiagnosed as RA
  • Waxes/wanes, spontaneously remits in 5–10 yr
    Giant cell reticulohistiocytoma, aka solitary reticulohistiocytoma = isolated, cutaneous tumor version of MRH


  • 25% internal malignancies (gastric, breast, and GU)
  • 6–17% autoimmune conditions
  • 30–60% hyperlipidemia


  • Histiocytes w/ “ground glass” appearance, oncocytic histiocytes
  • Mutinucleate giant cells
  • CD45+, CD68+, CD11b+, HAM56+, and vimentin+
  • Usually S100‐, Factor XIIIa‐, and CD34‐
Necrobiotic xanthogranuloma Sixth decade

  • Usu head/neck or trunk: esp. periorbital
  • Scleritis, episcleritis → possible blindness

    May have anemia, leukopenia, elevated ESR, and 20% HSM


  • Often chronic, progressive


  • 90% IgG paraproteinemia
  • 40% cryoglobulinemia


  • Hyaline necrobiosis, palisaded granuloma (cholesterol cleft)
  • Touton and foreign body giant cells
  • “Touton cell panniculitis”
  • CD15+, CD4+
  • CD1a−, S100−
Xanthoma disseminatum Any

  • Proliferation of foamy histiocytes despite normal serum lipids
  • Flexors, skin folds, an dmucous membranes (eyes, URT, and meninges → leads to DI)
  • Usually benign, self‐limiting



  • Unique scalloped histiocytes in early lesions
  • Histiocytes, foam cells, chronic infl cells, and Touton and foreign body giant cells
  • CD68+, Factor XIIIa+
  • CD1a−, S100−
Rosai–Dorfman Dorfman
aka Sinus histiocytosis with massive lymphadenopathy
10–30 yo, M > F

  • Generally benign, self‐limiting
  • Painless, cervical LAN
  • 40% have extranodal involvement (poor prognosis)
  • Skin is most common extranodal site



  • Expansion of LN sinuses by large foamy histiocytes, plasma cells, and multinucleate giant cells
  • Emperipolesis
  • S100+, Factor XIIa+
  • CD1a
Erdheim–Chester Middle age

  • Similar to XD, but 50% mortality
  • Symmetric sclerosis of metaphyses/diaphyses of long bones (virtually pathognomonic) → chronic bone pain
  • DI, renal and retroperitoneal infiltrates, xanthoma‐like skin lesions (esp eyelids), pulmonary fibrosis, CNS



  • Histiocytes, foam cells
  • CD68+, Factor XIIIa+
  • CD1a−
  • Usu S100−
Hemophagocytic lymphohistiocytosis Children

  • Rare, life‐threatening, rapidly progressive
  • Dx criteria: F, splenomegaly, cytopenia, hyperTG, hyper‐fibrinogenemia, hemophagocytosis on tissue bx
  • Nonspecific rashes in ~60%
  • Median survival: 2–3 mo (BM failure, sepsis)
  • Two types – Primary and Familial HLH – in both cases, triggered by infection, esp. EBV


  • CTD, malignancies, HIV

Familial HLH:



  • FHL1 – HPLH1
  • FHL2 – PRF1 (cytolytic granule content)
  • FHL3 – UNC13D (cytolytic granule secrection)
  • FHL4 – syntaxin‐11 (membr‐associated, SNARE family, docking/fusion)
Sea‐blue histiocytosis Inherited

  • Rare
  • BM, HSM – also lungs, CNS, eyes, and skin
  • Nodular lesions; eyelid infiltration


  • APOE mutations
  • One of the manifestations of Niemann–Pick type B
  • Common (<1/3) in BM bx’s of MDS
Large, azure blue, cytoplasmic granules with May‐Gruenwald stain (yellow‐brown on H&E, dark blue with toluidine or Giemsa)
Non‐Langerhans Cell Histiocytosis with Malignant Features
Malignant histiocytosis M > F 2:1

  • Very rare, life‐threatening
  • Liver, spleen, LN, and BM
  • p/w painful LAN, HSM, fever, and night sweats
  • Pancytopenia, DIC, and extranodal extension
  • 10–15% skin involvement (esp. lower legs, buttocks)

Variable

Xanthomas








































Type Distribution/appearance Associations
Xanthelasma palpebrarum Polygonal papules esp. near medial canthus May be associated with hyperlipidemia (50%) including any primary hyperlipoproteinemia or secondary hyperlipidemias such as cholestasis
Tuberous xanthomas Multilobulated tumors, pressure areas, extensors Hypercholesterolemia (esp. LDL), familial dysbetalipoproteinemia (type 3/broad beta dz), familial hypercholesterolemia (type 2), secondary hyperlipidemias (nephrotic syndrome, hypothyroidism)
Tendinous xanthomas Subcutaneous nodules esp. extensor tendons of hands, feet, Achilles, and trauma Severe hypercholesterolemia (esp. LDL), particularly type 2a, apolipoprotein B‐100 defects, secondary hyperlipidemias (esp. cholestasis, cerebrotendinous xanthomatosis, and beta sitosterolemia)
Eruptive xanthomas Crops of small papules on buttocks, shoulders, extensors, and oral Hypertriglyceridemia (esp. types 1, 4, and 5 hyperlipidemias), secondary hyperlipidemias (esp. DM2)
Plane xanthomas Palmar creases Familial dysbetalipoproteinemia (type 3), secondary hyperlipidemia (esp. cholestasis)
Generalized plane xanthomas Generalized, esp. head and neck, chest, flexures Monoclonal gammopathy, hyperlipidemia (esp. hypertriglyceridemia)
Xanthoma disseminatum Papules, nodules, and mucosa of upper aerodigestive tract Normolipemic
Verucciform xanthomas Solitary, oral or genital, adults Normolipemic

Hyperlipoproteinemias: Fredrickson classification
































































Type Name Defect, AR/AD Lipid profile Xanthomas Other clinical
I Hyperlipoproteinemia Lipoprotein lipase, AR ↑ Chylomicrons, chol, TG
↓ LDL, HDL
Eruptive xanthomas (2/3), lipemia retinalis ↑ CAD, HSM, and pancreatitis
IB Apolipoprotein C‐II deficiency APOC2 AR Similar to lipoprotein lipase deficiency
IIA* Familial hypercholesterolemia, LDL receptor disorder LDL receptor, AD ↑ LDL, chol, TG Tuberous, intertriginous, tendinous, planar xanthomas, xanthelasma, and corneal arcus ↑ CAD

Familial hyper‐cholesterolemia, type B APOB, AD Same as IIA
IIB Combined hyperlipoproteinemia Heterogeneous ↑ LDL, VLDL, chol, TG Xanthomas rare ↑ CAD
III Familial dysbetalipoproteinemia, Broad betalipoproteinemia APOE, AR ↑ Chylomicron remnants/VLDL, chol, TG Planar palmar crease, tuberous xanthomas, and xanthelasma ↑ CAD, DM2
IV Carbohydrate‐inducible lipemia AD ↑ VLDL, TG
↓ HDL
Tuberoeruptive xanthomas ↑ CAD, DM2, obesity, etoh, hypothyroidism, pancreatitis, uremia, myeloma, nephrotic, hypopituitarism, and glycogen storage type I
V Mixed hyperprebeta‐lipoproteinemia and chylomicronemia APOA5, AR/AD ↑ Chylomicrons, VLDL, TG, chol
↓ LDL, HDL
Eruptive xanthomas, lipemia retinalis Abd pain, pancreatitis, DM2, HTN, hyperuricemia, OCPs, etoh, and glycogen storage type I

Source: Susan B. Mallory. An Illustrated Dictionary of Dermatologic Syndromes, Second Edition, Taylor & Francis, 2006.


* Other familial hypercholesterolemia syndromes – AR hypercholesterolemia (ARH/LDLR adaptor protein mutations), AD hypercholesterolemia type 3 (PCSK9/PROPROTEIN CONVERTASE, SUBTILISIN/KEXIN‐TYPE, 9 mutations).


Vitamin Deficiencies/Hypervitaminoses


Vitamin A


Vitamin A supplementation helpful in rubeola


Deficiency = Phrynoderma (toadskin)



  • Due to fat malabsorption, diet; found in animal fat, liver, and milk
  • Night blindness, poor acuity in bright light, Bitot spots, keratomalacia, xerophthalmia, xerosis, follicular hyperkeratosis, fragile hair, apathy, mental and growth retardation

Hypervitaminosis A



  • Similar to medical retinoid treatment: dry lips, arthralgias, cheilitis, alopecia, onychodystrophy/clubbing, hyperpigmentation, impaired bone growth, hyperostosis, pseudotumor cerebri, lethary, anorexia

Vitamin B1 – Thiamine


Deficiency = Beriberi



  • Due to diet (polished rice), pregnancy, alcoholism, and GI disease
  • Glossitis, edema, glossodynia, neuropathy, Wernicke–Korsakoff, CHF

Vitamin B2 – Riboflavin


Deficiency



  • Alcoholics, malabsorption, neonatal phototherapy, and chlorpromazine
  • Oral‐ocular‐genital syndrome: cheilits, seborrheic dermatitis‐like rash, tongue atrophy, belpharitis, conjunctivitis, photophobia, genital and peri‐nasal dermatitis, and anemia

Vitamin B3 – Niacin/Nicotinic acid


Deficiency = Pellagra



  • May be due to precursor (tryptophan, Hartnup) deficiency, alcoholism, carcinoid tumor, INH, 5‐FU, azathioprine, GI disorders, and anorexia
  • Casal necklace eruption, photosensitivity, shellac‐like appearance, acral fissures, perineal rash, cheilitis, diarrhea, and dementia
  • Below granular layer (stratum malphighii): vacuolar changes

Vitamin B6 – Pyridoxine


Deficiency



  • Due to cirrhosis, uremia, isoniazid, hydralazine, OCP, phenelzine, and penicillamine
  • Rash resembling seborrheic dermatitis, intertrigo, cheilitis, glossitis, conjunctivitis, fatigue, neuropathy, disorientation, N/V

Vitamin B12 – Cyanocobalamin


Deficiency



  • Due to diet (found in animal products), pernicious anemia, and malabsorption
  • Glossitis, hyperpigmentation, canities, and neurologic symptoms

Vitamin C


Deficiency = Scurvy



  • Alcoholics, diet
  • Water‐soluble, fruits/vegetables
  • Perifollicular hyperkeratosis and petechiae, corkscrew hairs, hemorrhagic gingivitis, epistaxis, hypochondriasis, subperiosteal hemorrhage (pseudoparalysis), soft teeth, gingivitis, hematologic changes, and weakness

Vitamin D


Physiology:



  • Vit D2 and D3 in the diet are transported to the liver in chylomicrons and Vit D3 from the skin and Vit D2 and D3 from fat cell stores are bound to Vit D‐binding protein for transport to the liver
  • In the liver, Vit D‐25‐hydroxylase turns Vit D into 25‐hydroxyvitamin D, or 25(OH)D, the main circulating form of Vit D
  • 25(OH)D is biologically inactive until it is converted to 1,25‐dihydroxyvitamin D, or 1,25(OH)2D, by 25‐hydroxyvitamin D‐1α‐hydroxylase in the kidneys
  • 1,25(OH)2D is inactivated by 25‐hydroxyvitamin D‐24‐hydroxylase and turned into the calcitroic acid, which is excreted in bile
  • In osteoblasts, 1,25(OH)2D increases RANKL which bind RANK on preosteoclasts, leading to activation
  • In intestinal cells, 1,25(OH)2D binds VDR‐RXR, leading to increased calcium channel TRPV6 and calcium‐binding protein calbindin 9K60 mg2/dl2; between 42 and 52 mg2/dl2 is desirable in the ESRD population 60 mg2/dl2; between 42 and 52 mg2/dl2 is desirable in the ESRD population

Deficiency



  • Poor diet (Vit D is fat soluble – found in oily fish, eggs, butter, liver, cod‐liver oil), insufficient sun (need UVB to convert 7‐dehydrocholesterol to previtamin D3, which is quickly turned into vitamin D3), anticonvulsants, fat malabsorption, old age, chronic kidney disease, breast feeding (human milk has low Vit D)
  • Requirements: controversial, ~800 IU/d of vitamin D3
  • Alopecia, rickets/osteomalacia, osteoporosis, cancer (colon, breast, prostate, and hematologic), autoimmune disease, muscle weakness

Hypervitaminosis D



  • Hypercalcemia, calcinosis, anorexia, headache, N/V

Vitamin K


Deficiency



  • Due to diet (fat‐soluble, meat, green leafy vegetables; GI flora produces 50% of requirements), anorexia, CF, liver dz, malabsorption, coumadin, cephalosporins, salicylates, cholestyramine
  • Hemorrhage

Zinc deficiency



  • Due to AR genetic defect, diet (low zinc, excess fiber), malabsorption, CRF, alcoholism, TPN, cancer
  • Typically when wean breastfeeding but zinc in human breastmilk does have lower bioavailability than cowmilk and may sometimes be low; premature infants have reduced zinc stores, poor GI absorbance, and higher zinc needs
  • Acrodermatitis enteropathica (acral, periorificial, periungual, and cheilitis), diarrhea, alopecia, candida/staph superinfection, paronychia, irritable, photophobia, blepharitis, and failure to thrive
  • Resembles biotin deficiency, essential fatty acid deficiency, CF, Crohn, necrolytic migratory erythema
  • Low alkaline phosphatase
  • Histo: epidermal pallor ± psoriasiform hyperplasia, necrosis, subcorneal/intraepidermal vesicle (similar to necrolytic migratory erythema, necrolytic acral erythema, genetic deficiency of M subunit of LDH)
  • Zinc‐responsive diseases: necrolytic acral erythema, amicrobial pustulosis of the flexures and scalp

Biotin deficiency



  • Due to short gut (gut bacteria make biotin), malabsorption, avidin (raw egg white) consumption, biotinidase deficiency (infantile), multiple carboxylase synthetase, or holocarboxylase synthetase defects (neonatal)
  • Rash‐like zinc deficiency, alopecia, conjunctivitis, fatigue, and paresthesias

Essential fatty acid deficiency



  • Due to GI abnormalities/surgery, diet, chronic TPN
  • Rash resembling biotin and zinc deficiencies, alopecia, leathery skin, intertrigo
  • Eicosatrienoic acid: Arachidonic acid ratio > 4

Copper



  • Deficiency in Menkes, Wilson
  • Local, exogenous excess – green hair (copper in water)

Selenium deficiency



  • Component of glutathione peroxidase
  • Due to TPN, low soil content
  • Weakness, cardiomyopathy, elevated transaminases and CK, hypopigmentation (skin/hair), leukonychia

Lycopenemia



  • Excess consumption of red fruits/vegetables (tomatoes, papaya) → reddish skin

Carotenemia



  • Carotene‐containing foods: carrots, squash, oranges, spinach, corn, beans, eggs, butter, pumpkins, papaya, and baby foods
  • Yellow soles/palms, central face (sebaceous area)

Kwashiorkor



  • Protein deficiency
  • Due to diet, GI surgery, and HIV
  • Dyschromia, pallor, flaky paint desquamation, sparse, hypopigmented hair, flag sign, potbelly, edema, moon facies, cheilitis, soft nails, irritable, infections

Marasmus



  • Protein and caloric deficiency
  • Due to diet, neglect, anorexia, malabsorption, HIV, and liver/kidney failure
  • Xerotic, lax, thin skin, follicular hyperkeratosis, broken lanugo‐like hair, monkey/aged facies, and no edema/hypoproteinemia

PEDIATRIC AND PREGNANCY DERMATOLOGY


Vascular tumors and malformation




































Vascular tumor Vascular malformation

Infantile hemangioma Congenital hemangioma Kaposiform hemangioentothelioma; tufted angioma Arterial/capillary/venous/
lymphatic combined lesions (see below)
Presentation 10–15 d after birth
30% present as red macul
Commonly large at birth At birth or few days after birth Present at birth
Growth Rapid growth till 6 mo then slow growth till 1 yr of age
Superficial, deep, or mixed
No growth Slow growth during childhood, can be locally aggressive Growth proportional to child’s growth
Involution Slow, spontaneous involution
30% by age 3, 50% by age 5, 70% by age 7, 90% by age 9
Rapidly involuting congenital hemangioma (RICH) – usually regress completely by age 2.
Non‐involuting congential hemangioma (NICH)‐ No involution
No involution No spontaneous regression
Histology GLUT‐1: positive GLUT‐1: negative GLUT‐1: negative; KMS: positive GLUT‐1: negative

Vascular malformation














Slow flow Fast flow Combined
Presentation Capillary (Port wine stain, salmon patch, nevus flammeus)
Venous
Lymphatic
Arterial
AV malformation (congenital)
AV fistula (acquired)
Capillary‐venous
Lymphatic‐venous
Capillary lymphatic venous
Capillary arterivenous
Capillary lymphaticarteriovenous

Infantile Hemangioma (IH) Management


(From Cheng CE, Friedlander, SF. Semin Cut Med Surg 2015;35: 108–116)


Diagnosis: made based on medical history and clinical features



  1. Proliferating phase (<one year of age)

    1. Asymptomatic, inconspicuous lesions – clinical observation
    2. Endangering/symptomatic (ulceration, bleeding, rapid growth, functional impairment) or disfigurement

      1. Propanolol – First line treatment (see Section “Propranolol treatment for infantile hemangioma”)
      2. Corticosteroid – Second line treatment, for patients with complicated IH who do not respond to propranolol
      3. Topical therapy

        1. Timolol 0.5% gel forming (ophthalmic) solution BID – can be used for small, superficial IH. Potential for systemic absorption (higher risk in premies on scalp)
        2. Intralesional corticosteroid – potential systemic aborption and skin atrophy
        3. Intralesional propranolol – lack of efficacy

      4. PDL– for superficial lesions
      5. Surgical excision – for pedunculated IH

    3. Multifocal (>5–10)

      1. Consider liver US
      2. If + intrahepatic hemangioma – consider TSH for hypothyroidism and ECHO for high output cardiac failure if large
      3. Propranolol can work in hepatic hemangiomas – esp. in multifocal disease (Verasso et al. Hepatology 2017, Jan)

    4. Special location and situations

      1. Large subcutaneous lesions – may need ECHO due to risk of high‐output cardiac failture
      2. Segmental hemangioma/extensive hemangioma of the face/neck – risk of PHACE(S)

























        P Posterior fossa malformation Dandy–Walker, cerebellar hypoplasia/dysplasia
        H Hemangioma Facial or neck hemangioma >5 cm
        A Arteriral anomalies Dysplasia or hypoplasia of the large cerebral arteries
        C Cardiac defects Coarctation of the aorta, cardiac defects
        E Eye abnormalities Optic nerve hypoplasia, posterior segment abnormalities
        S Sternal clefting and supraumbilical raphe Sternal defect/cleft. Supraumbilical raphe

        Need MRI head and neck (including aortic arch) and ECHO prior to starting propranolol


      3. Periocular IH – risk of compromising vision, needs eye exam
      4. Beard/airway IH – can lead to airway obstruction
      5. Intertrigious areas (neck, axillary, and diaper area) – risk of ulceration.
      6. Lumbosacral IH – can be associated with tethered cord, spinal defects, GU anomalies, and anorectal malformations. Look for asymmetric gluteal crease, tufts of hair, sacral pits, and masses. Needs MRI of spine.
      7. Ulcerated IH

        1. Ddx: hemangioma, HSV, and perineal groove (self‐resolving)
        2. First line: local wound care: topical antibiotics (topical metronidazole gel + mupirocin), barrier creams, nonstick dressings, oral propranolol.
        3. Second line: becaplermin, pulsed dye laser
        4. Analgesia: oral acetaminophen or topical lidocaine 2–5% (risk for systemic absorption)

  2. Involuting phase (12–18 months of age)

    1. Asymptomatic, involuting lesions – clinical observation
    2. Symptomatic or large lesions – may consider treatment with propranolol to shrink lesion

  3. Involuted phase (>three years of age)

    1. Risk of scarring (Baselga E et al. JAMA Derm 2016;152(11):1239–1243)

      1. Mixed > superficial > deep
      2. Sharp step off border
      3. Cobblestone > smooth

    2. Atrophic scar – fractionated or ablative erb:yag or CO2 laser
    3. Residual redness – pulsed dye laser
    4. Redundant or fibrofatty skin – surgical excision
    5. May still consider propranolol in older patients

Propranolol Treatment for Infantile Hemangioma


(From Hoeger PH, Harper JI, Baselga E. et al. Eur J Pediatr 2015;174: 855.)



  • Propanolol has been used since 1964 at doses up to 6–8 mg/kg/d in infants and children for treatment of hypertension.
  • First report of propranolol in treatment of hemangioma in 2008
  • FDA approved for treatment of proliferating IH
  • Response rate of oral propranolol at 2–3 mg/kg/d × 6 mo = 96–98%
  • More efficacious and safer than steroid
Mar 13, 2021 | Posted by in Dermatology | Comments Off on 1: General Dermatology

Full access? Get Clinical Tree

Get Clinical Tree app for offline access